6 0 2 T I C s c i t Final Program u e p a r e h T l a n o i t n e v r e t n …1).pdf · 2017. 5. 2. · Xiaocheng Liu, MD Yili Liu, MD Yuqing Liu, MD Zaiying Lu, MD Fanchao Meng,

Final Program

Fina

l Pro

gram

C

hina

Inte

rven

tiona

l The

rape

utic

s (C

IT) 2

006

Table of Contents

Welcome Message

CIT2006 Organization

Registration

General Information

Social Events

Scientific Information

Program at a Glance

Detailed Program

Thursday, April 6, 2006

Friday, April 7, 2006

Saturday, April 8, 2006

Sunday, April 9, 2006

Live Case Centers

CIT TV Program

大会欢迎辞

大会组织结构

会议信息

会议日程一览表

会议详细日程

2006年4月6日星期四

2006年4月7日星期五

2006年4月8日星期六

2006年4月9日星期日

示教演示中心

Exhibitors List 参展单位

Exhibit Floorplan 展位图

Product Listing 参展单位简介

CIT TV 电视节目单

Acknowledgement

Sponsored Services

1

5

6

12

12

13

13

14

15

15

17

22

38

44

46

49

50

53

54

55

55

57

62

73

78

79

80

83

100

102

104

Mai

n En

tran

ce

ESCALA

TOR

Hall 2

Amphith

eater

Exhi

bitio

n Hall

2

2号展览厅

Res

taur

ant

LIFT

Busine

ss C

enter

LIFT

LOB

BY

5-1

5-2

5-3

Lunc

heon

Wor

ksho

ps

5-4

5-5

5-6

Bei

jing

Inte

rnat

iona

l Con

vent

ion

Cen

ter

Leve

l 1

北京国际会议中心

一层

Bei

jing

Inte

rnat

iona

l Con

vent

ion

Cen

ter

Le

vel

2


二层

LIFT

HA

LL 1

Stag

e

HA

LL 1

7

AM

edtro

nic

B Cordis

Y2002Pr

ess R

oom

媒体采访间

Rm A/B

/C/D

: Sim

ulatio

n Pro

gram

CB

.Bra

un

D Teru

mo

HA

LL 2

A

mph

ithe

ater

HA

LL 6

- 8

Slid

es P

revi

ew&

Sec

reta

riat

幻灯

片提

交处

及大

会秘

书处

LIFT

Hal

l 5

Facu

lty R

oom

Main Entrance

Cchea

rt

Biotro

nik

Cyber

Stat

ion

��

2016

To C

onti

nent

al G

rand

Hot

el BIC

C SERVIC

E DES

K

ESCALA

TOR

ESCALA

TOR

ESCALA

TOR To

Hall 5-

1--5

-6

Bei

jing

Inte

rnat

iona

l Con

vent

ion

Cen

ter

Leve

l 3


三层

LIFT

Hal

l 10

- 12

LIFT

Hal

l 3

Hal

l 16

C

Hal

l 16

B

Hal

l 16

A

Welcome Message

Dear colleagues and friends,

On behalf of the Organizing Committee of the CIT and Chinese Society of Cardiology, I would like to

welcome you all to the China Interventional Therapeutics (CIT) 2006 in conjunction with TCT at CIT

and EuroPCR at CIT to be held on April 6-9, 2006 in Beijing, China.

The CIT is sponsored by Chinese Society of Cardiology, Chinese Medical Association, and Board of

Directors, China Interventional Therapeutics, and co-sponsored by Cardiovascular Research Foundation

– TCT and Europa Organization - EuroPCR, Division of Medicine and Health Engineering, Chinese

Academy of Engineering, Kamakura Live Demonstration Organizing Committee, Japan, Hong Kong

College of Cardiology, Asian-Pacific Society of Interventional Cardiology, Chinese Medical Journal,

Chinese Journal of Cardiology, New York-Presbyterian Hospital / Columbia University Medical Center,

New York, USA, Clinique Pasteur, Toulouse, France, Scripps Memorial Hospital, La Jolla, USA, Queen

Elizabeth Hospital, Hong Kong, China, Guangdong Province Cardiovascular Institute, China, Shenyang

Northern Hospital, China, Beijing An Zhen Hospital, China, Peking University First Hospital, China,

Beijing Friendship Hospital, China, Shanghai Ruijin Hospital, China, and Cardiovascular Institute and

Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China.

TCT and EuroPCR will organize programs in conjunction with CIT. TCT at CIT will be in the morning

and EuroPCR at CIT in the afternoon of April 7, 2006. The Co-directors of TCT and EuroPCR will chair

the meetings; deliver important keynote lectures and moderate the live case transmissions from

Columbia University Medical Center, New York, USA and Clinique Pasteur, Toulouse, France, respectively.

Started in the year 2003, this annual meeting has become the largest scale interventional cardiology

meeting and one of the most educational teaching course in China, including live demonstration,

invited lecture, case review and discussion, workshop, symposium, simulation and abstract oral

presentation, etc. The topics of the meeting will cover the latest advances and techniques in coronary

intervention, peripheral intervention, congenital heart disease, valvular heart disease and cardiac

rhythm, etc.

We are expecting more than 2500 experts, cardiologists, radiologists, vascular medicine specialists,

industrial partners and other health care professionals with a special interest in the field of interventional

cardiology to attend the Congress. Participants will have the opportunity to share scientific information

and the latest advances, to exchange expertise in the field of interventional cardiology, to renew our

friendship and increase worldwide collaboration. The congress will also provide a unique opportunity

for companies to exhibit their new products and to contact with the cardiologists more closely.

Beijing is a highly civilized and ancient city rich in historical sites and full of cultural events. The city is

also an international metropolis with modern and efficient tourist systems. I hope all the delegates will

not only have a successful and productive congress, but also have a good time to enjoy the traditional

Chinese hospitality, and to enhance the international partnership.

Welcome to Beijing.

Gao Runlin, MD, FACC

Professor of Medicine

Course Director, China Interventional Therapeutics

President, Chinese Society of Cardiology

5

Course Director

Runlin Gao, MD

CIT2006 Organization

Jingxuan Guo, MD

Bingxian He, MD

Meixian He, MD

Shengshou Hu, MD

Tigang Huang, MD

Yonglin Huang, MD

Wenping Jiang, MD

Hongyi Jin, MD

Ruoyi Ke, MD

Yuannan, Ke, MD

Gengshan Li, MD

Huatai Li, MD

Shuguang Lin, MD

Guozhang Liu, MD

Lisheng Liu, MD

Wanche Liu, MD

Xiaocheng Liu, MD

Yili Liu, MD

Yuqing Liu, MD

Zaiying Lu, MD

Fanchao Meng, MD

Wenhang Qi, MD

Xuexian Qian, MD

Yijian Qian, MD

Jianhua Shao, MD

Luhua Shen, MD

Ruilong Sun, MD

Binyao Wang, MD

Jie Wang, MD

Shiwen Wang, MD

Ning Wu, MD

Yinsheng Wu, MD

Zhaosu Wu, MD

Xifu Yan, MD

Dingyin Zeng, MD

Yun Zhang, MD

Junren Zhu, MD

Shanjun Zhu, MD

Wenling Zhu, MD

Honorary Chairmen of Organizing Committee

Advisory Committee (sorted in alphabetic order of family names)

Haozhu Chen, MD

Mingzhe Chen, MD

Shulan Chen, MD

Xin Chen, MD

Zaijia Chen, MD

Changcong Cui, MD

Guizhu Dai, MD

Yuhua Dai, MD

Riying Du, MD

Qi Fang, MD

Jianzhang Feng, MD

Lansheng Gong, MD

Fusheng Gu, MD

Mingjiang Wu, MD Kai Zhao, MD Shengshou Hu, MD Yasuhiko Wanibuchi, MD Shuguang Lin, MD

Course Co-Directors (sorted in alphabetic order of family names)

Chu Pak Lau, MD Jean Marco, MD Gregg W. Stone, MD

Martin B. Leon, MD Shigeru Saito, MD Robaayah Zambahari, MD

Yean Leng Lim, MD, PhD Patrick W. Serruys, MD, PhD

Chinese Co-Directors (sorted in alphabetic order of family names)

Jilin Chen, MD

Jiyan Chen, MD

Ruping Dai, MD

Junbo Ge, MD

Yaling Han, MD

Dayi Hu, MD

Dejia Huang, MD

Yong Huo, MD

Guoliang Jia, MD

Shuzheng Lu, MD

Weifeng Shen, MD

Fangzheng Wang, MD

Yuejin Yang, MD

Shu Zhang, MD

Guoying Zhu, MD

6

Wenyi Guo, MD

Eberhard Grube, MD

David Holmes, Jr, MD

Congxin Huang, MD

Sanqing Jia, MD

Shiliang Jiang, MD

Osamu Katoh, MD

Ferdinand Kiemeneij, MD, PhD

Spencer B. King III, MD

Tian Hai Koh, MD

Mitchell W. Krucoff, MD

Jianjun Li, MD

Weimin Li, MD

Zhanquan Li, MD

Changsheng Ma, MD

Jieming Mao, MD

Gary S. Mintz, MD

Kuzuaki Mitsudo, MD

Marie-Claude Morice, MD

Jeffrey W. Moses, MD

Franz-Josef Neumann, MD

Thach Nguyen, MD

Shubin Qiao, MD

Xuewen Qin, MD

Ulrich Sigwart, MD

Harry Suryapranata, MD

Huay Cheem Tan, MD

Renu Virmani, MD

Jian'an, Wang, MD

Haichang Wang, MD

Lefeng Wang, MD

Weimin Wang, MD

Shulin Wu, MD

Xinchun Yang, MD

Yanzong Yang, MD

Min Yao, MD

Yaron Almagor, MD

Giancarlo Biamino, MD

Maurice Buchbinder, MD

Kejiang Cao, MD

Junzhu Chen, MD

Chung Seung Chiang, MD

Antonio Colombo, MD

Zhimin Du, MD

Eric Eeckhout, MD, PhD

Weiyi Fang, MD

Richard Fortuna, MD

Luyue Gai, MD

Wei Gao, MD

Shaoping Nie, MD

Shaoliang Chen, MD

Guangping Li, MD

Xinming Li, MD

Lang Li, MD

Xinming Li, MD

Haibo Liu, MD

Yin Liu, MD

Jianfang Luo, MD

Quan Fang, MD

Suyun Ma

Youfang Ni, MD

Juying Qian, MD

Lei Wang, MD

Yongjian Wu, MD

Bo Xu, MD

Guanglie Yan, MD

Lei Ge, MD

Hongbing Yan, MD

Ruiyan Zhang, MD

Shuyang Zhang, MD

Yujie Zhou, MD

Yundai Chen, MD

Ben He, MD

Wei Hua, MD

Hung Kwong Duncan Ho, MD

Tao Hong, MD

Zhenwen Huang, MD

Yongmao Jiang, MD

Quanmin Jing, MD

Scientific Committee (sorted in alphabetic order of family names)

Organizing Committee (sorted in alphabetic order of family names)

CIT2006 Organization(continued)

7

Invited Faculty

International

(sorted in alphabetic order of family names)

Rajiv Agarwal, MD IndiaYaron Almagor, MD IsraelDibya Kumar Baruah, MD IndiaGiancarlo Biamino, MD GermanyMaurice Buchbinder, MD USAWacin Buddhari, MD ThailandKenneth Chin, MD MalaysiaAntonio Colombo, MD ItalyCostantino Costantini, MD ArgentinaTino Costantini, MD ArgentinaLuis De la Fuente, MD ArgentinaDevang Desai, MD IndiaGerard Devlin, MD New ZealandEric Eeckhout, MD, PhD SwitzerlandJean Fajadet, MD FrancePeter Fitzgerald, MD, PhD USARichard Fortuna, MD USAEberhard Grube, MD GermanyMartial Hamon, MD FranceTetsuya Hata, MD JapanTan Kim Heung, MD MalaysiaDavid Holmes, Jr, MD USAJunko Honye, MD JapanLuigi Inglese, MD Italy

Mohammad Ishaq, MD PakistanRaul D. Jara, MD PhilippinesNigel Jepson, MD AustraliaYoshifumi Kan, MD JapanHo-nin Kanaya, MD JapanHideaki Kaneda, MD JapanOsamu Katoh, MD JapanFerdinand Kiemeneij, MD, PhD The NetherlandsSpencer B. King III, MD USATian Hai Koh, MD SingaporeMitchell W. Krucoff, MD USATak W. Kwan, MD USAKai Huat Lam, MD MalaysiaMartin B. Leon, MD USAMichael Lim, MD SingaporeRichard Lim, MD AustraliaYean Leng Lim, MD, PhD AustraliaYean Teng Lim, MD SingaporeHenry K. Lui, MD USASidney Tsz Ho Lo, MD AustraliaSimon Lo, MD MalaysiaHugo F. Londero, MD ArgentinaJean Marco, MD FranceMotomaru Masutani, MD JapanSamuel K. Mathew, MD India

Peter A. McCullough, MD USAIchiro Michishita, MD JapanGary S. Mintz, MD USAKazuaki Mitsudo, MD JapanMarie-Claude Morice, MD FranceJeffery W. Moses, MD USACol Mujeeb-Ul-Haq, MD PakistanToshiya Muramatsu, MD JapanFranz-Josef Neumann, MD GermanyRichard Ng, MD SingaporeSwee Choon Ng, MD MalaysiaThach Nguyen, MDUSASeong-Wook Park, MD KoreaTejas M. Patel, MD IndiaGia Khai Pham, MDVietnamManh Hung Pham, MD VietnamJenny Zhen Qin, MS, RN, CCRC USASufia Rahman, MD BangladeshWitold Ruzyllo, MD PolandShigerou Saito, MD JapanHideaki Sakai, MD JapanRamesh S. Saligrama, MD IndiaAlberto Sampaolesi, MD ArgentinaTeguh Santoso, MD IndonesiaIvan K. De Scheerder Belgium

Hubert Seggewiss, MD GermanyPatrick W. Serruys, MD, PhD The NetherlandsAshok Seth, MD IndiaG. L. Sharma, MD IndiaEak-Kyun Shin, MD KoreaUlrich Sigwart, MD SwitzerlandKui-Hian Sim, MD MalaysiaPieter R. Stella, MD The NetherlandsGregg W. Stone, MD USAHarry Suryapranata, MD The NetherlandsRurus Suryawan, MD IndonesiaAkihiko Takahashi, MD JapanHuay Cheem Tan, MD SingaporeShinji Tanaka, MD JapanShin-ichi Tohyama, MD JapanShailendra Trivedi, MD IndiaWasan Udayachalerm, MD ThailandGeorge W. Vetrovec, MD USASalvador Villablanca, MD ChileRenu Virmani, MD USAMarco Wainstein, MD, PhD BrazilJie Wang, MD, PhD USAMalcolm West, MD AustraliaShing-Chiu Wong, MD USARobaayah Zambahari, MD Malaysia

8

Invited Faculty(continued)

China

(sorted in alphabetic order of family names)Bao Wuye, MD BeijingCai Shanglang, MD ShandongCai Yunchang, MD GuizhouCao Kejiang, MD JiangsuChan Kam-Tim, MD Hong KongChen Fang, MD BeijingChen Jilin, MD BeijingChen Jiyan, MD GuangdongChen Junzhu, MD ZhejiangChen Keping, MD BeijingChen Lianglong, MD FujianChen Minglong, MD JiangsuChen Shaoliang, MD JiangsuChen Yundai, MD BeijingCheng Xiaoshu, MD JiangxiCheng Boron CW, MD Hong KongChiang Chung-Seung, MD Hong KongCui Lianqun, MD ShandongDai Jun, MD BeijingDai Ruping, MD BeijingDang Qun, MD TianjinDeng Hua, MD BeijingDing Yansheng, MD BeijingDong Jianzeng, MD Beijing

Du Xiuhai, MD GansuDu Zhimin, MD GuangdongFan Zhongjie, MD BeijingFang Quan, MD BeijingFang Weiyi, MD ShanghaiFeng Yanguang, MD HebeiFu Guosheng, MD ZhejiangFu Xianghua, MD HebeiFu Xiangyang, MD GuangdongGai Luyue, MD BeijingGao Runlin, MD BeijingGao Runzhi, MD HebeiGao Wei, MD BeijingGe Junbo, MD ShanghaiGe Lei, MD ShanghaiGuan Jun, MD ShandongGuan Zhenzhong, MD HeilongjiangGuo Jihong, MD BeijingGuo Lijun, MD BeijingGuo Tao, MD YunnanGuo Wenyi, MD ShanxiGuo Xingui, MD ShandongHan Lixian, MD HebeiHan Yaling, MD LiaoningHe Ben, MD Shanghai

He Guoxiang, MD ChongqingHe Qing, MD BeijingHo Hung Kwong Duncan, MD Hong KongHo Kau-Chung Charles, MD Hong KongHong Tao, MD BeijingHu Dayi, MD BeijingHua Wei, MD BeijingHuang Chaolian, MD BeijingHuang Congxin, MD HubeiHuang Dejia, MD SichuanHuang Jun, MD JiangsuHuang Lan, MD ChongqingHuang Lianjun, MD BeijingHuang Weijian, MD ZhejiangHuang Zhenwen, MD HenanHuang Zuo, MD ShanghaiHui Yongming, MD BeijingHuo Yong, MD BeijingJia Dalin, MD LiaoningJia Guoliang, MD ShaanxiJia Sanqing, MD BeijingJia Shaobin, MD NingxiaJiang Baoqi, MD BeijingJiang Hong, MD Hubei

Jiang Jinfa, MD ShanghaiJiang Shiliang, MD BeijingJiang Shisen, MD JiangsuJiang Tiemin, MD TianjinJiang Weijian, MD BeijingJiang Xiongjing, MD BeijingJiang Yongmao, MD BeijingJiang Yuru, MD HebeiJin Huigen, MD ShanghaiJin Lijun, MD GuangdongJin Yuanzhe, MD LiaoningJin Zhengyu, MD BeijingJing Quanmin, MD LiaoningKao Paul Hsien-Li, MD TaipeiKo Tak-Him Patrick, MD Hong KongLau Chu Pak, MD Hong KongLee Kang-Yin Michael, MD Hong KongLeung Sum-Kin, MD Hong KongLi Bao, MD ShanxiLi Chuan, MD ShandongLi Guangping, MD TianjinLi Guoqing, MD XinjiangLi Jianjun, MD BeijingLi Jifu, MD ShandongLi Kang, MD Beijing

9


Li Lang, MD GuangxiLi Shu-Kin, MD Hong KongLi Shumei, MD JilinLi Tianchang, MD BeijingLi Weimin, MD HeilongjiangLi Xinming, MD HainanLi Xueqi, MD HeilongjiangLi Zhanquan, MD LiaoningLing Feng, MD BeijingLiu Chaozhong, MD BeijingLiu Guoshu, MD BeijingLiu Haibo, MD BeijingLiu Huiliang, MD BeijingLiu Jian, MD BeijingLiu Jianping, MD ShaanxiLiu Kunshen, MD HebeiLiu Meilin, MDBeijingLiu Shaowen, MD ShanghaiLiu Tangwei, MD GuangxiLiu Tongku, MD JilinLiu Xiaofang, MD NingxiaLiu Xu, MD ShanghaiLiu Yajun, MD BeijingLiu Yin, MD QinghaiLiu Yin, MD Tianjin

Liu Youwen, MD GuangdongLu Baojing, MD ShanghaiLu Caiyi, MD BeijingLu Jiyuan, MD ShanxiLu Shuzheng, MD BeijingLuo Jianfang, MD GuangdongLuo Kailiang, MD ChongqingMa Changsheng, MD BeijingMa Genshan, MD JiangsuMa Hong, MD GuangdongMa Jian, MD BeijingMa Likun, MD AnhuiMa Maoru, MD XinjiangMa Suyun, MD BeijingMa Yexin, MD HubeiMa Yitong, MD XinjiangMao Jieming, MD BeijingMeng Qingheng, MD HenanMiao Zhilin, MD LiaoningNi Youfang, MD ShanghaiNie Shaoping, MD BeijingOuyang Feifan, MD Pu Jielin, MD BeijingQi Guoxian, MD LiaoningQi Xiangqian, MD Tianjin

Qi Xiaoyong, MD HebeiQian Jie, MD BeijingQian Juying, MD ShanghaiQiao Shubin, MD BeijingQin Qin, MD TianjinQin Xuewen, MD BeijingQin Yongwen, MD ShanghaiQu Peng, MD LiaoningRen Ziwen, MD BeijingShang Lihua, MD BeijingShang Xiaoming, MD HebeiShen Farong, MD ZhejiangShen Weifeng, MD ShanghaiShen Zhujun, MD BeijingShi Haiming, MD ShanghaiSong Xiantao, MD BeijingSu Xi, MD HubeiSun Baogui, MD ShanghaiSun Fucheng, MD BeijingSun Yingxian, MD LiaoningTang Lijiang, MD ZhejiangTian Jun, MD ShandongTse Tak-Fu, MD Hong KongWan Zheng, MD TianjinWang De, MD Beijing

Wang Dongqi, MDShaanxiWang Fangzheng, MD BeijingWang Feng, MD JiangxiWang Fengzhi, MD ShanxiWang Guangyi, MD BeijingWang Haichang, MD ShaanxiWang Jian'an, MD ZhejiangWang Lefeng, MD BeijingWang Lei, MD BeijingWang Lianqin, MDHebeiWang Mingsheng, MD BeijingWang Ningfu, MD ZhejiangWang Qibing, MD ShanghaiWang Qingsheng, MD ShandongWang Shih-Pu, MD TaipeiWang Shouli, MD LiaoningWang Weimin, MD BeijingWang Yan, MD FujianWang Yong, MD BeijingWang Yu, MD BeijingWang Yutang, MD BeijingWang Zulu, MD LiaoningWei Meng, MD ShanghaiWen Qinzhu, MD ShanghaiWen Shangyu, MD Heilongjiang

10


Yang Jiefu, MD BeijingYang Shusen, MD HeilongjiangYang Tianlun, MD HunanYang Tingshu, MD BeijingYang Xinchun, MD BeijingYang Yanzong, MD LiaoningYang Yuejin, MD BeijingYang Zhijian, MD JiangsuYao Min, MD BeijingYao Yan, MD BeijingYi Weimin, MD GuangdongYin Rongxiu, MD BeijingYip Hon-kan, MD TaipeiYou Shijie, MD BeijingYu Bo, MD HeilongjiangYuan Hong, MD HunanYuan Jinqing, MD BeijingYuan Zuyi, MD ShaanxiZhang Dadong, MD ShanghaiZhang Daifu, MD ShanghaiZhang Jiansheng, MD ShanghaiZhang Kuijun, MD BeijingZhang Ronglin, MD Jiangsu

Wong Philip, MD Hong KongWu Chee Wo, MD Hong KongWu Chiung-Jen, MD Taipei Wu Jianguo, MD BeijingWu Liqun, MD ShanghaiWu Qiming, MD BeijingWu Shulin, MD GuangdongWu Xuesi, MD BeijingWu Yongjian, MD BeijingWu Zhongxue, MD BeijingWu Zonggui, MD ShanghaiXu Biao, MD JiangsuXu Bo, MD BeijingXu Feng, MD BeijingXu Jing, MD TianjinXu Lishu, MD XinjiangXu Yawei, MD ShanghaiXu Zesheng, MD HebeiXu Zhongying, MD BeijingYan Guanglie, MD FujianYan Hongbing, MD BeijingYan Ji, MD AnhuiYan Xiaowei, MD Beijing

Zhang Ruiyan, MD ShanghaiZhang Ruiyun, MD YunnanZhang Shu, MD BeijingZhang Shulin, MD BeijingZhang Shuyang, MD BeijingZhang Xinghua, MD ShandongZhang Zheng, MD GansuZhang Zhiwei, MD GuangdongZhao Bingrang, MD TianjinZhao Linyang, MD JilinZhao Shihua, MD BeijingZhao Xingsheng, MD NeimengguZheng Hong, MD BeijingZheng Qiangsun, MD ShaanxiZhou Aiqing, MD ShanghaiZhou Jianqing, MD ZhejiangZhou Lijun, MD HeilongjiangZhou Shenghua, MD HunanZhou Xuchen, MD LiaoningZhou Yingling, MD GuangdongZhou Yujie, MD BeijingZhou Zan, MD BeijingZhu Guoying, MD Hubei

Zhu Jianhua, MDZhejiangZhu Liguang, MD GuangdongZhu Xianyang, MD LiaoningZou Yinghua, MD Beijing

Secretariat

Tian Meng

Huang Li

Chen Kai

Li Dan

Chen Chen

11

1. Registration Office and Opening HoursLobby, Level 1, Beijing International Convention CenterTel: +86 (10) 8497 9756 / 8497 9759 / 8497 9762

Opening Hours:

2. On-Site Registration Fees (in US dollars)

Delegate 450 Fellow 350 Accompanying Person 250

from English to Chinese will be provided for invited lectures in Hall 1，Hall 2 and Hall 17 during the Congress.

Banks and Currency Major credit cards like Master, American Express and Visa are acceptable in most big shopping centers and hotels. Major foreign currencies can be changed to the Chinese currency RMB at the airport, Bank of China or hotels.

Business Center There is a business center on the level 1 of the BICC that provides services such as copying, fax transmittal and receiving and general office supplies.

Cyber Station There is a congress cyber station located at lobby, level 2 of the BICC that provides access to internet.

Coffee Break Coffee, tea and snacks will be provided at 10:00-10:45 and 15:00-15:45 from April 7-9, 2006 in the BICC.

Meals All luncheon industrial satellite symposia provide meals for participants. Please use the lunch coupons in your registration envelop for admission.

Exhibition Exhibition Hall 2, Level 1, BICCExhibit Hours: 09:00-17:00 April 7-8, 2006 09:00-15:00 April 9, 2006

Accommodation For any enquires about hotel rooms, please go to Registration Desk for information (see Opening Hours at Registration).

Post-Congress Inquiry CIT2006 International Department Chinese Medical Association 42 Dongsi Xidajie, Beijing 100710, China Tel: +86 10 8515 8141 Fax: +86 10 6512 3754 Email: [email protected]

General Information

3. Registration Entitlements

Delegate Fellow Accompanying PersonScientific Sessions * * Abstracts Book & Program Book * * Exhibition * * *Congress Bag * * Certificate of Attendance * * Sponsored Symposia * * *FCT-1 *

Registration

Registration

April 6, 2006 08:00-18:00 April 7, 2006 07:30-17:30 April 8, 2006 08:00-17:30 April 9, 2006 08:00-12:00

Dates: April 6-9, 2006

Venue: Beijing International Convention Center (BICC)� 北京国际会议中心 8 Beichendonglu Rd, Beijing 100101, China Tel: +86 10 8497 3060

Language English is the official language. Simultaneous interpretation

General Information

4. Delegates IdentificationPlease wear your Congress badge for all Congress activities.

White: DelegateBlue: ExhibitorRed: Staff

12

Scientific Information

To All Chairs and SpeakersPlease refer to relevant parts in this section for information on Speaker Ready Room and AV equipment.

Speaker Ready Room (Slides and MS PowerPoint Preview)Room 2016, Level 2, BICCTel: +86(10) 8497 9783

Open: 08:00-18:00 April 6, 2006 Thursday07:30-18:00 April 7-9, 2006 Friday - SundayPlease hand in your slides to the staff in the Speaker Ready Room at least half day before your presentation. After your session ends, please go to the Speaker Ready Room to get your slides back.

If your slides are in MS PowerPoint format (disk), please hand it in at least one day before your presentation (except for those invited speakers who have already submitted their PowerPoint slides beforehand).

AV EquipmentTwo LCD projectors will be available in the meeting room.

Requirements for use of other AV equipment such as slide projectors, overhead projectors and VCRs and TV sets should be registered at the Speaker Ready Room at least one day before presentation.

Social Events

1. Opening Ceremony 1) Place: Hall # 1, Level 2, BICC 2) Time: 07:30-08:00, Friday, April 7, 20063) Admission: All registered participants are invited to participate in the event.

2. Peking Opera with Peking Roast Duck Dinner1) Time: 1800-2030, Friday, April 7, 2006 2) Shuttle bus: Please board the buses in front of the BICC from 17:45-18:003) Admission: US$40/pax (more than 10 people), US$50/pax (6-9 people)4) Attire: Informal

3. Acrobatics1) Time: 18:30-20:00, Saturday, April 8 20062) Shuttle bus: Please board the buses in front of the BICC from 18:15-18:303) Admission: US$30/pax (more than 10 people), US$35/pax (6-9 people)4) Attire: Informal

4. Night of Beijing Show 1) Time: 18:00-20:30, Sunday, April 9 20052) Shuttle bus: Please board the buses in front of the BICC from 17:45-18:003) Admission: US$50/pax (more than 10 people), US$55/pax (6-9 people)4) Attire: Informal Please purchase the ticket of social event 2, 3 & 4 at the Tour Desk and show it when boarding the bus. If you have booked the tickets before arrival, you need to go to the Tour Desk and exchange for tickets with the coupon in your registration package.

Scientific InformationSocial Events

13

Program at a Glance

07:3

0-08

:00

08:0

0-08

:30

08:3

0-09

:00

09:0

0-09

:30

09:3

0-10

:00

10:0

0-10

:30

10:3

0-11

:00

11:0

0-11

:30

11:3

0-12

:00

12:0

0-12

:30

12:3

0-13

:00

13:0

0-13

:30

13:3

0-14

:00

14:0

0-14

:30

14:3

0-15

:00

15:0

0-15

:30

15:3

0-16

:00

16:0

0-16

:30

16:3

0-17

:00

17:0

0-17

:30

17:3

0-18

:00

18:0

0-18

:30

18:3

0-19

:00

19:0

0-19

:30

Thur

sday

, A

pril

6,20

06

Frid

ay,

Apr

il 7,

2006

Satu

rday

,A

pril

8,20

06

Sund

ay,

Apr

il 9,

2006

Hal

l # 1

Hal

l # 2

Hal

l # 17

Hal

l # 1

Hal

l # 2

Hal

l # 17

Hal

l　# A

BC

D

Hal

l # 1

Hal

l # 2

Hal

l # 17

Hal

l # 7, 8

,11,

12

Hal

l # A

BC

D

Hal

l # 1

Hal

l # 2

Hal

l # 17

Hal

l # 7, 8,

11, 1

2

Reg

istr

atio

n

Ope

n-in

g of

CIT

Live

Cas

e fr

om C

olum

bia

Uni

vers

ity M

edic

al C

ente

r,N

ew Y

ork

TCT

at C

ITIn

vite

dLe

ctur

e

Sim

ulat

ion

- V

irtu

al R

ealit

y D

evic

es

Live

Cas

e fr

om S

crip

psM

emor

ial H

ospi

tal,

LaJo

lla

Invi

ted

Lect

ure

Live

Cas

e fr

om F

u W

aiH

ospi

tal,

Bei

jing

Live

Cas

e fr

om F

u W

aiH

ospi

tal,

Bei

jing

Bas

ic C

ours

e on

PC

I

TRI C

lub

with

Liv

e C

ase

from

Fri

ends

hip

Hos

pita

l, B

eijin

g

Cha

lleng

ing

Cas

e R

evie

w -

Mee

t the

Exp

erts

1

Sim

ulat

ion

- V

irtu

al R

ealit

y D

evic

es

Live

Cas

e fr

om A

nzhe

nH

ospi

tal,

Bei

jing

Invi

ted

Lect

ure

Live

Cas

e fr

om A

nzhe

nH

ospi

tal,

Bei

jing

CTO

Clu

b w

ith S

peci

al L

ive

Cas

e fo

r C

hron

ic T

otal

Occ

lusi

onfr

om F

u W

ai H

ospi

tal,

Bei

jing

1st A

nnua

l Sym

posi

um fo

r N

urse

and

Tec

hnol

ogis

t

Cha

lleng

ing

Cas

e R

evie

w -

Mee

t the

Exp

erts

2

Lunc

heon

Wor

ksho

ps(H

all #

2, 5

-1,

5-2

, 5-3

,5-

4, 5

-5, 5

-6,

6, 7

, 8,

17)

Clin

ical

Fol

low

-up

ofC

IT20

05 L

ive

Cas

e

Live

Cas

e fr

omSh

enya

ng N

orth

ern

Hos

pita

l, Sh

enya

ngB

asic

Cou

rse

on P

CI

Live

Cas

e fr

om R

uijin

Hos

pita

l, Sh

angh

ai

Live

Cas

e fr

om Q

ueen

Eliz

abet

h H

ospi

tal,

Hon

g K

ong

Why

and

How

to U

seIV

US

Live

Cas

e fr

om F

u W

aiH

ospi

tal,

Bei

jing

Euro

PCR

at C

ITLi

ve C

ase

from

Clin

ique

Pas

teur

,To

ulou

se

Hea

rt R

hyth

mLi

ve C

ase

from

Fu

Wai

Hos

pita

l

Sim

ulat

ion

- V

irtu

al R

ealit

y D

evic

es

Live

Cas

e fr

omG

PCI,

Gua

ngzh

ou

Invi

ted

Lect

ure

Live

Cas

e fr

omPU

FH, B

eijin

gIn

vite

dLe

ctur

e

Live

Cas

e fr

omFu

Wai

Hos

pita

l,B

eijin

g

Invi

ted

Lect

ure

Bas

ic C

ours

eon

PC

I

Live

Cas

e fr

omG

PCI,

Gua

ngzh

ou

Bas

icC

ours

eon

PC

I

Live

Cas

e fr

omPU

FH, B

eijin

gB

asic

Cou

rse

on P

CI

Hot

Top

ics

from

Asi

an-P

acifi

c R

egio

n an

d La

tin-A

mer

ica

Abs

trac

t Ora

l Pre

sent

atio

n

Sim

ulat

ion

- V

irtu

al R

ealit

y D

evic

es

Invi

ted

Lect

ure

Inte

rven

tiona

lC

ardi

olog

ist

Mee

ts C

ardi

acSu

rgeo

n

Aw

ard,

Con

clus

ion

and

Clo

sing

Even

ing

Sate

llit

eSy

mp

osi

a(H

all

# 2

,17

)

14

Thursday, April 6, 2006

Hall #2

Clinical Follow-up of CIT2005 Live Case

Moderators Shubin Qiao, Yundai Chen

12:00-12:20 Live Case Follow-up from Fu Wai Hospital Haibo Liu

12:20-12:35 Live Case Follow-up from Shenyang Northern Hospital Shouli Wang

12:35-12:50 Live Case Follow-up from Queen Elizabeth Hospital Chung-Seung Chiang

12:50-13:05 Live Case Follow-up from Kamakura General Hospital Shinji Tanaka

13:05-13:20 Live Case Follow-up from An Zhen Hospital Xiantao Song

13:20-13:30 Discussion

13:30-15:00 Live Case Transmission from Shenyang Northern Hospital, Shenyang

Moderators Spencer B. King III, Jiyan Chen

Discussants Ramesh S. Saligrama Marco Wainstein Lei Wang Yong Wang Chee Wo Wu Feng Xu

Operators Eberhard Grube Philip Wong Yaling Han

Basic Course on PCI 1

Moderators Jieming Mao, Dingyin Zeng

15:00-15:16 Selection and Application of Conventional and New Type Guiding Catheter Yuejin Yang15:16-15:32 Improvement of Guidewire for PCI Jiyan Chen

15:32-15:48 Selection of Drug Eluting Stents Jilin Chen

15:48-16:04 Is There a Role for BMS in the Era of DES? Yong Huo

16:04-16:20 Nightmares in Catheterization Laboratory Guoliang Jia


16:30-18:00 Live Case Transmission from Ruijin Hospital, Shanghai

Moderators Hugo F. Londero, Weiyi Fang

Discussants Nigel Jepson Xiongjing Jiang Sidney Tsz Ho Lo Alberto Sampaolesi Haiming Shi Salvador Villablanca Yawei Xu

Operators Costantino Costantini Weifeng Shen Paul Hsien-Li Kao Ruiyan Zhang

15

Thursday, April 6, 2006(continued)

Hall #17

Current Session 1- Why and How to Use IVUS

Moderators Gary S. Mintz, Junbo Ge

15:00-16:30 Live Case Transmission from Queen Elizabeth Hospital, Hong Kong

Co-Moderator Chung-Seung Chiang

Discussants Tino Costantini Junko Honye Jie Qian Juying Qian Huay Cheem Tan Yan Wang Yu Wang

Operators Hung Kwong Duncan Ho Kam-Tim Chan Michael Kang-Yin Lee

16:30-16:45 Pre-intervention IVUS Assessment of Intermediate Stenoses and Complex Lesions Junko Honye

16:45-17:00 Use of IVUS to Guide Stent Implantation and Assess Final Results Tino Costantini

17:00-17:15 IVUS Assessment of Mechanisms of Restenosis Gary S. Mintz

17:15-17:30 How to Measure and Report IVUS Findings Juying Qian

17:30-17:45 Use of IVUS to Study Acute Coronary Syndromes and Arterioscleroses Progression and Regression Junko Honye

17:45-18:00 An Overview of New Intracoronary Imaging Modalities Gary S. Mintz

Hall #2The Growing Body of DES Data from China: Final Results of China Cypher Select RegistrySponsored by Cordis, a Johnson and Johnson Company

Chairpersons Zhimin Du, Luyue Gai, Yong Huo, Lefeng Wang, Weimin Wang18:00-18:05 Introduction18:05-18:25 Final Clinical and Angiographic Results from A Nationwide Registry of the Cypher Select Sirolimus-eluting Stent Runlin Gao18:25-18:40 China Cypher Select Registry Subgroup Analysis - Bifurcation Shuzheng Lu18:40-18:55 China Cypher Select Registry Subgroup Analysis - Diabetes Mellitus Jilin Chen18:55-19:10 China Cypher Select Registry Subgroup Analysis - Small Vessel Disease Junzhu Chen19:10-19:25 China Cypher Select Registry Subgroup Analysis - Total Occlusion Yaling Han19:25-19:30 Discussion and Conclusion

Hall #17Endeavor in PerspectiveSponsored by MedtronicChairperson Runlin GaoModerators Jiyan Chen, Yuejin YangInterpreter Jian Liu18:00-18:05 Introduction18:05-18:30 IVUS Findings on Endeavor - SAFETY Aspect Peter Fitzgerald18:30-18:55 Endeavor Clinical Updates - EFFICACY Aspect Spencer B. King III18:55-19:15 DES in Perspective Junbo Ge19:15-19:25 Q&A19:25-19:30 Conclusion

Evening Satellite Symposia

18:00-19:30

16

Friday, April 7, 2006

Hall #1

7:30-8:00 Opening of CIT

Chairperson Runlin Gao

Co-Chairs Jilin Chen, Jiyan Chen, Junbo Ge, Yaling Han, Dayi Hu, Dejia Huang, Yong Huo, Guoliang Jia, Shuzheng Lu, Weifeng Shen, Yuejin Yang, Guoying Zhu

Plenary Session 1-TCT at CIT

Moderators Jeffrey W. Moses, Gary S. Mintz

8:00-9:30 Live Case Transmission from New York-Presbyterian Hospital/Columbia University Medical Center, New York

Co-Moderator Runlin Gao

Discussants Jiyan Chen Peter Fitzgerald Junbo Ge Eberhard Grube David Holmes, Jr Spencer B. King, III Mitchell W. Krucoff Shigeru Saito Yuejin Yang

Operators Martin B. Leon Gregg W. Stone Michael B. Collins George D. Dangas William A. Gray Edward M.Kreps Issam Moussa Robert J. Sommer

9:30-10:00 TCT Crossfire: A Glimpse into the Future of Interventional Vascular Therapy Martin B. Leon, Gregg W. Stone

TCT Hot Topics

10:00-10:20 Percutaneous Treatment of Aortic Valve Disease Eberhard Grube

10:20-10:40 Drug-Eluting Stents Revisited: Current Limitations and Futuristic Platforms Jeffrey W. Moses

10:40-11:00 Invasive Vulnerable Plaque Detection: Virtual Histology, OCT and Beyond Gary S. Mintz

Plenary Session 2-Invited lecture

Moderators Qi Fang, Haozhu Chen, Tak-Fu Tse

11:00-11:18 Training and Maintenance of Competence in Interventional Cardiology: the American Model Spencer B. King III

11:18-11:36 Second Generation of Drug Eluting Stents: What Comes Next? Mitchell W. Krucoff

11:36-11:54 Hypertrophic Cardiomyopathy: Catheter or Surgery Ulrich Sigwart


Plenary Session 3-Live Case Transmission from Fu Wai Hospital, Beijing

13:30-15:00

Moderators Eberhard Grube, Yuejin Yang

Discussants Lianglong Chen Yaling Han David Holmes, Jr Lijun Jin Zhanquan Li Shuzheng Lu Samuel K. Mathew Ulrich Sigwart Pieter R. Stella Robaayah Zambahari

Operators Antonio Colombo, Jeffrey W. Moses, Hubert Seggewiss, Shubin Qiao

IVUS Interpreter Gary S. Mintz

14:55-15:00 Update on Septal Ablation in HOCM Hubert Seggewiss (from Catheterization Laboratory to Venue via Transmission)

17

Friday, April 7, 2006(continued)

Plenary Session 4-EuroPCR at CIT

Moderators Patrick W. Serruys Marie-Claude Morice

State-of-the-art Lecture from EuroPCR

15:00-15:15 How to Prepare a High Risk Patient before PCI (Pharmacology Environment) Franz-Josef Neumann


15:20-15:35 PFO and ASD Closure: State-of- the-art Eric Eeckhout


15:40-15:55 Multivessel Disease PCI versus Surgery: State-of-the-art Patrick W. Serruys


16:00-16:20 Carotid stenting: State-of-the-art Giancarlo Biamino

16:20-16:30 Discussion and Conclusion

16:30-18:00 Live Case Transmission from Clinique Pasteur, Toulouse

Co-Moderator Runlin Gao

Discussants Jilin Chen Giancarlo Biamino Eric Eeckhout Martial Hamon Yong Huo Yean Leng Lim Franz-Josef Neumann Shigeru Saito Weifeng Shen

Operators Jean Fajadet Bruno Farah Jean Marco

Hall #2

Concurrent Session 2-Heart Rhythm

Moderators Xin Chen, Ruilong Sun, Mingzhe Chen, Yonglin Huang

13:30-13:50 Hot Topics in Boston Symposium on Atrial Fibrillation Jian Ma

13:50-14:10 Catheter Ablation: First Line or Second Line Therapy for the Treatment of Atrial Fibrillation Changsheng Ma

14:10-14:30 Catheter Ablation for the Treatment of Atrial Fibrillation: Common Sense and Dispute Yanzong Yang

14:30-14:50 The Mechanisms and Managements of Atrial Tachyarrhythmias after Catheter Ablation of Atrial Fibrillation Shulin Wu

14:50-15:10 Asymptomatic Preexcitation Syndrome: Risks and Managing Strategies Congcin Huang

15:10-15:30 Clinical Use of ICD: Difference between Guideline and Practice Dejia Huang

15:30-15:50 Cardiovascular Interventional Therapy Guided by Magnetic Navigation System: Current Status and New Trends Kejiang Cao

15:50-16:10 New Insights into Physical Pacing Fangzheng Wang

16:10-16:30 Recommendation / Guideline of Cardiac Resynchronization Therapy (CRT) Shu Zhang

Hall #1

18


16:30-18:00 Live Case Transmission from Fu Wai Hospital, Beijing

Case 1 Catheter Ablation of Atrial Fibrillation / Ventricular Tachycardia

Discussants Xinchun Yang Shaowen Liu Jianzeng Dong Minglong Chen

Operator Yan Yao

Case 2 CRT / ICD

Discussants Quan Fang Baogui Sun Farong Shen Jiefu Yang

Operator Wei Hua

Hall #ABCD

8:00-12:00 Simulation Virtual Reality Devices

Hall #A Medtronic Program

Hall #B Cordis Program

Hall #C B Braun Program

Hall #D Terumo Program


Hall #A Medtronic Program

Hall #B Cordis Program

Hall #C B Braun Program

Hall #D Terumo Program

Luncheon Workshops

12:15-13:15

Hall #2

Genous - A Symphony of Natural HealingSponsored by OrbusNeich

Moderators Runlin Gao, Yuejin Yang, Eberhard Grube

12:15-12:20 Introduction

12:20-12:45 Endothelial Progenitor Cell Capture Technology and Results of HEALING II Study Patrick W. Serruys

12:45-13:10 Cenous Bio-Engineered R Stent: the HEALING Clinical Development Program Harry Suryapranata

13:10-13:20 Q&A

13:20-13:25 Conclusion

Hall #17

Aspirin Consensus in Arteriosclerotic Cardiovascular DiseaseSponsored by Bayer

Moderators Runlin Gao, Chengbin Xu


12:20-13:05 Aspirin Consensus in Arteriosclerotic Cardiovascular Disease Xiaoying Li

13:05-13:20 Q&A


Hall #5-1

How to Differentiate DES Efficacy in the Era of Low TLR?Sponsored by Cordis, a Johnson and Johnson Company

Moderators Yaling Han, Dejia Huang, Guoying Zhu


12:20-12:45 Why Late Loss Is Becoming A Primary Endpoint for DES trials and Its Implication for PCI Outcomes David Holmes, Jr

12:45-13:10 Cypher Latest Data - from ACC and Beyond Shing-Chiu Wong

13:10-13:20 Q&A


19


Hall #5-2

AFIB Treatment 2005 - 2006Sponsored by Cordis, a Johnson and Johnson Company

Moderators Fangzheng Wang, Shu Zhang

12:15-12:45 AFIB Treatment: Advice/Guideline (2006) Congxin Huang

12:45-13:15 Perspective in Catheter Ablation for AFIB Changsheng Ma


Hall #5-3

Strategic Solution for Challenging CaseSponsored by MedtronicModerator Yong Huo12:15-12:35 Device Selection for Challenging Case Yujie Zhou12:35-12:55 Cougar in Real World by Experience Sharing Kai Huat Lam

12:55-13:15 Strategic Solution for Challenging Case Junbo Ge13:15-13:20 Q&A13:20-13:25 Conclusion

Hall #5-4

Optimization of Drug Eluting Stent ImplantationSponsored by GuidantModerators Jiyan Chen, Shubin Qiao12:15-12:35 Evidence Based: Rationalization BDC Usage to Optimize DES Implantation Changsheng Ma12:35-12:55 Case Report: Decrease ISR of DES via Pre-dilatation Weiyi Fang12:55-13:15 Case Report: Post-dilatation to Optimize DES Implantation Haichang Wang13:15-13:20 Q&A13:20-13:25 Conclusion

Hall #5-5

Firebird DES Clinical StudiesSponsored by MicroPort

Moderators Dadong Zhang, Weimin Wang, Yitong Ma

12:15-12:30 The Clinical Comparative Investigation of Rapamycin Eluting Stent between Firebird and Cypher Yuechun Gao

12:30-12:45 Firebird in Diabetic Patients Geng Wang

12:45-13:00 Short- and Long-term Outcomes of Firebird in CAD Patients Kai Wang

13:00-13:15 Clinical Effectiveness of Using Firebird DES to Prevent Restenosis in PCI Xian Jin


Hall #5-6

Contrast-induced Nephropathy (CIN) - the Fateful Weakness in PCISponsored by GE Health Care

Moderators Ben He


12:20-12:50 Contrast-induced Nephropathy (CIN) - Prevention & Strategy Peter A. McCullough

12:50-13:10 PCI in Patients with Renal Dysfunction Yujie Zhou

13:10-13:15 Q&A


20


Hall #6

Complex Intervention WorkshopSponsored by Invatec

Moderators Shuzheng Lu, Jianfang Luo


12:20-12:50 Carotid Stenting Giancarlo Biamino

12:50-13:10 Treatment of Intracoronary Thrombosis Shuzheng Lu

13:10-13:20 Q&A


Hall #7

From Treatment to Closure: Stent Complications and the Clinical Advantage in Post-Procedure HemostasisSponsored by St. Jude Medical

Moderators Lefeng Wang, Juying Qian


12:20-12:40 Drug-eluting Stents and Stent Thrombosis in Korea Eak-Kyun Shin Interpreter Yi Li

12:40-13:00 Access Comparison of Femoral and Radial Artery in Percutaneous Intervention, and the Clinical Value of Closure Device Jun Dai13:00-13:15 Q&A


Hall #8

Lipid Management for Patients Who Underwent PTCASponsored by MSD

Moderators Runlin Gao, Dayi Hu

12:15-12:45 Is Sustainable Aggressive Lipid Lowering for Patients Who Underwent PTCA? Dayi Hu

12:45-13:15 Is Aggressive Lipid Lowering Equal to Plaque Regression? Shuiping Zhao



18:00-19:30

Hall #2

Deliver with Confidence - the First Second Generation Drug Eluting Stent TAXUS Liberte Sponsored by Boston Scientific Chairperson Runlin Gao

Moderators Junbo Ge, Yong Huo, Weifeng Shen


18:05-18:45 Current PCI Challenges Versus New Technology: Strategies in Treating Complex PCI Antonio Colombo Interpreter Lei Ge

18:45-19:00 Unsurpassed Deliverability: TAXUS Liberte Platform Yaling Han

19:00-19:15 Evidence Based Medicine in PCI: TAXUS Clinical Programs Yuejin Yang19:15-19:25 Q&A


Hall #17

International Symposium on Biodegradable DESSponsored by Biosensors and JWMSChairperson Runlin Gao

Moderators Guoying Zhu, Shuzheng Lu, Yaling Han


18:05-18:25 Axxess Plus - the First Drug Eluting Stent for the Treatment of Bifurcation Lesions Eberhard Grube18:25-18:40 Excel DES in Real World Experience Teguh Santoso18:40-18:55 BioMatrix DES - My Experience in the Real World Tian Hai Koh18:55-19:15 Overview of DES Era Peter Fitzgerald19:15-19:25 Q&A19:25-19:30 Conclusion

21

Saturday, April 8, 2006

Hall #1Plenary Session 5-Live Case Transmission from Scripps Memorial Hospital, La Jolla

8:00-9:30

Moderators David Holmes, Jr, Yong Huo

Discussants Wacin Buddhari Antonio Colombo Luigi Inglese Tak W. Kwan Henry K. Lui Ivan K. De Scheerder Zhujun Shen Renu Virmani Ningfu Wang Jianhua Zhu

Operators Richard Fortuna Maurice Buchbinder

Plenary Session 6-Invited Lecture

Moderators Robaayah Zambahari, Mingzhe Chen, Thach Nguyen

9:30-9:45 Myocardial Salvage David Holmes, Jr

9:45-10:00 Drug Eluting Stents: Pathophysiology Renu Virmani

10:00-10:15 Unprotected Left Main Stenting - Treatment of Bifurcation Complex Coronary Interventions Antonio Colombo

10:15-10:30 Integrated Strategies for Treating Complex Lesions in Today's Stent Era Henry K. Lui

Plenary Session 7-Live Case Transmission from Fu Wai Hospital, Beijing

10:30-12:00

Moderators Marie-Claude Morice, Weifeng Shen

Discussants Antonio Colombo Eric Eeckhout Tian Hai Koh Lang Li Richard Lim Xinming Li Xueqi Li Xiaoyong Qi Ashok Seth Zhijian Yang

Operators Patrick W. Serruys, Runlin Gao, Franz-Josef Neumann

IVUS Interpreter Peter Fitzgerald

Plenary Session 8

Moderators Yaron Almagor, Zhimin Du

Live Case Transmission from Guangdong Province Cardiovascular Institute, Guangzhou

13:30-14:30

Discussants Lianjun Huang Kau-Chung Charles Ho Paul Hsien-Li Kao Xi Su Harry Suryapranata Rurus Suryawan Shailendra Trivedi Tianlun Yang Tingshu Yang

Operators Giancarlo Biamino Samuel K. Mathew Jiyan Chen

Invited Lecture

14:30-14:45 AMI Intervention in DES Era Harry Suryapranata

14:45-15:00 IVUS Insights from DES Clinical Trials and Case Experience Peter Fitzgerald

22

Saturday, April 8, 2006(continued)

Plenary Session 9

Moderators Franz-Josef Neumann, Jilin Chen

Live Case Transmission from Peking University First Hospital, Beijing

15:00-15:45

Discussants Luigi Inglese Jinfa Jiang Shisen Jiang Yuanzhe Jin Ferdinand Kiemeneij Jiyuan Lu Toshiya Muramatsu Kui-Hian SimOperators Marie-Claude Morice, Yong Huo

Invited Lecture15:45-16:00 Randomized Comparison of Two Modes of Thrombus Removal on Acute MI Ferdinand Kiemeneij16:00-16:15 How to Select Distal Protection Device in Carotid Angioplasty Hugo F. Londero16:15-16:30 The Concept of Global Revascularization in the Coronary Patient Luigi Inglese

Plenary Session 10

Moderators Yean Leng Lim, Lefeng Wang

Live Case Transmission from Fu Wai Hospital, Beijing

16:30-17:30

Discussants Yuqing Hou Weijian Huang Col Mujeeb-Ul-Haq Gia Khai Pham Witold Ruzyllo George W. Vetrovec Dadong Zhang Hong Zheng

Operators Mitchell W. Krucoff, Eric Eeckhout, Shiliang Jiang, Zhongying Xu

Invited Lecture17:30-17:45 Primary Trans-catheter Closure of Post-infarction VSD with Amplatzer Septal Occluder Witold Ruzyllo17:45-18:00 New Concept in CTO-PCI- CART Technique Osamu Katoh

Hall #2


Moderators Mitchell W. Krucoff, Shuzheng Lu

Discussants Kenneth Chin Hung Kwong Duncan Ho Bao Li Dongqi Wang Philip Wong Shuyang Zhang

Operators Jilin Chen, Yaron Almagor, Harry Suryapranata, Toshiya Muramatsu

IVUS Interpreter Peter Fitzgerald


Moderators Junzhu Chen, Haichang Wang, Xuewen Qin

10:00-10:15 Indication for PCI: from Clinical Practice to ESC Guideline 2005 Weifeng Shen

10:15-10:30 How to Make Decision for Complete or Incomplete Revascularization? Guoying Zhu

10:30-10:45 Unprotected Left Main Intervention: Is Evidence Enough? Yaling Han

10:45-11:00 Optimal Strategy of Percutaneous Intervention for Bifurcation Lesions Junbo Ge

11:00-11:15 Guideline and Practice of Anti- thrombotic Therapy with PCI Weimin Li

11:15-11:30 Lipid Lowering Therapy in PCI Wei Gao

11:30-11:45 Reperfusion Therapy for Acute Myocardial Infarction: from Guideline to Practice Ben He

11:45-12:00 PCI in Patient with Heart Failure and/or Renal Dysfunction Yujie Zhou

23



Moderators Guoying Zhu, Weimin Wang

13:30-13:45 Unsolved Issues of Current DES Weiyi Fang

13:45-14:00 Percutaneous Revascularization for NSTE-ACS Lefeng Wang

14:00-14:15 Post-dilatation with High Pressure Balloon after Stent Implantation, Do We Really Need? Ruiyan Zhang

14:15-14:30 Intermediate Stenosis: Can We just DES it? Guoxiang He

14:30-15:30 Live Case Transmission from Guangdong Province Cardiovascular Institute, Guangzhou

Discussants Lianqun Cui Qun Dang Lixian Han Jun Huang Zheng Zhang Shenghua Zhou

Operators Huay Cheem Tan, Jiyan Chen


Moderators Guoliang Jia, Wei Gao

15:30-15:45 Update on Stem Cell Therapy in AMI Zhanquan Li

15:45-16:00 Percutaneous Coronary Intervention for Ostial Lesion in the Ear of DES Weimin Wang

16:00-16:30 Live Case Transmission from Peking University First Hospital, Beijing

Discussants Xingui Guo Shaobin Jia Guoqing Li Shumei Li Biao Xu Shuyang Zhang

Operator Teguh Santoso

16:30-16:45 Application of Coronary CT Angiography Zhengyu Jin

16:45-17:00 PCI in Long Lesion and Small Vessel: from Clinical Trial to Daily Practice Shubin Qiao

17:00-17:30 Live Case Transmission from Peking University First Hospital, Beijing

Discussants Xingui Guo Shaobin Jia Guoqing Li Shumei Li Biao Xu Shuyang Zhang

Operator Yong Huo

17:30-17:45 How to Manage Peripheral Vascular Complications with PCI? Lan Huang

17:45-18:00 Management of No-Reflow and Distal Embolization Hongbing Yan

Hall #2

24


Hall #17

Concurrent Session 3-TRI Club

Sponsored by CIT, supported through An Educational Grant from Terumo

8:00-8:10 Introduction of TRI Club Runlin Gao

8:10-9:20 Section 1

Moderators Sanqing Jia, Ichiro Michishita

8:10-8:50 Live Case Transmission from Friendship Hospital, Beijing

Discussants Genshan Ma Hideaki Sakai Akihiko Takahashi Haichang Wang Hongbing Yan Min Yao

Operators Shigeru Saito, Lei Wang

8:50-9:05 Minimally Invasive strategies in PCI

Martial Hamon

9:05-9:20 Trans-radial Carotid and Vertebral Interventions Chiung-Jen Wu

9:20-10:30 Section 2

Moderators Yujie Zhou, Chiung-Jen Wu


Discussants Zhimin Du Guosheng Fu Wenyi Guo Tiemin Jiang Rurus Suryawan Ho-nin Kanaya

Operators Ferdinand Kiemeneij Tak Sun Tse

10:00-10:15 Minimally Invasive Diagnostic Angiography and Coronary Intervention by Trans-forearm Arterial Approach Xianghua Fu

10:15-10:30 Access Complications with Trans-radial Intervention, Prevention and Management Quanmin Jing

10:30-11:40 Section 3

Moderators Xianghua Fu, Tejas M. Petal


Discussants Lei Ge Hideaki Kaneda G. L. Sharma Meng Wei Shangyu Wen Bo Yu

Operators Yuejin Yang, Weijie Li

11:10-11:20 Changes in the Diameter of the Radial Artery after TRA or TRI Yoshifumi Kan

10:20-11:30 Challenging CTO Lesion by TRI Motomaru Masutani

11:30-11:40 Trans-Radial Coronary Stenting with Severe ASD and Acute Myocardial Infarction Tetsuya Hata

11:40-11:55 Introduction of Terumo Latest Technology - TRI Simulator Min Yao

11:55-12:00 Conclusion of TRI Club at CIT Sanqing Jia

25


Hot Topics from Asian-Pacific Region and Latin America

13:30-15:00 Section 1

Moderators Richard Ng, Dejia Huang, Tak-Him Patrick Ko

13:30-13:45 Drug Eluting Stent versus Bare Metal Stent in the Treatment of Distal Unprotected Left Main Bifurcation Lesions Eak-Kyun Shin

13:45-14:00 Cost-effectiveness of Sirolimus Eluting Stents in a Brazilian Clinical Practice Marco Wainstein

14:00-14:15 Initial Experience and Clinical Follow up with Firebird Stent in Chile Salvador Villablanca

14:15-14:30 Subacute Complications after Drug Eluting Stent and its Management Devang Desai

14:30-14:45 Assessment of the Efficacy of DES Implantation to Treat De Novo Ostial Coronary Artery Lesions Costantino Costantini


15:00-15:15 Tea Break

15:15-16:30 Section 2

Moderators Swee Choon Ng Fang Chen Hon-kan Yip

15:15-15:30 Effect of Cilostazol on the Restenosis after Drug Eluting Stent in Diabetic Patients Seong-Wook Park

15:30-15:45 Treatment of Bifurcation Lesions 2006 Sidney Tsz Ho Lo

15:45-16:00 Primary Angioplasty, Is the Best Therapeutical Option in Acute Myocardial Infarction? Alberto Sampaolesi

16:00-16:15 Role of PCI when CABG Is Declined either by the Patient or the Surgeon, Is Partial Revascularization An Answer? Mohammad Ishaq


16:30-16:45 Tea Break

16:45-18:00 Section 3

Moderators Raul D. Jara, Weimin Li, Shu-Kin Li

16:45-17:00 Genetic Engineering and the Future of Interventional Cardiology Luis De la Fuente

17:00-17:15 Assessment of Equivocal Coronary Lesions with Emphasis on the Doppler Flow Wire Gerard Devlin

17:15-17:30 Percutaneous Pulmonary Valvoloplasty Using Inoue Balloon in Adult Patients with Pulmonary Valve Stenosis Manh Hung Pham

17:30-17:45 Treatment Options for Coronary AV Fistula Wasan Udayachalerm


Hall #17

26


Challenging Case Review - Meet the Expert 1

8:00-12:00

Hall #11

8:00-10:00 Section 1 (5min presentation + 10min discussion) / case

Moderators Guoying Zhu, Quanmin Jing

Commentators Xiaoshu Cheng Maoru Ma Peng Qu Zesheng Xu

8:00-8:15 Treatment Strategy of Chronic Total Occlusion Combined with Severe Aneurysm in RCA Yu Cao

8:15-8:30 PCI for Chronic Total Occlusion in Patient after Renal Transplantation Zening Jin

8:30-8:45 Long Diffuse Lesion Shaoping Nie

8:45-9:00 Reverse Crush Stenting in LAD Bifurcation Lei Ge

9:00-9:15 PCI for Chronic Total Occlusion by Trans-radial Approach Yingxin Zhao

9:15-9:30 PCI of Long Saphenous Vein Graft Occlusion Xin Chen

9:30-9:45 Treatment of Distal RCA Stenosis by Using Deep Seating Technique with 5Fr Guiding Catheter Jun Tian

9:45-10:00 Fracture of Cypher Select Stent Combined with Late Aneurysm Xiantao Song


Moderators Guoliang Jia, Changsheng Ma

Commentators Tao Guo Yexin Ma Feng Wang Shusen Yang

10:00-10:15 Transcatheter Aspiration in the Treatment of Intracoronary Thrombus on Acute Myocardial Infarction Liting Zhang

10:15-10:30 PCI of Left Main Bifurcation and RCA Stenosis with 6-month Angiographic Follow-up Weiyi Fang

10:30-10:45 Application of OCT and IVUS in Diagnosis of Coronary Artery Disease Shaobo Chen

10:45-11:00 Chronic Total Occlusion and Bifurcation Zhigang Han

11:00-11:15 Treatment of LCX CTO Using Rotablator Followed by DES Implantation Weiming Li

11:15-11:30 Primary PCI in Acute Myocardial Infarction for Eldly Yong Xia

11:30-11:45 Intracoronary Stenting Causing Perforation and Emergent CABG Guohong Chen

11:45-12:00 PCI for LAD Chronic Total Occlusion through Bilateral Radial Ateries Access Xianghua Fu

27


Hall #12


Moderators Shubin Qiao, Yundai Chen

Commentators Qing He Yean Teng Lim Swee Choon Ng Pieter R. Stella

8:00-8:15 Percutaneous Intervention of Chronic Total Occlusion in Left Main Combined with RCA and Renal Artery Stenoses Qi Zhang

8:15-8:30 Acute Total Occlusion of the Left Main Artery during Coronary Angiography Result in Cardiac Arrest &Its Management Massoud Ghasemi

8:30-8:45 TCT Live Case - PCI of Left Main Chronic Total Occlusion with Retrograde Wiring Technique Junbo Ge

8:45-9:00 Revascularization of the Right Coronary Artery with Multiple Stents Carlos Gadda

9:00-9:15 Double Vessel Chronic Total Occlusions Shouli Wang

9:15-9:30 Multiple Coronary Arteries Revascularization Carlos Sztejfman

9:30-9:45 Primary PCI for Acute Inferior Myocardial Infartion with Severe Angulation and Huge Thrombus Burden Lang Li

9:45-10:00 Angioplasty of Non-protected CFX Artery Alvero Bordenav


Moderators Shuzheng Lu, Yingling Zhou

Commentators Jifu Li Qingheng Meng Fengzhi Wang Jiansheng Zhang

10:00-10:15 PCI of Total Occlusions in LAD and RCA Combined with LCX Severe Stenosis Yiqiang Yuan

10:15-10:30 Ostial Left Main Stenosis and Proximal LAD Chronic Total Occlusion Qing Zhang

10:30-10:45 Primary PCI in Acute Myocardial Infarction with Total Occlusions in Both LAD and LCX Guowei Zhou

10:45-11:00 Application of GuardWire in the Treatment of RCA Total Occlusion Yibing Shao

11:10-11:15 Application of Sprinter Balloon in the Treatment of LAD Chronic Total Occlusion Fucheng Sun

11:15-11:30 Recanalization of Proximal Left Subclavian Total Occlusion with Antegrade and Retrograde Wiring Technique Xiongjian Jiang

11:30-11:45 Transcatheter Closure of PDA Combined with Severe Pulmonary Hypertension Jiandong Ding

11:45-12:00 Staged PCI of Infarct Related LAD Stenosis after Acute Myocarddial Infarction Genshan Ma

28


Abstract Oral Presentation

13:30-18:00

Hall #7

13:30-15:00 Section 1 - Coronary Heart Disease

Moderators Tigang Huang, Xiaowei Yan, Qing He

13:30-13:40 Predictors of Major Adverse Cardiac Events after Percutaneous Coronary Intervention from One-Year Follow-up: Fu Wai Experience Weidong Pei

13:40-13:50 Efficacy of Stenting for Unprotected Left Main Coronary Artery Disease in 297 Patients Yaling Han

13:50-14:00 Clinical Assessment on Myocardium Perfusion of Myocardial Infarction after Selective PCI Using MCE Techniques Yundai Chen

14:00-14:10 A Single Center Investigation of Bare-metal or Drug-eluting Stent Restenosis from Chinese Han Population Jianjun Li

14:10-14:20 Comparative Evaluation of Immediate, Intermediate and Long-term Effects for A Long Stent or Multiple Stents Implanted Consecutively in Patients with Long Diffuse Coronary Lesion Xinhong Liu

14:20-14:30 Comparing Evaluative Methods on Myocardial Reperfusion after Percutaneous Coronary Intervention Hong Wang

14:30-14:40 Prognosis and Clinical Characteristics of Revascularization with Metabolic Syndrome and the Factors Affecting the Outcomes Rong Hu

14:40-14:50 TBA Ping Ji

14:50-15:00 Prognostic Significance of Complete Right Bundle Branch Block Immediately after Percutaneous Transluminal Septal Myocardial Ablation in Series of Chinese Patients with Hypertrophic Obstructive Cardiomyopathy Shaoliang Chen

15:00-16:30 Section 4 - Coronary Heart DiseaseModerators Ruoyi Ke, Luhua Shen, Guangping Li

15:00-15:10 Independent Predictors and Long-term Prognostic Impact of No-reflow in Patients with Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention Jie Deng

15:10-15:20 Ventricular Tachycardia or Fibrillation in the Cardiac Catheterization Laboratory among Patients with Acute ST Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention: Incidence, Predictors, and One-year Outcomes Yanchun Liang

29


15:20-15:30 The Efficacy and Safety of Combining Tirofiban Treatment with Percutaneous Coronary Intervention in Acute ST Segment Elevation Myocardial Infarction Bo Luan

15:30-15:40 Viable Myocardium Impact on Left Ventricular Function after Late Revascularization of Infarct- relatedArtery in Acute Myocardial Infarction Likun Ma

15:40-15:50 In-hospital Effect of Emergency Percutaneous Coronary Intervention on Elderly Patients with Acute Myocardial Infarction Geng Wang

15:50-16:00 Prophylactic Treatment with Diltiazem and Nitroglycerin in Emergent PCI for the No- reflow/Slow-flow in Acute Myocardial Infarction Yu Wang

16:00-16:10 Frequency of Infarct Related Artery with Myocardial Bridge and Its Effect on Primary PCI Results Hongbing Yan

16:10-16:20 The Incidence of Radiographic Contrast Nephropathy and Its Risk Factors and Prognosis Hongbing Yan

16:20-16:30 TBA Yu Yang


Moderators Yuhua Dai, Youfang Ni, Yitong Ma

16:30-16:40 Acute Myocardial Infarction after 1 month Post Percutaneous Coronary Intervention, Late Stent Thrombosis or New Lesion? Yongjian Wu

16:40-16:50 Clinical Characters and Management of 41 patients with Coronary In-stent Thrombosis Yaling Han

16:50-17:00 The Relationship between Sex Hormones and Extent of Coronary Artery Disease in Chinese Postmenopausal Women Odgerel Tumur

17:00-17:10 A Study on the Feasibility and Safety of Emergent Percutaneous Coronary Intervention with Trans-radial Access in Acute Myocardial Infarction Patients Weimin Li

17:10-17:20 Six Hours Ambulation after Coronary Angiogram through Femoral Approach without Pressure Bandaging Jincheng Guo

17:20-17:30 Comparative Study on Coronary Angiogram by Trans- femoral and Trans-radial Approach Shuzhi Lu

17:30-17:40 Application of Perclose ¢Û in Patients at High Risk for Bleeding after Primary PCI Hongbing Yan

17:40-17:50 Incidence and Outcome of Radial Artery Occlusion Following Trans-radial Coronary Intervention Yujie Zhou

17:50-18:00 Nursing after Percutaneous Coronary Intervention by Trans- radial Approach Ying Wang

Hall #7

30


Hall #8

13:30-15:00 Section 2 - Heart Rhythm

Moderators Yinsheng Wu, Jihong Guo, Jian'an Wang13:30-13:40 Incidence of Pulmonary Vein Tachycardia and Its Impact on the Follow-up Outcomes in Patients with Atrial Fibrillation Jianzeng Dong

13:40-13:50 The Clinical Use of Cardiac Resyncronization Therapy in Patient with Ischemic Cardiomyopathy and Nonischemic Cardiomyopathy Wei Hua

13:50-14:00 The Role of Pectinate Muscle in Perpetuation of Atrial Fibrillation Shulong Zhang

14:00-14:10 Predictors of Recurrence of Atrial Tachyarrhythmias after Circumferential Pulmonary Vein Ablation for Patients with Atrial Fibrillation: A Prospective Study Xingpeng Liu

14:10-14:20 The Clinical Evaluation of Circumferential Pulmonary Vein Isolation in Cases with Persistent Atrial Fibrillation Xu Liu

14:20-14:30 Radiofrequence Ablation of Anteroseptal Focal Atrial Tachycardia from the Aortic Noncoronary Sinus Cusp Fusheng Ma

14:30-14:40 Circumferential Pulmonary Vein Ablation Guided by Double- Lasso Catheters and Three- dimensional Electroanatomic Mapping for the Treatment of Atrial Fibrillation Kai Tang

14:40-14:50 Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients with Nonischemic Heart Diseases Utilizing Entrainment Mapping and/or CARTO System Zulu Wang

14:50-15:00 Comparison of Pulmonary Vein Diameter in Patients with Idiopathic Atrial Fibrillation and Atrial Fibrillation Combined with Hypertension Shulong Zhang

15:00-16:30 Section 5 - Heart RhythmModerators Ruilong Sun Zhenwen Huang Lihua Shang

15:00-15:10 The Role of Purkinje Potential and Diastolic Potential in Radiofrequency Catheter Ablation of Idiopathic Left Ventricular Tachycardia Zulu Wang

15:10-15:20 Ventricular Repolarization Sequence During Right Ventricular Endocardial and Left Ventricular Epicardial Pacing: Monophasic Action Potential Mapping in Swine Shulong Zhang

15:20-15:30 TBA Dongsheng Gao

31


15:30-15:40 Different Patterns of Interatrial Conduction in Atrial Flutter and Its Relationship with the Flutter Wave in the Surface ECG Hao Han

15:40-15:50 Global Dispersion of Ventricular Repolarization During Right Ventricular Endocardial and Left Ventricular Epicardial Pacing: Monophasic Action Potential Mapping in Swine Shulong Zhang

15:50-16:00 Analyses of Complications and Mortality for Biventricular Pacing Therapy in Patients with Congestive Heart Failure Dongmei Wang

16:00-16:10 Clinical Study of Unconscious Sedation with Propofol during Trans-catheter Ablation of Atrial Fibrillation Deyong Long

16:10-16:20 Assessment of Left Ventricular Mechanical Dyssynchrony by Real-time Three-dimensional Echocardiography Jie Cui

16:20-16:30 Age Associated Changes in Human Atrial Electrophysiology Yanchun Liang


Moderators Binyao Wang Guoshu Liu Yin Liu

16:30-16:40 The Vessel Area in the Segment of Myocardial Bridging Is Smaller than the Reference: An Intravascular Ultrasound Analysis Juying Qian

16:40-16:50 Effect of Hepatocyte Growth Factor on Post-infarction Left Ventricular Remodeling and Angiogenesis Mingbao Song

16:50-17:00 Study of Valsartan Eluting-stents to Prevent Restenosis in Animals Lei Wang

17:00-17:10 TBA Ruiyan Zhang

17:10-17:20 Intracoronary Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells for Ischemic Cardiomyopathy due to Isolated Chronic Occluded Left Anterior Descending Artery Shaoliang Chen

17:20-17:30 The Effect on Cardiac Function in the Patients with Twice Intracoronary Autologus Bone Marrow Mononuclear Cells Transplantation in Different Interval after Acute Myocardial Infarction Junbo Ge

17:30-17:40 Ligating LAD with its Whole Length Rather than Diagonal Branches as Coordinate Is More Advisable in Establishing Myocardial Infarction Model of Swine Junbo Ge

17:40-17:50 Cell Transplantation for the Treatment of Chronic Myocardial Infarction in Swines Using Vascular Endothelial Growth Factor-Expressing Bone Marrow Stromal Cells Fu Yi

17:50-18:00 The Relationship between hs- CRP, ProMMP-1, TIMP-1 and Coronary Plaque Morphology: Intravascular Ultrasound Study Xingwei Zhang

Hall #8

32


Hall #11

13:30-15:00 Section 3 - Congenital Heart Disease

Moderators Shihua Zhao Guangyi Wang Yongwen Qin

13:30-13:40 Clinical Results of Transcatheter Closure of Perimembranous Ventricular Septal Defects in 320 Patients Xianyang Zhu

13:40-13:50 Appraisal of Efficacy and Safety of Intra-crest Ventricular Septal Defects Device Occlusion Daxin Zhou

13:50-14:00 The Clinical Research in Patients with Foramen Secundum ASD Combine Arrhythmia with Interventional Therapy Dongan Deng

14:00-14:10 TBA Zening Jin

14:10-14:20 Transcatheter Closure of Atrial Septal Defects under Echocardiographic Guidance Xiaojing Ma

14:20-14:30 Radiofrequency Perforation and Balloon valvuloplasty for Pulmonary Atresia with Intact Ventricular Septum Xianyang Zhu

14:30-14:40 Clinical Report of Transcatheter Devices Closure of PDA in 690 Patients Xianyang Zhu

14:40-14:50 Treatment of Aortic Pseudoaneurysm with Interventional Procedure Lianjun Huang

14:50-15:00 Percutaneous Transcatheter Closure of Coronary-pulmonary Artery Fistula Using Metallic Coils Dongmei Shi


Moderators Fusheng Gu Junzhu Chen Guanglie Yan

15:00-15:10 Outcomes of Using Firebird Rapamycin Eluting Stents in Routine Coronary Intervention Practice: One-year Results from the Pilot Study of Firebird in China (FIC) Registry Haibo Liu

15:10-15:20 Evaluation on Six-month Clinic Results of Treating Coronary Artery Disease by EXCELTM Stent with Degradable Polymer Rapamycin-coating Yuxiao Zhang

15:20-15:30 The Primary Outcome of FIBISTEMI (Firebird DES Stent vs BMS In STEMI) Trial Hongbing Yan

15:30-15:40 Short and Intermediate Term Clinical Outcome of Sirolimus- eluting Stent Implantation in Patients with Acute ST-segment Elevation Myocardial Infarction Qiang Zhang

33


15:40-15:50 Efficacy of Paclitaxel Eluting Stents Implantation in Unprotected Left Main Coronary Artery of 119 Patients Yaling Han

15:50-16:00 Early- and Mid-term Clinical Observation of Drug-eluting Stent Implantation in Elderly Patients with Unprotected Left Main Coronary Artery Disease Yong Wang

16:00-16:10 Short-and Mid-term Outcomes of Two Drug-eluting Stents in Bifurcation Lesions Jilin Chen

16:10-16:20 One Year Outcome Following Sirolimus-eluting Stent Implantation in Coronary Bifurcation Lesions Lei Ge

16:20-16:30 Angiographic and Clinical Outcome for the Treatment of In-stent Restenosis with Sirolimus-eluting Stent Compared to Paclitaxel-eluting Stent Jianjun Li

Hall #ABCD


Hall #A Medtronic ProgramHall #B Cordis ProgramHall #C B Braun ProgramHall #D Terumo Program


Hall #A Medtronic ProgramHall #B Cordis ProgramHall #C B Braun ProgramHall #D Terumo Program

Luncheon Workshops

12:15-13:15

Hall #2

Pfizer SeminarSponsored by Pfizer

Moderators Guoliang Jia, Shuzheng Lu


12:20-12:50 Importance of intensive lipid lowering on ACS with Statin Therapy Weifeng Shen

12:50-13:20 ACS Patient Standardize Anticoagulation Therapy: Learning from Latest Guideline Yaling Han


34


Hall #17

Clinical Study and Practice of PARTNER Sirolimus Eluting Coronary Stent SystemSponsored by Lepu

Moderators Yuejin Yang, Haichang Wan, Lianqun Cui

12:15-12:30 Clinical Application of PARTNER Sirolimus Eluting Coronary Stent System in Complex Lesions Shuzheng Lu

12:30-12:45 Characteristics of Clinical Application of PARTNER Sirolimus Eluting Stent System Tingshu Yang

12:45-13:00 Application of Drug Eluting Stent in the Treatment of Bifurcation Lesion Shaoliang Chen

13:00-13:15 Case Study of PARTNER Sirolimus Eluting Stent System Chaolian Huang

13:15-13:20 Q&A


Hall #5-1

PTCA Technique and Device SelectionSponsored by Cordis, a Johnson and Johnson Company

Moderators Yong Huo, Junbo Ge

12:15-12:35 PTCA Technique and Device Selection in Bifurcation Paul Hsien-Li Kao

12:35-12:55 PTCA Technique and Device Selection by Trans-radial Approach Shubin Qiao

12:55-13:15 PTCA Technique and Device Selection in Chronic Total Occlusion Shuzheng Lu


Hall #5-2

Futuristic Stent TechnologySponsored by Biotronik

Moderator Yujie Zhou, Jianjun Li


12:20-12:45 New Generation of Drug Eluting Stent - Costar Martial Hamon

12:45-13:05 AMS Clinical Data Martial Hamon

13:05-13:20 Q&A


Hall #5-3

Guiding Curves Selection - the Key to Successful InterventionSponsored by Medtronic

Moderators Changsheng Ma

12:15-12:35 Guiding Selection Experience on RBU Sk Leung

12:35-12:55 Guiding Selection Experience on EBU Yundai Chen

12:55-13:15 Guiding Selection Experience on Other Curves Juying Qian

13:15-13:20 Q&A


Hall #5-4

Trace the Source: Stent and Guide Wire BasicsSponsored by Guidant

Moderators Jilin Chen

12:15-12:45 What Is An Ideal Stent Platform for DES? Yaling Han

12:45-13:15 How to Choose A Guide Wire? Start from Its Design Weimin Wang

13:15-13:20 Q&A


35


Hall #5-5

Firebird Case ReviewsSponsored by MicroPort

Moderators Li Zhanquan Weiyi Fang Hongbing Yan

12:15-12:27 Firebird in Left Main Lesions and Follow-up Buxing Chen

12:27-12:39 Firebird in Complex Lesions Yuanzhe Jin

12:39-12:51 Reverse Crushing in Bifurcation Lesions Shuxuan Jin

12:51-13:03 Firebird in LAD CTO Jian Liu

13:03-13:15 How to Treat LM Dissection Zhongping Nin


Hall #5-6

Leading Technique on Cardiac ImagingSponsored by Siemens

Moderators Runlin Gao Kejiang Cao Jiaxing Xu

12:15-12:40 Magnetic Guidance: Application to Coronary Intervention George W. Vetrovec

12:40-13:05 Improvements in Cardiac Imaging with Dual Source CT Axel Wimmer

13:05-13:20 Q&A


Hall #6

Latest Update on Biodegradable DES ProductsSponsored by JWMS and Biosensors

Moderators Wei Gao, Lefeng Wan

12:15-12:25 Introduction of JWMS and Excel Biodegradable DES Launch Jack Wang

12:25-12:45 Update on Biodegradable DES Product Excel Junbo Ge

12:45-13:05 Axxion - 30Days MACE Thomas A. Ischinger

13:05-13:20 Manufacturing on DES Jack Wang


Hall #7

Clinical Application of FPD Digital Cardiac System to PCI Sponsored by Shimadzu

Moderator Yuejin Yang


12:20-13:00 Clinical Application of FPD Digital Cardiac System to PCI Bo Zhang

13:00-13:10 Q&A


36


Hall #8

Statin Multi-biologic on PCI PatientsSponsored by MSDModerator Wei Gao


12:20-13:10 Statin Multi-biologic on PCI Patients Brian Tomlinson

13:10-13:20 Q&A13:20-13:25 Conclusion


18:00-19:30

Hall #2

Broken Cocoon Butterfly - From Vision to DES from GUIDANT Sponsored by Guidant


Moderators Junbo Ge, Yuejin Yang


18:05-18:25 The Best of Bare Metal: A Vision of Usage in Real World Setting Mitchell W. Krucoff Interpreter Jian Liu

18:25-18:45 Xience V Compared with other DES Renu Virmani Interpreter Yi Li

18:45-19:10 Second Generation Drug Eluting Stent: Xience V Program and SPIRIT Trials Patrick W. Serruys Interpreter Zhujun Shen

19:10-19:25 Q&A


Hall #17

Evidence-based Medicine: Firebird in Real World

Sponsored by MicroPort

Chairpersons Weifeng Shen, Yaling Han,

Changsheng Ma,

Harry Suryapranata


18:05-18:25 Comparison Study of Firebird

with Cypher and Taxus in Daily

Clinical Practice

Shubin Qiao

18:25-18:45 30-days Clinical Outcomes

from A Nationwide Firebird

Rapamycin Eluting Stent

Registry - Firebird in China

Study

Runlin Gao

18:45-19:00 First 6-months Follow-up

Results from Latin American

Firebird Registry

Salvador Villablanca

19:00-19:15 One-year Clinical Outcomes of

Chinese Sirolimus Eluting Stent

in Treating Unselected Patients

with Coronary Artery Disease -

a "Real-world" Prospective

Multi-center Registry

Qi Zhang

19:15-19:25 Q&A


37


Hall #1

Plenary Session 11-Live Case Transmission from An Zhen Hospital, Beijing

8:00-9:30

Moderators Yean Teng Lim, Ben He

Discussants Rajiv Agarwal Jue Chen Boron CW Cheng Chaozhong Liu Huiliang Liu Simon Lo Richard Ng Guoxian Qi Eak-Kyun Shin Jianguo Wu

Operators Shuzheng Lu, Martial Hamon, Shing-Chiu Wong

Plenary Session 12-Invited lecture

Moderators Shih-Pu Wang, Ruping Dai, Chung-Seung Chiang

9:30-9:45 Update on Coronary Physiology Eric Eeckhout

9:45-10:00 Update on REALITY and SYNTAX Trials Marie-Claude Morice

10:00-10:15 Renal Angioplasty: Indication and Outcome Paul Hsien-Li Kao

10:15-10:30 Thoracic Aortic Aneurysm - Clinical and Pathogenetic Correlates Malcolm West

Plenary Session 13-Live Case Transmission from An Zhen Hospital, Beijing

10:30-11:30

Moderators Tian Hai Koh, Shaoliang Chen

Discussants Dibya Kumar Baruah Devang Desai Chaolian Huang Kai Huat Lam Kang Li Caiyi Lu Sufia Rahman Qiming Wu Yongjian Wu

Operators Ashok Seth, Shuzheng Lu

11:30-12:00 Magnetic Navigation Video Case Dialogue George W. Vetrovec

Plenary Session 14 - Invited Lecture

Moderators Kejiang Cao, Xinchun Yang, Wenyi Guo

13:30-13:45 Saphenous Vein Graft Interventions Shing-Chiu Wong

13:45-14:00 Percutaneous Coronary Interventions in Patients with Medical Contra-Indications Thach Nguyen

14:00-14:15 Neurological Complications and PCI Martial Hamon

14:15-14:30 Physiologic Feasibility of Ventricular Sourcing: VSTENT Jie Wang

14:30-14:45 Screening for Coronary Artery Disease Yean Leng Lim

14:45-15:00 Will CT Coronary Angiogram Replace Invasive Coronary Angiogram? Michael Lim

38

Sunday, April 9, 2006(continued)

Plenary Session 15 - Interventional Cardiologist Meets Cardiac Surgeon

Moderator Runlin Gao

15:00-15:20 1st CABG in China Memorial Lecture - the Futuristic Lesser- Invasive “Surgical Vision”: from Coronaries to Valves to Arrhythmias to Structural Defects Shengshou Hu

15:20-15:40 Complex Percutaneous Coronary Interventions: How Far Can We Go in the Era of DES? Shuzheng Lu

15:40-16:00 Roundtable Discussion

Discussants Shengshou Hu Yong Huo Guoliang Jia Shuzheng Lu Weifeng Shen Guoying Zhu

16:00-16:30 Award, Conclusion and Closing of CIT


Co-Chairs Jilin Chen, Jiyan Chen, Junbo Ge, Yaling Han, Dayi Hu, Dejia, Huang, Yong Huo, Guoliang Jia, Shuzheng Lu,Weifeng Shen, Yuejin Yang, Guoying Zhu

Hall #2

Concurrent Session 4-CTO Club

Moderators Junbo Ge, Yaling Han

8:00-8:05 Course Objective Junbo Ge

8:05-8:20 Why Should We Treat Chronic Total Occlusion? Yundai Chen

8:20-8:35 Challenging CTO: My Experience 1 Yaling Han

8:35-8:50 Challenging CTO: My Experience 2 Junbo Ge

8:50-9:05 Challenging CTO: My Experience 3 Hugo F. Londero

9:05-9:20 Challenging CTO: My Experience 4 Jianjun Li

9:20-9:40 Case Review from US CTO Summit Jeffrey W. Moses


Co-Moderators Patrick W. Serruys, Jeffrey W. Moses

Discussants Tan Kim Heung Sum-Kin Leung Shubin Qiao Teguh Santoso Lengfeng Wang

Operators Osamu Katoh, Shigeru Saito, Kazuaki Mitsudo, Shouli Wang, Lei Ge, Min Yao

IVUS Interpreter Junko Honye

11:40-11:55 Penetration of Hard Occluded Lesions with the Extra Stiff Guidewire Kazuaki Mitsudo (from Catheterization Laboratory to Venue via Transmission)

11:55-12:00 Conclusion Yaling Han

39


Hall #17

1st Annual Symposium for Nurse and Technologist

8:00-10:00 Section 1

Moderators Jingxuan Guo, Jenny Zhen Qin, Qi Feng

8:00-8:20 To Nurse and Technologist: What Should You Know in the Era of High Technology for interventional Vascular Therapy? Jingxuan Guo

8:20-8:50 Interventional Cardiology Research: What Can We Do to Make It A Success? Jenny Zhen Qin Interpreter Jie Qian

8:50-9:10 How to Perform Quantitative Coronary Angiography? Toshimitsu Shimizu Interpreter Qihui Yang

9:10-9:30 IVUS Guided PCI Jae Yoon Ko Interpreter Zhe Jin

9:30-9:50 ECG Change due to Chest Pain Young Keun Lee Interpreter Zhe Jin


10:00-12:00 Section 2

Moderators Yulan Wu, Guihua Hou, Pidong Liu

10:00-10:15 Device Selection for Percutaneous Coronary Diagnosis and Intervention Tianchang Li

10:15-10:30 Standard and Selection for X- ray Exposure Position of Coronary Angiogram Guosheng Fu

10:30-10:45 Translation of Evidence into Practice Tao Liang

10:45-11:00 Administration Model at Cardiovascular Interventional Center in Asian Heart Hospital Ying Wang

11:00-11:15 As An X-ray Technician, How to Assist in Cardiac Intervention? Zhongchao Lu

11:15-11:30 Pulmonary Embolization after Percutaneous Coronary Intervention: Prevention, Early Identification and Clinical Nursing Xiaomei Zhang

11:30-11:40 Prevention and Treatment of Transfusion Reaction during Percutaneous Coronary Intervention Fei Li

11:40-11:50 Bifurcation Stenting with IVUS and OCT Guidance Hao Wang


40


Challenging Case Review - Meet the Expert 2

8:00-12:00

Hall #11


Moderators Jiyan Chen, Lang Li

Commentators Tak W. Kwan Michael Lim Henry K. Lui Robaayah Zambahari

8:00-8:15 Treatment of Calcified Tortuous RCA Stenosis with 5-in-6 Terumo Guiding Catheter Ruiyan Zhang

8:15-8:30 Crush Aorto-Renal Stenting Massoud Ghasemi

8:30-8:45 Application of Sprinter Balloon in the Treatment of Angulated Coronary Lesion Xuchen Zhou

8:45-9:00 Vertebral and Subclavian Stenting Massoud Ghasemi

9:00-9:15 Nightmare in a Takayasu Case Hernan Chamorro

9:15-9:30 TBA Alexander Garcia Escuderio

9:30-9:45 Transcatheter Closure of Seconary Huge ASD Daxin Zhou

9:45-10:00 TBA Alexander De LaCasa


Moderators Jilin Chen, Wenyi Guo

Commentators Tao Hong Dalin Jia Xinghua Zhang Xingsheng Zhao

10:00-10:15 Miscarriage of Justice for Infarct- related Lesion Among Multiple Occluded Vessel in Acute Myocardial Infarction and Multiple Intracoronary Sub- acute Thrombosis Geng Wang

10:15-10:30 RCA Total Occlusion and Left Main Coronary Artery Disease Combined with Abnormality of origin of LAD Chenjun Zhang

10:30-10:45 Chronic Total Occlusion, Coronary Dissection and Abrupt Closure Hongyuan Xia

10:45-11:00 Complication Management of PCI for LAD Chronic Total Occlusion Bao Li

11:00-11:15 Successful Salvage of Patient underwent Primary PCI in Acute Myocardial Infarction Combined with Acute Stroke Defeng Pan

11:15-11:30 PCI of Left Main Coronary Artery with Cillote Technique Shaoxiang Wong

11:30-11:45 Application of Dedicated FrontierTM Stent in the Treatment of Bifurcation Lesion Shangyu Wen

11:45-12:00 Stent Dislodgement and Its Management Yuchen Zhang

41


Hall #12


Moderators Yong Huo, Lijun Guo

Commentators Yongming Hui Likun Ma Zheng Wan Hong Yuan

8:00-8:15 Transcatheter Aspiration in the Treatment of Intracoronary Thrombus on Acute Myocardial Infarction Ning Tan

8:15-8:30 Primary PCI Supporting by GuardWire in Acute ST Elevation Myocardial Infarction Hai Gao

8:30-8:45 Successful Management of Thrombus Containing Lesion in RCA Quanmin Jing

8:45-9:00 Left Main Bifurcation Lesion Weijie Li

9:00-9:15 Chronic Total Occlusion Yue Li

9:15-9:30 Retrograde Penetration Wiring and Balloon Dilation in Combination with Antegrade Seesaw Wiring Strategy in Treating Chronic Total Occlusion of Right Coronary Artery Qiong Wang

9:30-9:45 Intrastent Thrombosis after Kissing Stent Implantation Xiaojun Bai

9:45-10:00 Emergent PCI on Acute Myocardial Infarction Complicated with Cardiogenic Shock Yuxiao Zhang


Moderators Weimin Li, Xuchen Zhou

Commentators Jinqing Yuan Shulin Zhang Zhiwei Zhang Lijun Zhou

10:00-10:15 DES Implantation with Y-stenting to Treat Severe Ostial Stenosis Causing by Plaque Modification Chengxiang Li

10:15-10:30 Intracstent Sub-acute Thrombosis in Both LAD and LCX and Multiple Occlusions after Repeat PCI Jiandong Wu

10:30-10:45 PCI in LCX with Abnormality of Origin Yin Liu

10:45-11:00 Left Main Dissection Causing by the Treatment of LAD Yonggui Ge

11:00-11:15 Followed-up Angiography and IVUS of DES Implantation, What Is the Next Step? Zhan Gao

11:15-11:30 Multiple Intrastent Sub-acute Thrombosis Jianping Li

11:30-11:45 A Simple Strategy for Treating Distal Left Main Trifurcation Yong Wang

11:45-12:00 Successful Salvage of Acute Pericardiac Tamponade during PCI Procedure Bin Wang

42


Luncheon Workshops

12:15-13:15

Hall #2

Drug Therapy for AMI: COMMIT/CCS-2 StudySponsored by AstraZeneca

Moderator Runlin Gao


12:20-13:05 Drug Therapy for AMI: COMMIT/CCS-2 Study Lixin Jiang

13:05-13:20 Q&A


Hall #6

GuardWire System EZ Adaptor: A Saving Life Technology Sponsored by Medtronic

Moderator Jilin Chen

12:15-12:30 Clinical Indication of Embolic Protection Device and SAFER Trial Update Paul Hsien-Li Kao

12:30-12:45 AMI Clinical Trial in Hong Kong with Embolic Protection Device CK Chan

12:45-13:00 Does Emerald Trial represent the reality? Hongbing Yan

13:00-13:15 EZ Adaptor Introduction and Cases Sharing Chengxiang Li

13:15-13:20 Q&A


Hall #7

Interesting and Educational Case Reviews - Focus on the Complications of PCI by Trans-radial ApproachSponsored by Fu Wai HospitalModerator Shubin Qiao

Commentators Weimin Li Weimin Wang Lefeng Wang Shuyang Zhang Quanmin Jing Lei Wang Xianghua Fu

12:15-12:20 Objective

12:20-12:35 Case 1 with Comments Jun Dai

12:35-12:50 Case 2 with Comments Weixian Yang

12:50-13:05 Case 3 with Comments Bin Lu

13:05-13:20 Case 4 with Comments Haibo Liu


Hall #8

Interesting and Educational Case Reviews - Focus on the Complications of PCISponsored by An Zhen Hospital

Moderator Yundai Chen

Commentators Zhimin Du Shaoliang Chen Jianhua Zhu Wenyi Guo Yuanzhe Jin Xuchen Zhou

12:15-12:20 Objective

12:20-12:30 Case 1 with Comments Xiantao Song

12:30-12:40 Case 2 with Comments Shaoping Nie

12:40-12:50 Case 3 with Comments Yuechun Gao

12:50-13:00 Case 4 with Comments Yingxin Zhao

13:00-13:10 Case 5 with Comments Tong Liu

13:10-13:20 Case 6 with Comments Zhuxiao Ling


43

Live Case Centers

An Zhen Hospital, Beijing, CHINA

Operators: Shuzheng Lu Yundai Chen Fang Chen Changsheng Ma Yujie Zhou Hongbing Yan Zhizhong Li Weidong Zhang Quanming Zhao

Invited Operators: Martial Hamon Shing-Chiu Wong Ashok Seth

Cardiovascular Institute and Fu Wai Hospital, Beijing, CHINA

Operators: Runlin Gao

Jilin Chen Yuejin Yang Shubin Qiao Jianjun Li Xuewen Qin Min Yao Haibo Liu YongjianWu Jinqing Yuan Jue Chen Jun Dai Shijie You Pei Zhang Jie Qian Zhan Gao Chaowei Mu Kefei Dou Hong Qiu Shiliang Jiang Zhongying Xu Wei Hua Yan Yao

Invited Operators: Antonio Colombo Jeffrey W. Moses Hubert Seggewiss Gary S. Mintz Patrick W. Serruys Franz-Josef Neumann Peter Fitzgerald Mitchell W. Krucoff Eric Eeckhout Yaron Almagor Harry Suryapranata Toshiya Muramatsu Osamu Katoh Shigeru Saito Kazuaki Mitsudo Junko Honye Shouli Wang Lei Ge

Clinique Pasteur, Toulouse, FRANCE

Operators: Jean Fajadet Bruno Farah Jean Marco

Guangdong Province Cardiovascular Institute, Guangzhou, CHINA

Operators: Jiyan Chen Lijun Jin Jianfang Luo Ning Tan

Invited Operators: Giancarlo Biamino Samuel K. Mathew Huay Cheem Tan

44

Live Case Centers(continued)

Friendship Hospital, Beijing, CHINA

Operators: Lei Wang Hongwei Li Yuchen Zhang Hui Chen

Invited Operators: Shigeru Saito Ferdinand Kiemeneij Yuejin Yang Tak Sun Tse Weijie Li

New York-Presbyterian Hospital / Columbia University Medical Center, New York, USA

Operators: Martin B. Leon Gregg W. Stone Michael B. Collins George D. Dangas William A. Gray Edward M. Kreps Issam Moussa Robert J. Sommer

Peking University First Hospital, Beijing, CHINA

Operators: Yong Huo Tao Hong Ming Chen Jianping Li

Invited Operators: Marie-Claude Morice Teguh Santoso

Queen Elizabeth Hospital, Hong Kong, CHINA

Operators: Hung Kwong Duncan Ho Kam-Tim Chan Michael Kang-Yin Lee

Ruijin Hospital, Shanghai, CHINA

Operators: Weifeng Shen Ruiyan Zhang Qi Zhang Jiansheng Zhang Zhenkun Yang Jian Hu

Invited Operators: Costantino Costantini Paul Hsien-Li Kao

Scripps Memorial Hospital, La Jolla, USA

Operators: Richard Fortuna Maurice Buchbinder

Shenyang Northern Hospital, Shenyang, CHINA

Operators: Yaling Han Quanmin Jing Yingyan Ma Bo Luan Geng Wang Yanchun Liang

Invited Operators: Eberhard Grube Philip Wong

45

Thursday, April 6,2006

Hotel TV

20:00-21:30 Basic Course on PCI 1 � (15:00-16:30, 2006-4-6, Hall #2）

Selection and Application of Conventional and New Type Guiding Catheter Yuejin Yang

Improvement of Guidewire for PCI Jiyan Chen

Selection of Drug Eluting Stents Jilin Chen

Is There a Role for BMS in the Era of DES? Yong Huo

Nightmares in Catheterization Laboratory Guoliang Jia

21:30-23:00 Current Session 1- Why and How to Use IVUS (16:30-18:00, 2006-4-6, Hall #17) Pre-intervention IVUS Assessment of Intermediate Stenoses and Complex Lesions Junko Honye

Use of IVUS to Guide Stent Implantation and Assess Final Results Tino Costantini IVUS Assessment of Mechanisms of Restenosis Gary S. Mintz

How to Measure and Report IVUS Findings

Juying Qian Use of IVUS to Study Acute Coronary Syndromes and Arterioscleroses Progression and Regression

Junko Honye An Overview of New Intracoronary Imaging Modalities Gary S. Mintz

Friday, April 7,2006

Beijing International Convention Center TV

07:30-09:00 Live Case Transmission from Shenyang Northern Hospital, Shenyang (13:30-15:00, 2006-4-6, Hall #2)09:00-10:30 The Growing Body of DES Data from China: Final Results of China Cypher Select Registry (18:00-19:30, 2006-4-6, Hall #2) Final Clinical and Angiographic Results from A Nationwide Registry of the Cypher Select Sirolimus-eluting Stent Runlin Gao China Cypher Select Registry Subgroup Analysis - Bifurcation Shuzheng Lu China Cypher Select Registry Subgroup Analysis - Diabetes Mellitus Jilin Chen China Cypher Select Registry Subgroup Analysis - Small Vessel Disease Junzhu Chen China Cypher Select Registry Subgroup Analysis - Total Occlusion Yaling Han10:30-12:00 Live Case Transmission from Queen Elizabeth Hospital, Hong Kong (15:00-16:30, 2006-4-6, Hall #17)

13:30-15:00 Endeavor in Perspective (18:00-19:30, 2006-4-6,Hall #17) IVUS Findings on Endeavor - SAFETY Aspect Peter Fitzgerald Endeavor Clinical Updates - EFFICACY Aspect Spencer B. King III DES in Perspective Junbo Ge15:00-16:30 Live Case Transmission from Ruijin Hospital, Shanghai (16:30-18:00, 2006-4-6, Hall #2)

16:30-18:00 Live Case Transmission from New York-Presbyterian Hospital/Columbia University Medical Center, New York (8:00-9:30, 2006-4-7, Hall#1)

CIT TV Program

46

Hotel TV

20:00-21:30 TCT at CIT (9:30-11:00, 2006-4-7, Hall #1) TCT Crossfire: A Glimpse into the Future of Interventional Vascular Therapy Martin B. Leon, Gregg W. Stone Percutaneous Treatment of Aortic Valve Disease Eberhard Grube Drug-Eluting Stents Revisited: Current Limitations and Futuristic Platforms Jeffrey W. Moses Invasive Vulnerable Plaque Detection: Virtual Histology, OCT and Beyond Gary S. Mintz

21:30-22:30 Plenary Session 2-Invited lecture Training and Maintenance of Competence in Interventional Cardiology: the American Model Spencer B. King III Second Generation of Drug Eluting Stents: What Comes Next? Mitchell W. Krucoff Hypertrophic Cardiomyopathy: Catheter or Surgery Ulrich Sigwart

22:30-24:00 Plenary Session 4-EuroPCR at CIT How to Prepare a High Risk Patient before PCI (Pharmacology Environment) Franz-Josef Neumann PFO and ASD Closure: State-of- the-art Eric Eeckhout Multivessel Disease PCI versus Surgery: State-of-the-art Patrick W. Serruys Carotid stenting: State-of-the-art Giancarlo Biamino

Saturday, 8 April, 2006


07:30-09:00 Plenary Session 3-Live Case Transmission from Fu Wai Hospital, Beijing (13:30-15:00, 2006-4-7, Hall #1)

09:00-10:30 Deliver with Confidence - the First Second Generation Drug Eluting Stent TAXUS Liberte (18:00-19:30, 2006-4-7, Hall #2) Current PCI Challenges Versus New Technology: Strategies in Treating Complex PCI Antonio Colombo Unsurpassed Deliverability: TAXUS Liberte Platform Yaling Han Evidence Based Medicine in PCI: TAXUS Clinical Programs Yuejin Yang

16:30-18:00 Live Case Transmission from Clinique Pasteur, Toulouse (16:30-18:00, 2006-4-7,Hall #1)

13:30-15:00 International Symposium on Biodegradable DES (18:00-19:30, 2006-4-7, Hall #17) Axxess Plus - the First Drug Eluting Stent for the Treatment of Bifurcation Lesions Eberhard Grube Excel DES in Real World Experience Teguh Santoso BioMatrix DES - My Experience in the Real World Tian Hai Koh Overview of DES Era Peter Fitzgerald

15:00-16:30 Plenary Session 5-Live Case Transmission from Scripps Memorial Hospital, La Jolla (8:00-9:30, 2006-4-8, Hall #1)

16:30-18:00 Plenary Session 7-Live Case Transmission from Fu Wai Hospital, Beijing (10:30-12:00, 2006-4-8,Hall #1)

CIT TV Program(continued)

47

Hotel TV

20:00-21:00 Plenary Session 6-Invited Lecture (09:30-10:30, 2006-4-8, Hall #1) Myocardial Salvage David Holmes, Jr Drug Eluting Stents: Pathophysiology Renu Virmani Unprotected Left Main Stenting - Treatment of Bifurcation Complex Coronary Interventions Antonio Colombo Integrated Strategies for Treating Complex Lesions in Today's Stent Era Henry K. Lui

21:00-23:00 Basic Course on PCI 2 (10:00-12:00, 2006-4-8, Hall # 2) Indication for PCI: from Clinical Practice to ESC Guideline 2005 Weifeng Shen How to Make Decision for Complete or Incomplete Revascularization? Guoying Zhu Unprotected Left Main Intervention: Is Evidence Enough? Yaling Han Optimal Strategy of Percutaneous Intervention for Bifurcation Lesions Junbo Ge Guideline and Practice of Anti- thrombotic Therapy with PCI Weimin Li Lipid Lowering Therapy in PCI Wei Gao Reperfusion Therapy for Acute Myocardial Infarction: from Guideline to Practice Ben He PCI in Patient with Heart Failure and/or Renal Dysfunction Yujie Zhou

23:00-00:10 Concurrent Session 3-TRI Club (8:10-9:20, 2006-4-8,Hall #17)

Live Case Transmission from Friendship Hospital, Beijing Minimally Invasive strategies in PCI Martial Hamon Trans-radial Carotid and Vertebral Interventions Chiung-Jen Wu



07:30-09:00 The SPIRIT of XIENCE: Broken Cocoon Butterfly - from Vision to XIENCE The Best of Bare Metal: A Vision of Usage in Real World Setting Mitchell W. Krucoff Xience V Compared with other DES Renu Virmani Second Generation Drug Eluting Stent: Xience V Program and SPIRIT Trials Patrick W. Serruys09:00-10:00 Live Case Transmission from Guangdong Province Cardiovascular Institute, Guangzhou (13:30-14:30, 2006-4-8, Hall #1)0:00-11:30 Evidence-based Medicine: Firebird in Real World (18:00-19:30, 2006-4-8, Hall #17) Comparison Study of Firebird with Cypher and Taxus in Daily Clinical Practice Shubin Qiao 30-days Clinical Outcomes from A Nationwide Firebird Rapamycin Eluting Stent Registry - Firebird in China Study Runlin Gao First 6-months Follow-up Results from Latin American Firebird Registry Salvador Villablanca One-year Clinical Outcomes of Chinese Sirolimus Eluting Stent in Treating Unselected Patients with Coronary Artery Disease - a "Real-world" Prospective Multi-center Registry Qi Zhang11:30-12:15 Live Case Transmission from Peking University First Hospital, Beijing (15:00-15:45, 2006-4-8, Hall #1)

CIT TV Program(continued)

48

大会欢迎辞

各位专家教授和各位同仁：

中国介入心脏病学大会(CIT)2006暨TCT at CIT和EuroPCR at CIT将于2006年4月6日至9日在北京国际会议中心召开。我谨代表大会组委会和中华医学会心血管病学分会诚挚地邀请您参与此次盛会。

本届大会由中华医学会心血管病学分会、中华医学会、中国介入心脏病学大会

(CIT)理事会、心血管研究基金会 - TCT、 Europa组织 - EuroPCR联合主办。协办单位包括中国工程院医药卫生工程学部、日本镰仓介入演示会组委会、香港心脏病学院、

亚太介入心脏病学会、中华医学杂志英文版、中华心血管病杂志、美国纽约长老会医

院/哥伦比亚大学医疗中心、法国图卢兹巴斯德医院、美国圣地亚哥SCRIPPS纪念医院、香港伊丽莎白女王医院、广东心血管病研究所、沈阳军区总医院、北京安贞医院、北

京大学第一医院、北京友谊医院、上海瑞金医院和阜外心血管病医院。

本次会议期间TCT和EuroPCR将与CIT举行联合学术活动。TCT at CIT安排在2006年4月7日上午，EuroPCR at CIT安排在当日下午。届时来自TCT和EuroPCR的国外著名专家将主持会议、进行重点学术报告及主持现场转播的美国纽约长老会医

院/哥伦比亚大学医疗中心和法国图卢兹巴斯德医院的示教手术演示。

自2003年举办第一届会议以来，CIT大会已经成为国内介入心脏病学领域规模最大的学术会议和最具教育意义的教学课程之一。大会内容包括现场手术转播、特

邀报告、病例回顾以及讨论、研讨会、卫星会、模拟器演示课程，论文摘要口头发

言等等。会议的学术议题涉及冠脉介入、外周血管介入、先天性心脏病、瓣膜病以

及心律等方面的最新进展和技术演示。

我们预计大会将有超过2500名包括心脏病领域、放射领域、血管病领域和其它相关卫生领域内的专家、学者以及企业合作伙伴前来与会。与会代表可以通过大会

与同道们进行专业领域内的最新研究和动态的学术交流，以此来增进彼此间的友谊，

促进双方的合作。大会同时也给予了各企业、公司展示自己在相关学术领域的最新

研究成果的机会。

北京是一座具有丰富文化历史和古迹的城市。北京也是一座现代化的国际大都市。

我真诚的希望各位代表在北京与会期间生活愉快！

高润霖教授CIT2006大会主席

中华医学会心血管病学分会主任委员

49

会议组织结构

主席

高润霖

联合主席 (按姓氏拼音排序)

Chu Pak Lau, MD Martin B. Leon, MD Yean Leng Lim, MD, PhD Jean Marco, MD

Shigeru Saito, MD Patrick W. Serruys, MD, PhD Gregg W. Stone, MD Robaayah Zambahari, MD 中方联合主席 (按姓氏拼音排序)

陈纪林陈纪言戴汝平葛均波韩雅玲

胡大一黄德嘉霍勇贾国良吕树铮

沈卫峰王方正杨跃进张澍朱国英

组织委员会名誉主席

吴明江赵楷胡盛寿 Yasuhiko Wanibuchi 林曙光

专家指导委员会 (按姓氏拼音排序)

陈灏珠陈明哲� 陈树兰� 陈新 � 陈在嘉

崔长琮� 戴闺柱戴玉华� 杜日映方圻 �

冯建章龚兰生� 顾复生郭静萱� 何秉贤

何梅先胡盛寿黄体钢� 黄永麟蒋文平

金宏义柯若仪柯元南李庚山� 李华泰

林曙光刘国仗刘力生刘万车刘晓程

刘伊丽刘玉清陆再英孟繁超� 戚文航

钱学贤� 钱贻简邵建华沈潞华孙瑞龙

王彬尧王杰 � 王士雯吴宁 � 吴印生

吴兆苏闫西艴曾定尹� 张运诸骏仁

祝善俊朱文玲

学术委员会 (按姓氏拼音排序)

Yaron Almagor, MD Giancarlo Biamino, MD Maurice Buchbinder, MD 曹克将

陈君柱� Chung Seung Chiang, MD Antonio Colombo, MD 杜志民

Eric Eeckhout, MD, PhD 方唯一 � Richard Fortuna, MD 盖鲁粤

高炜� 郭文怡� Eberhard Grube, MD David Holmes, Jr, MD

黄从新� 贾三庆� 蒋世良� Osamu Katoh, MD

Ferdinand Kiemeneij, MD, PhD Spencer B. King III, MD Tian Hai Koh, MD Mitchell W. Krucoff, MD

李建军� 李为民� 李占全� 马长生

毛节明� Gary S. Mintz, MD Kuzuaki Mitsudo, MD Marie-Claude Morice, MD

Jeffrey W. Moses, MD Franz-Josef Neumann, MD Thach Nguyen, MD 乔树宾

秦学文� Ulrich Sigwart, MD Harry Suryapranata, MD Huay Cheem Tan, MD

Renu Virmani, MD 王建安� 王海昌� 王乐丰

王伟民� 吴书林� 杨新春� 杨延宗

姚民

50

主席团

组织委员会 (按姓氏拼音排序)

陈韵岱陈绍良

方全葛雷

何奔� 华伟 �

Hung Kwong Duncan Ho

洪涛黄振文

姜永茂� 荆全民

李广平李浪 �

李新明刘海波�

柳茵罗建方�

马素云倪幼芳�

聂绍平� 钱菊英

王雷吴永健�

徐波颜光烈�

颜红兵张瑞岩�

张抒扬周玉杰

境外主席团 (按姓氏拼音排序)

Rajiv Agarwal, MDIndiaYaron Almagor, MD IsraelDibya Kumar Baruah,MD IndiaGiancarlo Biamino,MD GermanyMaurice Buchbinder, MD USAWacin Buddhari, MD ThailandKam-Tim Chan, MD Hong KongBoron CW Cheng, MD Hong KongChung-Seung Chiang,MD Hong KongKenneth Chin, MD MalaysiaAntonio Colombo, MD ItalyCostantino Costantini, MD ArgentinaTino Costantini, MD ArgentinaLuis De la Fuente, MD Argentina

Devang Desai, MDIndia

Gerard Devlin, MDNew Zealand

Eric Eeckhout, MD, PhD Switzerland

Jean Fajadet, MD France

Peter Fitzgerald, MD, PhD USA

Richard Fortuna, MD USA

Eberhard Grube, MD Germany

Martial Hamon, MD

FranceTetsuya Hata, MD JapanTan Kim Heung, MDMalaysiaDavid Holmes, Jr, MD USAJunko Honye, MD JapanLuigi Inglese, MD ItalyMohammad Ishaq, MD PakistanRaul D. Jara, MD PhilippinesNigel Jepson, MD AustraliaYoshifumi Kan, MD JapanHo-nin Kanaya, MD JapanHideaki Kaneda, MD JapanOsamu Katoh, MD JapanFerdinand Kiemeneij, MD, PhD The NetherlandsSpencer B. King III, MD USATian Hai Koh, MD SingaporeMitchell W. Krucoff, MD USATak W. Kwan, MD USAKai Huat Lam, MD Malaysia

Martin B. Leon, MD USAMichael Lim, MD SingaporeRichard Lim, MD AustraliaYean Leng Lim, MD, PhD AustraliaYean Teng Lim, MD SingaporeHenry K. Lui, MD USASidney Tsz Ho Lo, MD AustraliaSimon Lo, MD MalaysiaHugo F. Londero, MDArgentinaJean Marco, MD FranceMotomaru Masutani, MDJapanSamuel K. Mathew, MD IndiaPeter A. McCullough, MD USAIchiro Michishita, MDJapanGary S. Mintz, MD USAKazuaki Mitsudo, MDJapanMarie-Claude Morice, MD FranceJeffery W. Moses, MDUSACol Mujeeb-Ul-Haq, MD PakistanToshiya Muramatsu, MD JapanFranz-Josef Neumann, MD GermanyRichard Ng, MD SingaporeSwee Choon Ng, MD MalaysiaThach Nguyen, MDUSASeong-Wook Park, MDKoreaTejas M. Patel, MD IndiaGia Khai Pham, MDVietnam

Manh Hung Pham, MD VietnamJenny Zhen Qin, MS, RN, CCRC USASufia Rahman, MD BangladeshWitold Ruzyllo, MDPolandShigerou Saito, MD JapanHideaki Sakai, MD JapanRamesh S. Saligrama, MD IndiaAlberto Sampaolesi, MDArgentinaTeguh Santoso, MDIndonesiaIvan K. De ScheerderBelgiumHubert Seggewiss, MDGermanyPatrick W. Serruys, MD, PhD The NetherlandsAshok Seth, MD IndiaG. L. Sharma, MD IndiaEak-Kyun Shin, MD KoreaUlrich Sigwart, MD SwitzerlandKui-Hian Sim, MDMalaysiaPieter R. Stella, MD The NetherlandsGregg W. Stone, MD USAHarry Suryapranata, MD The NetherlandsRurus Suryawan, MD IndonesiaAkihiko Takahashi, MDJapanHuay Cheem Tan, MDSingaporeShinji Tanaka, MD JapanShin-ichi Tohyama, MD JapanShailendra Trivedi, MDIndiaWasan Udayachalerm, MDThailand

51

主席团

George W. Vetrovec, MD USASalvador Villablanca, MD ChileRenu Virmani, MD USAMarco Wainstein, MD, PhD BrazilJie Wang, MD, PhD USAMalcolm West, MD AustraliaShing-Chiu Wong, MD USARobaayah Zambahari, MD Malaysia

境内主席团(按姓氏拼音排序)

� 包务业� 蔡尚郎�

� 蔡运昌� 曹克将�

� 陈方 � 陈纪林

� 陈纪言� 陈珏

� 陈君柱� 陈柯萍�

� 陈良龙� 陈明龙

� 陈绍良� 陈韵岱�

� 程晓曙� 崔连群�

� 戴军 � 戴汝平

� 党群 � 邓华

� 丁燕生� 董建增�

� 杜修海� 杜志民

� 范中杰� 方全

� 方唯一� 冯燕光�

� 傅国胜� 傅向华

� 傅向阳� 盖鲁粤�

� 高润霖� 高润芝�

� 高炜 � 葛均波

� 葛雷 � 关振中�

� 管军 � 郭继鸿�

� 郭丽君� 郭涛

� 郭文怡� 郭新贵�

� 韩立宪� 韩雅玲�

� 何奔 � 何国祥

� 何青 � 洪涛

� 侯玉清� 胡大一�

� 华伟 � 黄超联

黄从新� 黄德嘉�

黄峻 � 黄岚

黄连军� 黄伟剑

黄振文� 黄佐

惠永明霍勇

贾大林� 贾国良

贾三庆� 贾绍斌�

江洪 � 江时森�

姜铁民 � 姜卫剑

姜永茂� 姜玉茹 �

蒋宝琦� 蒋金法�

蒋世良� 蒋雄京

金惠根� 金元哲�

金征宇� 靳立军�

荆全民� 李保

李川 � 李广平�

李国庆� 李继福�

李建军� 李康

李浪 � 李淑梅�

李田昌� 李为民�

李新明� 李学奇

李占全� 凌峰

刘朝中� 刘国树�

刘海波� 刘惠亮

刘健 � 刘建平�

刘坤申� 刘梅林�

刘少稳� 刘唐威

刘同库� 刘晓方�

刘旭 � 刘亚君�

刘寅 � 刘幼文

柳茵 � 卢才义

吕宝经� 吕吉元�

吕树铮� 罗建方

罗开良� 马长生�

马根山� 马虹

马坚 � 马礼坤

马茂儒� 马素云�

马业新� 马依彤�

毛节明� 孟庆恒

苗志林� 倪幼芳�

聂绍平� 浦介麟�

齐国先� 齐向前

齐晓勇� 钱杰

钱菊英� 乔树宾�

秦勤 � 秦学文

秦永文� 曲鹏

任自文� 商丽华�

尚晓明 � 沈法荣

沈卫峰� 沈珠军�

施海明� 宋现涛�

苏日希� 孙宝贵

孙福成� 孙英贤�

唐礼江� 田军

万征 � 王德

王东琦� 王方正�

王风 � 王凤芝�

王广义� 王海昌

王建安� 王乐丰�

王雷 � 王连芹�

王明生� 王宁夫

王齐兵� 王庆胜�

王守力� 王伟民�

王焱 � 王勇

王禹 � 王玉堂�

王祖禄� 魏盟

温沁竹� 温尚煜

吴建国� 吴立群�

吴其明� 吴书林�

吴学思� 吴永健

吴中学� 吴宗贵�

徐标 � 徐波

徐亚伟� 徐泽升

徐仲英� 许锋

许静 � 许力舒 �

严激 � 严晓伟

颜光烈� 颜红兵�

杨杰孚� 杨树森�

杨天伦� 杨廷树

杨新春� 杨延宗�

杨跃进� 杨志健�

姚民 � 姚焰

衣为民� 尹荣秀�

尤士杰� 于波

袁洪 � 袁晋青

袁祖贻� 张大东�

张代富� 张建盛�

张奎俊� 张荣林

张瑞岩� 张瑞云�

张抒扬� 张树林�

张澍 � 张兴华

张钲 � 张智伟�

赵炳让� 赵林阳�

赵世华� 赵兴胜

郑宏 � 郑强荪�

周爱卿� 周建庆�

周立君� 周胜华

周旭晨� 周颖玲�

周玉杰� 周赞

朱国英� 朱建华

朱立光� 朱鲜阳�

邹英华

田梦

黄莉

陈凯

李丹

陈晨

秘书处

52

会议信息

7.展览本次会议期间同时举行心脏介入相关医药器械等方面的展览。

展览地点：北京国际会议中心一层2号展厅

展览时间：4月7-8日 9:00-17:00 4月9日 9:00-15:00

1.会议时间 2006年4月6日-9日

2.会议地点北京国际会议中心

北京市朝阳区北辰东路8号邮编：100101 电话：010-84973060

3.会议语言 CIT2006会议正式语言为英语，其中2 号会议厅为中文会场，1号会议厅和17 号会议厅为英文会场，配备现场同声翻译，届时请在国际会议中心各会议厅门口办理同传耳机租用手续。

4.代表标识胸卡是参会代表的标识。

� 请在参加会议活动和使用茶点时佩戴胸卡。

� 没有佩带胸卡的代表将无法进入会场听会。

佩戴白色胸卡的为会议正式代表；

佩戴蓝色胸卡的为参展公司代表；

佩戴红色胸卡的为会议工作人员。

5.茶歇大会将在4月7日-9日

10:00-10:45和15:00-15:45 在北京国际会议中心提供茶歇。

6.用餐本次会议进餐地点如下，请凭餐券就餐。

8.会议重要活动安排

开幕式

地点：北京国际会议中心二层一号会议厅

时间：2006年4月7日早7:30-8:00 注意事项：厅内不得吸烟

9.学术交流

A．学术交流日程

学术交流完全按大会最终日程册安排进行，请发言的代表注意自己的发言日期和时间并提前作好准备。

B．幻灯片

本次大会备有试片室（北京国际会议中心二层2016房间），请发言的代表在发言前至少半天去试片室将您的幻灯片（或光盘、U盘、软盘）进行试片 (上午发言的请于前一天下午试片)，然后直接将片盒 (或光盘、U盘、软盘 ) 交给试片室工作人员，发言完毕再到试片室取回。

C．试片室开放时间

4月6日 08:00 - 18:00 4月7-9日 07:30 - 18:00

10.返程票预定

大会将在报到现场为代表提供办理机票和火车票的服务，请需要的代表于报到当日到大会票务代理处咨询办理。大会票务代理将尽量满足您的要求，但不能完全保证车次和班次，对此请予以谅解。

早餐午餐晚餐

4月6日五洲大酒店五洲大酒店

二层大宴会厅二层大宴会厅

4月7日代表所在酒店用餐国际会议中心午餐盒五洲大酒店

二层大宴会厅


二层大宴会厅


二层大宴会厅

53

会议日程一览表

07:3

0-08

:00

08:0

0-08

:30

08:3

0-09

:00

09:0

0-09

:30

09:3

0-10

:00

10:0

0-10

:30

10:3

0-11

:00

11:0

0-11

:30

11:3

0-12

:00

12:0

0-12

:30

12:3

0-13

:00

13:0

0-13

:30

13:3

0-14

:00

14:0

0-14

:30

14:3

0-15

:00

15:0

0-15

:30

15:3

0-16

:00

16:0

0-16

:30

16:3

0-17

:00

17:0

0-17

:30

17:3

0-18

:00

18:0

0-18

:30

18:3

0-19

:00

19:0

0-19

:30

注

册20

06年

4月6日

星期四

2006年

4月7日

星期五

2006年

4月8日

星期六

2006年

4月9日

星期日

1号厅

2号厅

17号

厅

1号厅

2号厅

17号

厅

AB

CD

厅

1号厅

2号厅

17号

厅

7, 8

, 11,

12号

厅

AB

CD

厅

1号厅

2号厅

17号

厅

7, 8

, 11,

12号

厅

开幕

辞手

术转

播-

哥伦

比亚

大学

医疗

中心

/纽约

长老

会医

院TC

T at

CIT

特邀

报告

模拟

器教

程

手术

转播

-圣

地亚

哥Sc

rip

ps

纪念

医院

特邀

报告

手术

转播

-北

京阜

外医

院

手术

转播

-北

京阜

外医

院冠

脉介

入基

本教

程

“经

桡动

脉介

入治

疗”

俱乐

部及

手术

转播

-北

京友

谊医

院

“挑

战性

”病

例讨

论 1

模拟

器教

程

手术

转播

-北

京安

贞医

院特

邀报

告手

术转

播-

北京

安贞

医院

CTO

俱乐

部及

慢性

完全

闭塞

病变

手术

转播

专场

-北

京阜

外医

院

第一

届护

士和

技术

人员

研讨

会

“挑

战性

”病

例讨

论 2

CIT

2005

示教

病例

临床

随访

手术

转播

-沈

阳军

区总

医院

冠脉

介入

基本

教程

手术

转播

-上

海瑞

金医

院

手术

转播

-香

港伊

丽莎

白女

王医

院为

什么

和怎

样应

用血

管内

超声

手术

转播

-北

京阜

外医

院Eu

roPC

R at

CIT

手术

转播

-图

卢兹

巴斯

德医

院

心律

失常

手术

转播

-北

京阜

外医

院

午间

研讨

会

(2,5

-1, 5

-2, 5

-

3,5-

4, 5

-5,5

-6,

6,7,

8,1

7号厅

)

模拟

器教

程

手术

转播

-广东

省心

血管

病研

究所

特邀

报告

手术

转播

-北

京大

学第

一医

院特

邀报

告手

术转

播-

北京

阜外

医院

特邀

报告

冠脉

介入

基本

教程

手术

转播

-广东

省心

血管

病研

究所

冠脉

介入

基本

教程

手术

转播

-北

京大

学第

一医

院冠

脉介

入基

本教

程

亚太

和拉

美介

入心

脏病

学热

点论

坛

论文

交流

模拟

器教

程

特邀

报告

内外

争鸣

发奖

、总

结和

闭幕

辞

晚间

卫星

会

(2,1

7号厅

)

54


2号厅

CIT2005示教病例临床随访

主持人乔树宾, 陈韵岱

12:00-12:20 阜外医院示教病例随访结果刘海波

12:20-12:35 沈阳军区总医院示教病例随访结果王守力

12:35-12:50 伊丽莎白女王医院示教病例随访结果 Chung-Seung Chiang

12:50-13:05 湘南镰仓总医院示教病例随访结果 Shinji Tanaka

13:05-13:20 北京安贞医院示教病例随访结果宋现涛

13:20-13:30 讨论

13:30-15:00 手术转播-沈阳军区总医院

主持人 Spencer B. King III, 陈纪言

讨论者 Ramesh S. Saligrama Marco Wainstein 王雷王勇 Chee Wo Wu 许锋

术者 Eberhard Grube, Philip Wong, 韩雅玲

冠脉介入基本教程1

主持人毛节明, 曾定尹

15:00-15:16 传统和新型引导导管的选择和应用杨跃进

15:16-15:32 PCI导引钢丝的改进陈纪言

15:32-15:48 药物洗脱支架的选择陈纪林

15:48-16:04 药物洗脱支架时代金属裸支架的角色霍勇

16:04-16:20 导管室的噩梦贾国良

16:20-16:30 讨论

16:30-18:00 手术转播-上海瑞金医院

主持人 Hugo F. Londero, 方唯一

讨论者 Nigel Jepson 蒋雄京 Sidney Tsz Ho Lo Alberto Sampaolesi 施海明 Salvador Villablanca 徐亚伟

术者 Costantino Costantini, 沈卫峰, Paul Hsien-Li Kao, 张瑞岩

17号厅

同步分会1 - 为什么和怎样应用血管内超声

主持人 Gary S. Mintz, 葛均波

15:00-16:30 手术转播-香港伊丽莎白女王医院

协同主持 Chung-Seung Chiang

讨论者 Tino Costantini Junko Honye 钱杰钱菊英 Huay Cheem Tan 王焱王禹

术者 Hung Kwong Duncan Ho, Kam-Tim Chan, Michael Kang-Yin Lee

16:30-16:45 术前临界狭窄和复杂病变的血管内超声评估 Junko Honye

16:45-17:00 应用血管内超声指导支架置入和评价最终结果 Tino Costantini

17:00-17:15 血管内超声评价再狭窄的机制 Gary S. Mintz

17:15-17:30 怎样测量和报告血管内超声的发现钱菊英

17:30-17:45 应用血管内超声研究急性冠脉综合征和粥样硬化的进展和消退 Junko Honye

17:45-18:00 新型冠脉内影象设备的概论 Gary S. Mintz

55


晚间卫星会

18:00-19:30

2号厅

来自中国不断发展中的药物洗脱支架数据：中国Cypher Select注册登记研究的最终结果

Cordis, a Johnson and Johnson Company主办

主席杜志民, 盖鲁粤, 霍勇, 王乐丰, 王伟民

18:00-18:05 简介

18:05-18:25 全国性Cypher Select雷帕霉素药物洗脱支架注册登记研究最终临床和造影结果高润霖

18:25-18:40 中国Cypher Select注册登记研究分叉病变亚组分析吕树铮

18:40-18:55 中国Cypher Select注册登记研究糖尿病亚组分析陈纪林

18:55-19:10 中国Cypher Select注册登记研究小血管病变亚组分析陈君柱

19:10-19:25 中国Cypher Select注册登记研究完全闭塞病变亚组分析韩雅玲

19:25-19:30 讨论和总结

17号厅

Endeavor药物洗脱支架前景展望

Medtronic主办

主席高润霖

主持人陈纪言, 杨跃进

翻译刘健

18:00-18:05 简介

18:05-18:30 Endeavor植入后血管内超声结果－安全性方面 Peter Fitzgerald

18:30-18:55 Endeavor临床最新进展－有效性方面 Spencer B. King III

18:55-19:15 药物洗脱支架前景展望葛均波

19:15-19:25 问答

19:25-19:30 总结

56


1号厅

7:30-8:00 开幕式

主席高润霖

联合主席陈纪林, 陈纪言, 葛均波, 韩雅玲, 胡大一黄德嘉, 霍勇, 贾国良, 吕树铮, 沈卫峰, 杨跃进, 朱国英

大会1-TCT at CIT

主持人 Jeffrey W. Moses, Gary S. Mintz

8:00-9:30 手术转播-纽约长老会医院 / 哥伦比亚大学医疗中心

协同主持高润霖

讨论者陈纪言

Peter Fitzgerald

葛均波

Eberhard Grube

David Holmes, Jr

Spencer B. King, III

Mitchell W. Krucoff

Shigeru Saito

杨跃进

术者 Martin B. Leon, Gregg W. Stone, Michael B. Collins, George D. Dangas, William A. Gray, Edward M.Kreps, Issam Moussa, Robert J. Sommer

9:30-10:00 TCT"交叉火力"：血管介入治疗的未来

Martin B. Leon, Gregg W. Stone

TCT热点

10:00-10:20 经皮主动脉瓣治疗

Eberhard Grube

10:20-10:40 再谈药物洗脱支架：当前的局限性和未来的平台 Jeffrey W. Moses

10:40-11:00 创伤性易损斑块检测：VH、OCT及更远

Gary S. Mintz

大会2-特邀报告

主持人方圻, 陈灏珠, Tak-Fu Tse

11:00-11:18 心脏介入医师能力的培训和保持：美国模式 Spencer B. King III

11:18-11:36 第二代药物洗脱支架：继而是什么？ Mitchell W. Krucoff

11:36-11:54 肥厚心肌病：导管还是手术？ Ulrich Sigwart

11:54-12:00 讨论

大会3-手术转播-阜外心血管病医院

13:30-15:00

主持人 Eberhard Grube, 杨跃进

讨论者陈良龙韩雅玲 David Holmes, Jr 靳立军李占全吕树铮 Samuel K. Mathew Ulrich Sigwart Pieter R. Stella Robaayah Zambahari

术者 Antonio Colombo, Jeffrey W. Moses, Hubert Seggewiss, 乔树宾

IVUS解说 Gary S. Mintz

14:55-15:00 肥厚梗阻型心肌病间隔消融的最新进展 Hubert Seggewiss (自导管室转播至会场)

大会4-EuroPCR at CIT

主持人 Patrick W. Serruys, Marie-Claude Morice

EuroPCR当代最新观点报告

15:00-15:15 在经皮冠脉介入治疗前怎样准备高危病人(药物环境)? Franz-Josef Neumann

15:15-15:20 讨论

15:20-15:35 卵圆孔未闭和房间隔缺损封堵：

� � 当代最新观点 Eric Eeckhout

15:35-15:40 讨论

57


15:40-15:55 多支血管病变经皮冠脉介入和搭桥手术对比：当代最新观点 Patrick W. Serruys

15:55-16:00 讨论

16:00-16:20 颈动脉支架术：当代最新观点 Giancarlo Biamino

16:20-16:30 讨论和总结

16:30-18:00 手术转播-图卢兹巴斯德医院

协同主持高润霖

讨论者陈纪林 Giancarlo Biamino Eric Eeckhout Martial Hamon 霍勇 Yean Leng Lim Franz-Josef Neumann Shigeru Saito 沈卫峰

术者 Jean Fajadet, Bruno Farah, Jean Marco

2号厅

同步分会2 - 心律失常

主持人陈新, 孙瑞龙, 陈明哲, 黄永麟

13:30-13:50 波士顿房颤会议热点介绍马坚

13:50-14:10 房颤导管消融术：一线还是二线治疗马长生

14:10-14:30 房颤的导管消融治疗：共识与问题杨延宗

14:30-14:50 房颤导管射频消融术后房性心律失常的机制及处理吴书林

14:50-15:10 无症状预激综合征-风险与处理策略黄从新

15:10-15:30 ICD临床应用-指南与现实的差距黄德嘉

15:30-15:50 磁导航心血管介入-作用及前景曹克将

15:50-16:10 生理性起搏新概念王方正

16:10-16:30 心脏同步化治疗(CRT)建议/指南张澍

16:30-18:00 手术转播-阜外心血管病医院

病例 1 房颤 / 室速射频消融术

讨论者杨新春刘少稳董建增陈明龙

术者姚焰

病例 2 CRT / ICD植入术

讨论者方全孙宝贵沈法荣杨杰孚

术者华伟

ABCD厅8:00-12:00 模拟器教程

A厅美敦力课程

B厅强生课程

C厅贝朗课程

D厅泰尔茂课程

13:30-18:00 模拟器教程

A厅美敦力课程

B厅强生课程

C厅贝朗课程

D厅泰尔茂课程

午间研讨会

12:15-13:15

2号厅

Genous - 自然修复的新篇章

OrbusNeich主办

主持人高润霖, 杨跃进, Eberhard Grube

12:15-12:20 简介

58


12:20-12:45 内皮祖细胞捕获技术和HEALING II临床结果 Patrick W. Serruys

12:45-13:10 Genous生物工程支架：HEALING临床研究的发展 Harry Suryapranata

13:10-13:20 问答

13:20-13:25 总结

17号厅

阿司匹林在动脉硬化性心血管疾病中的临床应用：中国专家共识

Bayer主办

主持人高润霖, 徐成斌

12:15-12:20 简介

12:20-13:05 阿司匹林在动脉硬化性心血管疾病中的临床应用：中国专家共识李小鹰

13:05-13:20 问答

13:20-13:25 总结

5-1号厅

在靶病变血管重建率较低的时代如何分辨DES 的优劣?


主持人韩雅玲, 黄德嘉, 朱国英

12:15-12:20 简介

12:20-12:45 为何晚期管腔丢失成为首要终点?它对临床结果的意义 David Holmes, Jr

12:45-13:10 Cypher最新研究成果 - ACC以及其他 Shing-Chiu Wong

13:10-13:20 问答

13:20-13:25 总结

5-2号厅

心房颤动的治疗2005 - 2006


主持人王方正, 张澍

12:15-12:45 心房颤动治疗: 目前建议/指南(2006) 黄从新

12:45-13:15 房颤导管消融术的前景展望马长生

13:15-13:25 讨论和总结

5-3号厅

疑难病变的解决策略

Medtronic主办

主持人霍勇

12:15-12:35 疑难病变的器械选择周玉杰

12:35-12:55 Cougar使用经验分享 Kai Huat Lam

12:55-13:15 疑难病变的解决策略葛均波

13:15-13:20 问答

13:20-13:25 总结

5-4号厅

前呼后应, 前途广阔 - 优化药物支架治疗结果

Guidant主办

主持人陈纪言, 乔树宾

12:15-12:35 循证医学：合理使用球囊以优化药物支架治疗结果马长生

12:35-12:55 病例报道：通过预扩张降低药物支架再狭窄方唯一

12:55-13:15 病例报道：利用后扩张优化药物支架治疗结果王海昌

13:15-13:20 问答

13:20-13:25 总结

59


5-5号厅

Firebird临床研究交流

微创公司主办

主持人张大东, 王伟民, 马依彤

12:15-12:30 国产与进口雷帕霉素药物洗脱支架临床应用对比观察高阅春

12:30-12:45 Firebird在糖尿病患者中应用王耿

12:45-13:00 Firebird雷帕霉素药物洗脱支架治疗冠心病的近远期疗效观察王凯

13:00-13:15 国产药物支架预防再狭窄的临床应用金贤

13:15-13:25 讨论和总结

5-6号厅

造影剂肾病-介入心脏病学的致命缺陷

GE Health Care主办

主持人何奔

12:15-12:20 简介

12:20-12:50 造影剂肾病-预防与策略 Peter A. McCullough

12:50-13:10 慢性肾功能不全患者的PCI治疗策略周玉杰

13:10-13:15 问答

13:15-13:20 总结

6号厅

复杂介入治疗研讨会

Invatec主办

主持人吕树铮, 罗建方

12:15-12:20 简介

12:20-12:50 颈动脉支架的植入 Giancarlo Biamino

12:50-13:10 冠脉内血栓的处理吕树铮

13:10-13:20 问答

13:20-13:25 总结

7号厅

介入治疗从开始直至终止：支架植入后的并发症以及术后止血的临床价值

St. Jude Medical主办

主持人王乐丰, 钱菊英

12:15-12:20 简介

12:20-12:50 韩国药物支架应用及支架内血栓的问题 Eak-Kyun Shin翻译：� 李怡

12:50-13:10 股动脉与桡动脉介入途径的比较及血管闭合器的临床应用价值戴军

13:10-13:20 问答

13:20-13:25 总结

8号厅

PTCA患者的血脂管理的新动态

MSD主办

主持人高润霖, 胡大一

12:15-12:45 强化降脂能持否？胡大一

12:45-13:15 强化降脂=斑块逆转？赵水平

13:15-13:25 讨论和总结

晚间卫星会

18:00-19:30

2号厅

掌握在手,自由在心 - 第一个第二代药物洗脱支架TAXUS Liberte

Boston Scientific主办

主席高润霖

主持人葛均波, 霍勇, 沈卫峰

18:00-18:05 简介

18:05-18:45 迎接挑战: 复杂PCI治疗新技术,新策略 Antonio Colombo翻译: 葛雷

60


18:45-19:00 无以伦比的通过性: TAXUS Liberte支架平台技术韩雅玲

19:00-19:15 循证医学在PCI的实践: TAXUS临床试验进展杨跃进

19:15-19:25 问答

19:25-19:30 总结

17号厅

国际生物降解药物洗脱支架研讨会

Biosensors和吉威医疗主办

主席高润霖

主持人朱国英, 吕树铮, 韩雅玲

18:00-18:05 简介

18:05-18:25 第一个用于分叉病变治疗的药物洗脱支架Axxess Plus Eberhard Grube

18:25-18:40 Excel药物洗脱支架的真实体验 Teguh Santoso

18:40-18:55 我使用BioMatrix药物洗脱支架的真实体验 Tian Hai Koh

18:55-19:15 对药物洗脱支架时代总的观点 Peter Fitzgerald

19:15-19:25 问答

19:25-19:30 总结

61


1号厅

大会5 - 手术转播-圣地亚哥Scripps纪念医院

08:00-09:30

主持人 David Holmes, Jr, 霍勇

讨论者 Wacin Buddhari Antonio Colombo Luigi Inglese Tak W. Kwan Henry K. Lui Ivan K. De Scheerder 沈珠军 Renu Virmani 王宁夫朱建华

术者 Richard Fortuna Maurice Buchbinder大会6 - 特邀报告

主持人 Robaayah Zambahari 陈明哲 Thach Nguyen

09:30-09:45 心肌的抢救 David Holmes, Jr

9:45-10:00 药物洗脱支架：病理学 Renu Virmani

10:00-10:15 无保护左主干支架术-复杂分叉病变的介入治疗 Antonio Colombo

10:15-10:30 在当今支架年代治疗复杂病变的综合策略 Henry K. Lui

大会7 - 手术转播-阜外心血管病医院

10:30-12:00

主持人 Marie-Claude Morice, 沈卫峰

讨论者 Antonio Colombo Eric Eeckhout Tian Hai Koh 李浪 Richard Lim 李新明李学奇齐晓勇 Ashok Seth 杨志健

术者 Patrick W. Serruys 高润霖 Franz-Josef Neumann

IVUS解说 Peter Fitzgerald

大会8

主持人 Yaron Almagor, 杜志民

手术转播-广东省心血管病研究所

13:30-14:30

讨论者黄连军 Kau-Chung Charles Ho Paul Hsien-Li Kao 苏日希 Harry Suryapranata Rurus Suryawan Shailendra Trivedi 杨天伦杨廷树

术者 Giancarlo Biamino Samuel K. Mathew 陈纪言

特邀报告

14:30-14:45 药物洗脱支架时代的急性心肌梗死介入治疗 Harry Suryapranata

14:45-15:00 IVUS深刻了解药物洗脱支架临床试验和病例经验 Peter Fitzgerald

大会9

主持人 Franz-Josef Neumann, 陈纪林

手术转播-北京大学第一医院

15:00-15:45

讨论者 Luigi Inglese 蒋金法江时森金元哲 Ferdinand Kiemeneij 吕吉元 Toshiya Muramatsu Kui-Hian Sim

术者 Marie-Claude Morice

� � 霍勇

62


特邀报告

15:45-16:00 急性心肌梗死两种血栓去除的随机对照 Ferdinand Kiemeneij

16:00-16:15 颈动脉血管成形术中怎样选择远端保护装置？ Hugo F. Londero

16:15-16:30 冠心病患者中全身血管重建的概念 Luigi Inglese

大会10

主持人 Yean Leng Lim, 王乐丰

手术转播-阜外心血管病医院

16:30-17:30

讨论者侯玉清黄伟剑 Col Mujeeb-Ul-Haq Gia Khai Pham Witold Ruzyllo George W. Vetrovec 张大东郑宏

术者 Mitchell W. Krucoff Eric Eeckhout 蒋世良, 徐仲英

特邀报告

17:30-17:45 应用Amplatzer间隔封堵器经导管封堵心梗后室间隔缺损 Witold Ruzyllo

17:45-18:00 慢性完全闭塞介入治疗中CART技术的新概念 Osamu Katoh

2号厅


主持人 Mitchell W. Krucoff, 吕树铮

讨论者 Kenneth Chin Hung Kwong Duncan Ho 李保王东琦 Philip Wong 张抒扬

术者陈纪林 Yaron Almagor Harry Suryapranata Toshiya MuramatsuIVUS解说 Peter Fitzgerald


主持人陈君柱, 王海昌, 秦学文

10:00-10:15 冠脉介入治疗适应症：从临床实践到ESC指南2005 沈卫峰

10:15-10:30 如何决定完全或不完全血管重建术? 朱国英

10:30-10:45 无保护左主干介入治疗：证据足够吗? 韩雅玲

10:45-11:00 分叉病变介入治疗的理想策略葛均波

11:00-11:15 PCI的抗栓治疗-指南与实践李为民

11:15-11:30 PCI中的降脂治疗高炜

11:30-11:45 急性心机梗死的再灌注治疗：从指南到实践何奔

11:45-12:00 心肾功能不全患者的PCI 周玉杰


主持人朱国英, 王伟民

13:30-13:45 当前药物洗脱支架未解决的问题方唯一

13:45-14:00 非ST段抬高型急性冠脉综合征的经皮血管重建王乐丰

14:00-14:15 支架释放后高压球囊后扩张，我们真的需要吗？张瑞岩

14:15-14:30 临界病变：我们能直接用药物支架治疗它们吗? 何国祥

14:30-15:30 手术转播-广东省心血管病研究所讨论者崔连群党群韩立宪黄峻张钲周胜华术者 Huay Cheem Tan, 陈纪言

63



主持人贾国良, 高炜

15:30-15:45 急性心肌梗死中干细胞治疗的最新进展李占全

15:45-16:00 药物洗脱支架时代开口病变的介入治疗王伟民

16:00-16:30 手术转播-北京大学第一医院

讨论者郭新贵贾绍斌李国庆李淑梅徐标张抒扬

术者 Teguh Santoso

16:30-16:45 冠脉CT血管造影的应用金征宇

16:45-17:00 长病变和小血管的PCI：从临床试验到日常实践乔树宾

17:00-17:30 手术转播-北京大学第一医院

讨论者郭新贵贾绍斌李国庆李淑梅徐标张抒扬

术者霍勇

17:30-17:45 PCI中怎样处理周围血管并发症? 黄岚

17:45-18:00 无复流和远端栓塞的预防和处理颜红兵

17号厅

同步分会3-"经桡动脉介入治疗俱乐部", CIT主办, Terumo赞助

8:00-8:10 TRI俱乐部介绍高润霖

8:10-9:20 第一节

主持人贾三庆, Ichiro Michishita

8:10-8:50 手术转播-北京友谊医院

讨论者马根山 Hideaki Sakai Akihiko Takahashi 王海昌颜红兵姚民

术者 Shigeru Saito, 王雷

8:50-9:05 经皮冠脉介入治疗中的微创策略 Martial Hamon

9:05-9:20 经桡动脉颈动脉和颅内动脉介入治疗 Chiung-Jen Wu

9:20-10:30 第二节

主持人周玉杰, Chiung-Jen Wu


讨论者杜志民傅国胜郭文怡姜铁民 Rurus Suryawan Ho-nin Kanaya

术者 Ferdinand Kiemeneij, Tak-Sun Tse

10:00-10:15 经前臂动脉微创化冠心病诊断与治疗傅向华

10:15-10:30 经桡动脉介入治疗中路径的并发症及预防处理荆全民

10:30-11:40 第三节

主持人傅向华, Tejas M. Petal


讨论者葛雷 Hideaki Kaneda G. L. Sharma 魏盟温尚煜于波

术者杨跃进, 李伟杰

11:10-11:20 经桡动脉造影或介入治疗后桡动脉直径的变化 Yoshifumi Kan

10:20-11:30 经桡动脉挑战慢性完全闭塞病变 Motomaru Masutani

64


11:30-11:40 急性心肌梗死合并严重室间隔缺损的经桡动脉冠脉支架术 Tetsuya Hata

11:40-11:55 泰尔茂最新TRI模拟器介绍姚民

11:55-12:00 总结和展望贾三庆

亚太和拉美介入心脏病学热点论坛13:30-15:00 第一节

主持人 Richard Ng, 黄德嘉, Tak-Him Patrick Ko

13:30-13:45 药物洗脱支架对比金属裸支架-无保护左主干末端分叉病变的介入治疗 Eak-Kyun Shin

13:45-14:00 雷帕霉素药物洗脱支架在巴西临床实践中的性价比研究 Marco Wainstein

14:00-14:15 Fierbird药物支架在智利应用的初步经验和临床随访 Salvador Villablanca

14:15-14:30 药物洗脱支架后亚急性并发症及其处理 Devang Desai

14:30-14:45 药物洗脱支架治疗冠状动脉开口病变的疗效评价 Costantino Costantini

14:45-15:00 讨论

15:00-15:15 茶歇

15:15-16:30 第二节

主持人 Swee Choon Ng, 陈方, Hon-kan Yip

15:15-15:30 培达对于糖尿病患者药物洗脱支架后再狭窄的效果 Seong-Wook Park

15:30-15:45 分叉病变的治疗2006 Sidney Tsz Ho Lo

15:45-16:00 直接血管成形术是急性心肌梗死时最佳的治疗选择吗？ Alberto Sampaolesi

16:00-16:15 当CABG被患者或外科医生拒绝时PCI 的角色，部分血管重建可行吗？ Mohammad Ishaq

16:15-16:30 讨论

16:30-16:45 茶歇

16:45-18:00 第三节

主持人 Raul D. Jara, 李为民, Shu-Kin Li

16:45-17:00 基因工程学和介入治疗的未来 Luis De la Fuente

17:00-17:15 多普乐血流导丝在评价临界冠脉病变中的重要意义 Gerard Devlin

17:15-17:30 应用Inoue球囊成形术治疗成年肺动脉瓣狭窄 Manh Hung Pham

17:30-17:45 冠状动静脉瘘的治疗选择 Wasan Udayachalerm

17:45-18:00 讨论

11-12号厅

"挑战性"病例讨论18:00-12:00

11号厅

8:00-10:00 第一场 (5分钟演讲+10分钟讨论) / 例

主持人朱国英, 荆全民

点评程晓曙马茂儒曲鹏徐泽升

8:00-8:15 慢性闭塞病变合并右冠严重扩张病变手术策略曹宇

8:15-8:30 肾移植术后患者的CTO病变处理金泽宁

8:30-8:45 冠状动脉弥漫长病变聂绍平

8:45-9:00 Reverse Crush 支架术治疗前降支分叉病变葛雷

9:00-9:15 经桡动脉慢性闭塞病变介入治疗赵迎新

9:15-9:30 静脉桥血管长闭塞病变的PCI一例陈欣

65


9:30-9:45 应用5F引导导管深插技术治疗右冠脉远端病变田军

9:45-10:00 Cypher Select支架断裂合并动脉瘤形成1例宋现涛

10:00-12:00 第三场 (5分钟演讲+10分钟讨论) / 例

主持人贾国良, 马长生

点评郭涛马业新王风杨树森

10:00-10:15 经导管血栓吸出术在处理急性心肌梗死冠脉内血栓中的应用张励庭

10:15-10:30 左主干分叉病变合并右冠闭塞病变介入及6个月造影随访方唯一

10:30-10:45 OCT联合IVUS在冠状动脉病变诊断中的应用陈少伯

10:45-11:00 慢性闭塞病变、分叉病变韩志刚

11:00-11:15 旋磨+药物支架治疗LCX慢性闭塞病变李惟铭

11:15-11:30 高龄急性心肌梗死患者急诊PCI一例夏勇

11:30-11:45 冠脉支架术血管破裂及急诊CABG 陈国红

11:45-12:00 经双侧桡动脉入径造影下LAD慢性闭塞病变的介入治疗傅向华

12号厅

8:00-10:00 第二场 (5分钟演讲+10分钟讨论) / 例

主持人乔树宾, 陈韵岱

点评何青 Yean Teng Lim Swee Choon Ng Pieter R. Stella

8:00-8:15 左主干慢性闭塞合并右冠脉、肾动脉狭窄介入治疗张奇

8:15-8:30 Acute Total Occlusion of the Left MainArtery during Coronary Angiography Result in Cardiac Arrest & Its Management Massoud Ghasemi

8:30-8:45 TCT2005手术转播病例-导引钢丝对吻技术治疗左主干完全闭塞病变葛均波

8:45-9:00 Revascularization of the Right Coronary Artery with Multiple Stents Carlos Gadda

9:00-9:15 双支冠脉慢性完全闭塞病变王守力

9:15-9:30 Multiple Coronary Arteries Revascularization Carlos Sztejfman

9:30-9:45 急性下壁心肌梗死 (严重成角、巨大血栓病变) 的急诊介入治疗李浪

9:45-10:00 Angioplasty of Non-protected CFX Artery Alvero Bordenav

10:00-12:00 第四场 (5分钟演讲+10分钟讨论) / 例

主持人吕树铮, 周颖玲

点评李继福孟庆恒王凤芝张建盛

10:00-10:15 前降支及右冠完全闭塞、回旋支近段严重狭窄病变的介入治疗袁义强

10:15-10:30 LM开口病变+LAD近端慢性完全堵塞病变病例张清

10:30-10:45 LAD LCX均闭塞的急性心肌梗死成功PCI 周国伟

10:45-11:00 右冠CTO病变Guardwire应用病例邵一兵

11:00-11:15 Sprinter球囊在左前降支慢性完全闭塞病变中的应用孙福成

11:15-11:30 左锁骨下动脉近端闭塞的再通一双向会师技术

蒋雄京

11:30-11:45 伴重度肺动脉高压动脉导管未闭患者的介入治疗丁建东

11:45-12:00 左前降支梗死相关病变AMI后PCI 马根山

66


论文交流

13:30-18:00

7号厅

13:30-15:00 第一场-冠心病

主持人黄体钢, 严晓伟, 何青

13:30-13:40 经皮冠状动脉介入治疗术后主要不良心血管事件预测因素的一年随访研究：阜外单中心经验裴卫东

13:40-13:50 冠状动脉支架术治疗297例无保护左主干病变的中期疗效韩雅玲

13:50-14:00 应用心肌声学造影评价前壁心肌梗死患者择期PCI改善心肌组织灌注的临床研究陈韵岱

14:00-14:10 1633例中国汉族连续患者金属裸支架和药物洗脱支架再狭窄的单中心研究李建军

14:10-14:20 评价长支架及多个支架序贯置入治疗冠心病弥漫性长病变患者的临床疗效及中、远期随访研究刘新宏

14:20-14:30 经皮冠状动脉介入术后心肌灌注评价方法比较及相关临床意义王红

14:30-14:40 代谢综合征对冠心病血运重建术患者住院和随访结果的影响胡荣

14:40-14:50 冠状动脉的流体气蚀特点以及对再狭窄的分析季平

14:50-15:00 Prognostic Significance of Complete Right Bundle Branch Block Immediately after Percutaneous Transluminal Septal Myocardial Ablation in Series of Chinese Patients with Hypertrophic Obstructive Cardiomyopathy 陈绍良

15:00-16:30 第四场-冠心病

主持人柯若仪, 沈潞华, 李广平

15:00-15:10 急性心肌梗死急诊介入治疗无复流发生的独立预测因素及对长期预后的影响邓捷

15:10-15:20 急性ST段抬高性心肌梗死患者在导管室行急诊冠状动脉介入治疗中室性心动过速或心室颤动的发生率、预测因子和一年预后梁延春

15:20-15:30 ST段抬高急性心肌梗死介入治疗联合应用替罗非班临床资料的分析栾波

15:30-15:40 急性心肌梗死后存活心肌对梗死相关血管晚期血运重建后左室功能的影响马礼坤

15:40-15:50 急诊介入治疗对老年急性心肌梗死患者近期疗效的影响王耿

15:50-16:00 急性心肌梗死急诊冠脉成形术时联合使用硫氮卓酮、硝酸甘油预防无血流-慢血流并发症的临床对比研究王禹

16:00-16:10 STEMI梗死相关动脉合并心肌桥的发生率及其对直接PCI结果的影响颜红兵

16:10-16:20 STEMI直接PCI造影剂肾病的发生率、危险因素及预后颜红兵

16:20-16:30 AMI患者PCI术后侧枝循环即刻消失的临床意义杨煜

16:30-18:00 第七场-冠心病

主持人戴玉华, 倪幼芳, 马依彤

16:30-16:40 冠状动脉介入治疗远期发生急性心肌梗死的原因-支架内晚期血栓形成？新生病变？吴永健

16:40-16:50 41例冠状动脉支架内血栓形成患者的临床特点及治疗韩雅玲

16:50-17:00 中国绝经后妇女性激素与冠心病程度的关系 Odgerel Tumur

17:00-17:10 经桡动脉急诊PCI安全性与可行性研究李为民

17:10-17:20 经皮股动脉冠状动脉造影术后无加压包扎6小时下地活动郭金成

17:20-17:30 经股动脉和桡动脉途径行冠状动脉造影的对照研究吕树志

67


17:30-17:40 � 第3代Perclose血管缝合器在PCI后高危�� 出血患者的应用研究� � 颜红兵

17:40-17:50 � 经桡动脉冠状动介入术后并发桡动� � 脉闭塞分析� � 周玉杰

17:50-18:00 � 经桡动脉行冠状动脉介入治疗的护理 � � 王瑛

8号厅

13:30-15:00 � 第二场-心律失常

主持人 � 吴印生, 郭继鸿, 王建安

13:30-13:40 � 肺静脉心动过速发生率及其对心房颤动�� 患者射频消融术后随访结果的影响� � 董建增

13:40-13:50 � 心室再同步起搏治疗缺血性与非缺血性�� 心肌病的临床应用 � � 华伟

13:50-14:00 � 右心耳梳状肌在房性心律失常中作用 � � 张树龙

14:00-14:10 � 心房颤动环肺静脉消融术后复发预测� � 因素的前瞻性研究 � � 刘兴鹏

14:10-14:20 � 环肺静脉消融电隔离治疗持续性心房� � 颤动的疗效观察 � � 刘旭

14:20-14:30 � 主动脉无冠状窦内射频消融前间隔局� � 灶性心动过速 � � 麻付胜

14:30-14:40 � 双Lasso导管及三维电解剖标测指导下�� 环肺静脉口线性消融治疗心房颤动 � � 唐恺

14:40-14:50 � 拖带标测法或/和CARTO系统指导经导�� 管消融非缺血性心脏病合并室性心动过速 � � 王祖禄

14:50-15:00 � 特发性房颤与原发性高血压患者肺静脉�� 口直径的比较 � � 张树龙

15:00-16:30 � 第五场-心律失常

主持人 � 孙瑞龙, 黄振文, 商丽华

15:00-15:10 � 标测Purkinje电位和舒张期电位在特发�� 性左室室性心动过速消融中的作用 � � 王祖禄

15:10-15:20 � Ventricular Repolarization Sequence �� During Right Ventricular Endocardial �� and Left Ventricular� � Epicardial Pacing: Monophasic � �� Action Potential Mapping in Swine � � 张树龙

15:20-15:30 � 儿童房室结折返性心动过速患者经冷�� 冻消融和射频消融的结果比较 � � 高东升

15:30-15:40 � 峡部依赖性心房扑动心房间传导途径�� 及其与F波的关系 � � 韩昊

15:40-15:50 � Global Dispersion of Ventricular � �� Repolarization During Right � �� Ventricular Endocardial and Left� � Ventricular Epicardial Pacing: � �� Monophasic Action Potential � �� Mapping in Swine� � 张树龙

15:50-16:00 � 双心室同步起搏治疗充血性心衰的手�� 术并发症及术后死亡率分析� � 王冬梅

16:00-16:10 � 心房颤动射频消融术中应用异丙酚深�� 度镇静的临床研究� � 龙德勇

16:10-16:20 � 实时三维超声心动图评价左室收缩� � 同步性的临床研究� � 崔洁

16:20-16:30 � 年龄相关的心房电生理特性的改变 � � 梁延春

16:30-18:00 � 第八场-冠心病

主持人 � 王彬尧, 刘国树, 柳茵

16:30-16:40 � 心肌桥节段冠状动脉血管面积小于参�� 照节段：血管内超声研究结果� � 钱菊英

16:40-16:50 � 外源性肝细胞生长因子对兔心肌梗死�� 后左室重塑及血管新生的影响� � 宋明宝

16:50-17:00 � 缬沙坦洗脱支架对AT2受体表达影响� � 试验研究� � 王雷

17:00-17:10 � 雷帕霉素洗脱支架扩张程度对内膜� � 增生影响血管内超声研究� � 张瑞岩

68


17:10-17:20 Intracoronary Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells for Ischemic Cardiomyopathy due to Isolated Chronic Occluded Left Anterior Descending Artery 陈绍良

17:20-17:30 The Effect on Cardiac Function in the Patients with Twice Intracoronary Autologus Bone Marrow Mononuclear cells Transplantation in Different Interval after Acute Myocardial Infarction 葛均波

17:30-17:40 Ligating LAD with its whole length rather than diagonal branches as coordinate is more advisable in establishing myocardial infarction model of swine 葛均波

17:40-17:50 骨髓基质细胞结合血管内皮生长因子基因心内膜注射治疗猪慢性心肌缺血模型的疗效易甫

17:50-18:00 hs-CRP、ProMMP-1、TIMP-1与冠状动脉斑块稳定性关系的血管内超声研究张邢炜

11号厅

13:30-15:00 第三场-先心病

主持人赵世华, 王广义, 秦永文

13:30-13:40 经导管介入治疗膜部室间隔缺损320 例的临床疗效分析朱鲜阳

13:40-13:50 嵴内型室间隔缺损封堵治疗的疗效和安全性周达新

13:50-14:00 介入治疗继发孔房缺合并心律失常的临床研究邓东安

14:00-14:10 老年房间膈缺损(ASD)介入治疗前左室欲适应治疗可预防充血性心衰金泽宁

14:10-14:20 超声心动图在房间隔缺损介入封堵术中的应用马小静

14:20-14:30 经导管射频打孔联合球囊扩张治疗室间隔完整的肺动脉瓣闭锁朱鲜阳

14:30-14:40 动脉导管未闭封堵术690例临床报告朱鲜阳

14:40-14:50 主动脉假性动脉瘤的介入治疗黄连军

14:50-15:00 冠状动脉肺动脉瘘的介入治疗史冬梅

15:00-16:30 第六场-冠心病

主持人顾复生, 陈君柱, 颜光烈

15:00-15:10 国产火鸟支架在临床日常冠脉介入治疗中的应用-中国火鸟支架登记研究 (FIC) 预试验一年随访结果刘海波

15:10-15:20 载雷帕霉素可降解多聚体涂层支架 (EXCELTM) 治疗冠心病6个月临床效果评价张玉霄

15:20-15:30 FIBISTEMI（Firebird DES Stent vs BMS In STEMI）试验的初步结果颜红兵

15:30-15:40 ST段抬高型急性心肌梗死使用药物支架的临床结果分析张强

15:40-15:50 紫杉醇洗脱支架治疗119例无保护左主干病变的初步经验韩雅玲

15:50-16:00 药物洗脱支架治疗老年冠心病无保护左主干病变近中期疗效观察王勇

16:00-16:10 应用双药物洗脱支架治疗分叉病变的近中期临床疗效陈纪林

16:10-16:20 雷帕霉素药物洗脱支架在冠脉分叉病变植入后一年结果葛雷

16:20-16:30 雷帕霉素和紫杉醇药物洗脱支架治疗支架内再狭窄的造影与临床结果的对比研究李建军

69


ABCD厅

8:00-12:00 模拟器教程

A厅美敦力课程B厅强生课程C厅贝朗课程D厅泰尔茂课程

13:30-18:00 模拟器教程A厅美敦力课程B厅强生课程C厅贝朗课程D厅泰尔茂课程

午间研讨会12:15-13:15

2号厅

辉瑞抗凝降脂研讨会

Pfizer主办

主持人贾国良, 吕树铮

12:15-12:20 简介

12:20-12:50 从他汀对斑块的作用看ACS患者强化降脂治疗的重要性沈卫峰

12:50-13:20 从最新指南看ACS患者的规范化抗凝治疗韩雅玲

13:20-13:25 总结

17号厅

乐普药物支架临床应用与实践

乐普公司主办

主持人杨跃进, 王海昌, 崔连群

12:15-12:30 Partner药物支架在复杂病变中的临床实践吕树铮

12:30-12:45 Partner药物支架临床应用特点杨庭树

12:45-13:00 药物支架在分叉病变中的应用陈绍良

13:00-13:15 Partner药物支架手术案例讨论黄超联

13:15-13:20 问答13:20-13:25 总结

5-1号厅

介入技术与器械选择


主持人霍勇, 葛均波

12:15-12:35 分叉病变PTCA技术和器械选择 Paul Hsien-Li Kao12:35-12:55 经桡动脉介入技术和器械选择乔树宾

12:55-13:15 慢性完全闭塞病变的PTCA技术和器械选择吕树铮

13:15-13:25 讨论和总结

5-2号厅

未来的支架技术

Biotronic主办

主持人周玉杰, 李建军

12:15-12:20 简介

12:20-12:45 新一代药物洗脱支架：Costar Martial Hamon12:45-13:05 新一代金属可吸收支架临床数据 Martial Hamon13:05-13:20 问答

13:20-13:25 总结

5-3号厅

指引导管头部形状的正确选择是介入手术成功的关键

Medtronic主办

主持人马长生

12:15-12:35 RBU使用经验介绍 SK Leung12:35-12:55 EBU使用经验介绍陈韵岱

12:55-13:15 其它头部形状使用经验介绍钱菊英

13:15-13:20 问答

13:20-13:25 总结

70


5-4号厅

追本溯源, 英雄本色 - 支架、导丝设计原理及其应用

Guidant主办

主持人陈纪林

12:15-12:45 什么是药物支架理想的支架平台？韩雅玲

12:45-13:15 如何选择导丝？从导丝设计谈起王伟民

13:15-13:20 问答

13:20-13:25 总结

5-5号厅

Firebird 病例讨论

微创公司主办

主持人李占全, 方唯一, 颜红兵

12:15-12:27 Firebird 在左主干病变中应用与随访陈步星

12:27-12:39 Firebird在复杂病变中应用金元哲

12:39-12:51 分叉病变处理：Reverse Crushing 金叔宣

12:51-13:03 Firebird支架治疗前降支CTO病变刘健

13:03-13:15 左主干撕裂的处理宁忠平

13:15-13:25 讨论和总结

5-6号厅

心脏影像学的技术先锋

Siemens主办

主持人高润霖, 曹克将,徐家兴

12:15-12:40 磁力的引导：在冠脉介入的应用 George W. Vetrovec

12:40-13:05 双源CT对心脏成像的提高 Axel Wimmer

13:05-13:20 问答

13:20-13:25 总结

6号厅

可降解涂层药物洗脱支架的最新进展

吉威医疗和Biosensors主办

主持人高炜, 王乐丰

12:15-12:25 简介吉威医疗和Excel可降解涂层药物支架上市仪式 Jack Wang

12:25-12:45 新型可降解涂层药物支架Excel的临床最新进展葛均波

12:45-13:05 紫杉醇药物支架Axxion的30天结果 Thomas A. Ischinger

13:05-13:20 药物支架制造工艺的发展 Jack Wang

13:20-13:25 总结

7号厅

平板血管机在PCI中的临床应用

Shimadzu主办

主持人杨跃进

12:15-12:20 简介

12:20-13:00 平板血管机在PCI中的临床应用张铂

13:00-13:10 问答

13:10-13:15 总结

8号厅

PCI病人应用他汀的生物多样性

MSD主办

主持人高炜

12:15-12:20 简介

12:20-13:10 PCI病人应用他汀的生物多样性 Brian Tomlinson

13:10-13:20 问答

13:20-13:25 总结

71


晚间卫星会18:00-19:30

2号厅

厚积薄发, 破茧化蝶 - 从 Vision 到 GUIDANT药物支架

Guidant主办

主席 � 高润霖

主持人 � 葛均波, 杨跃进

18:00-18:05 � 简介

18:05-18:25 � 最好的裸支架：源于临床的使用经验 � � Mitchell W. Krucoff翻译 �� 刘健

18:25-18:45 � Xience V与其他药物支架的病理学比较 � � Renu Virmani翻译 �� 李怡

18:45-19:10 � 新一代药物支架：Xience V和SPIRIT� � 系列试验 � � Patrick W. Serruys翻译 �� 沈珠军

19:10-19:25 � 问答

19:25-19:30 � 总结

17号厅

循证医学：真实世界的火鸟

微创公司主办

主席 � 沈卫峰, 韩雅玲, 马长生, � � Harry Suryapranata

18:00-18:05 � 简介

18:05-18:25 � Firebird与Cypher、Taxus临床应用� � 对比研究 � � 乔树宾

18:25-18:45 � 全国性注册登记FIC研究30天结果 � � 高润霖

18:45-19:00 � 拉丁美洲Firebird注册登记研究最初� � 6个月随访结果 � � Salvador Villablanca

19:00-19:15 � 国产雷帕霉素药物洗脱支架治疗冠心�� 病一年临床随访 - 多中心注册研究 � � 张奇

19:15-19:25 � 问答

19:25-19:30 � 总结

72


1号厅

大会11-手术转播-北京安贞医院

8:00-9:30

主持人 Yean Teng Lim, 何奔

讨论者 Rajiv Agarwal 陈珏 Boron CW Cheng 刘朝中刘惠亮 Simon Lo Richard Ng 齐国先 Eak-Kyun Shin 吴建国

术者吕树铮 Martial Hamon, Shing-Chiu Wong

大会12-特邀报告

主持人 Shih-Pu Wang, 戴汝平 Chung-Seung Chiang

9:30-9:45 冠状动脉生理学最新观点 Eric Eeckhout

9:45-10:00 REALITY和SYNTAX试验最新结果 Marie-Claude Morice

10:00-10:15 肾动脉血管成形术：适应症和疗效 Paul Hsien-Li Kao

10:15-10:30 胸主动脉瘤-临床与病理的关系 Malcolm West

大会13-手术转播-北京安贞医院

10:30-11:30

主持人 Tian Hai Koh, 陈绍良

讨论者 Dibya Kumar Baruah Devang Desai 黄超联 Nigel Jepson Kai Huat Lam 李康卢才义 Sufia Rahman 吴其明吴永健

术者 Ashok Seth, 吕树铮

11:30-12:00 磁导航介入治疗示教病例录象讨论 George W. Vetrovec

大会14 - 特邀报告

主持人曹克将, 杨新春, 郭文怡

13:30-13:45 大隐静脉旁路移植血管介入治疗 Shing-Chiu Wong

13:45-14:00 对药物治疗禁忌的患者行经皮冠脉介入治疗 Thach Nguyen

14:00-14:15 神经系统并发症和经皮冠脉介入治疗 Martial Hamon

14:15-14:30 经左室直接血流灌注的生理可行性研究：VSTENT Jie Wang

14:30-14:45 冠心病的筛查 Yean Leng Lim

14:45-15:00 CT冠脉造影能取代有创性冠脉造影吗？ Michael Lim

大会15 - 内外争鸣

主持人高润霖

15:00-15:20 中国第一例冠脉搭桥手术纪念讲座未来更加微创化的"外科梦想"：从冠脉到其他胡盛寿

15:20-15:40 复杂经皮冠脉介入治疗：在药物支架时代我们能走多远？吕树铮

15:40-16:00 圆桌讨论

讨论者胡盛寿霍勇贾国良吕树铮沈卫峰朱国英

16:00-16:30 发奖、总结和闭幕辞

主席高润霖

联合主席陈纪林, 陈纪言, 葛均波, 韩雅玲, 胡大一黄德嘉, 霍勇, 贾国良, 吕树铮, 沈卫峰杨跃进, 朱国英

73


2号厅

同步分会4 - CTO俱乐部

主持人葛均波, 韩雅玲

8:00-8:05 教程目的简介葛均波

8:05-8:20 为什么我们应该治疗慢性完全闭塞病变？陈韵岱

8:20-8:35 挑战慢性完全闭塞病变：我的经验1 韩雅玲

8:35-8:50 挑战慢性完全闭塞病变：我的经验2 葛均波

8:50-9:05 挑战慢性完全闭塞病变：我的经验3 Hugo F. Londero

9:05-9:20 挑战慢性完全闭塞病变：我的经验4 李建军

9:20-9:40 来自美国CTO峰会的病例回顾 Jeffrey W. Moses


协同主持 Patrick W. Serruys Jeffrey W. Moses

讨论者 Tan Kim Heung Sum-Kin Leung 乔树宾 Teguh Santoso 王乐丰

术者 Osamu Katoh Shigeru Saito Kazuaki Mitsudo 王守力葛雷� � 姚民

IVUS解说 Junko Honye

11:40-11:55 使用超硬导引钢丝开通坚硬闭塞病变 Kazuaki Mitsudo (自导管室转播至会场)

11:55-12:00 总结韩雅玲

17号厅

第一届护士和技术人员研讨会

8:00-10:00 第一场

主持人郭敬萱, Jenny Zhen Qin, 冯琪

8:00-8:20 护士和技术人员在血管介入治疗高技术时代应该了解什么？郭敬萱

8:20-8:50 介入心脏病学研究：我们怎样辅助其成功？ Jenny Zhen Qin翻译钱杰

8:50-9:10 怎样完成定量冠状动脉造影？ Toshimitsu Shimizu翻译杨屺辉

9:10-9:30 血管内超声引导下进行冠脉介入治疗 Jae Yoon Ko翻译金哲

9:30-9:50 胸痛引起的心电图改变 Young Keun Lee翻译金哲

9:50-10:00 讨论和总结

10:00-12:00 第二场

主持人武玉兰, 侯桂华, 刘丕栋

10:00-10:15 冠脉介入诊疗器械选择李田昌

10:15-10:30 冠状动脉造影投照位规范与选择傅国胜

10:30-10:45 循证护理与实践梁涛

10:45-11:00 "亚心"介入中心的管理及护理模式王英

11:00-11:15 心脏介入治疗中放射技术员的主动配合作用鲁忠超

11:15-11:30 冠脉介入术后肺栓塞：预防、早期识别及临床护理张晓梅

11:30-11:40 PCI中输液反应的预防和处理经验李菲

11:40-11:50 IVUS和OCT引导下分叉病变的介入治疗王灏

11:50-12:00 讨论和总结

74


11-12号厅

"挑战性"病例讨论28:00-12:00

11号厅

8:00-10:00 第五场 (5分钟演讲+10分钟讨论) / 例

主持人陈纪言, 李浪

点评 Tak W. Kwan Michael Lim Henry K. Lui Robaayah Zambahari

8:00-8:15 TERUMO 5F指引导管辅助6F指引导管治疗RCA钙化扭曲长病变张瑞岩

8:15-8:30 Crush Aorto-Renal Stenting Massoud Ghasemi

8:30-8:45 Sprinter 球囊在成角病变中的应用

周旭晨

8:45-9:00 Vertebral and Subclavian Stenting Massoud Ghasemi

9:00-9:15 Nightmare in a Takayasu Case Hernan Chamorro

9:15-9:30 TBA Alexander Garcia Escuderio

9:30-9:45 继发性大房间隔缺损介入封堵1例报道周达新

9:45-10:00 TBA Alexander De LaCasa

10:00-12:00 第七场 (5分钟演讲+10分钟讨论) / 例

主持人陈纪林, 郭文怡

点评洪涛贾大林张兴华赵兴胜

10:00-10:15 急性心肌梗死多支血管闭塞"犯罪" 病变误判合并反复支架内亚急性学血栓王耿

10:15-10:30 右冠闭塞、左主干病变并前降支起源异常一例张陈匀

10:30-10:45 慢性闭塞病变、冠状动脉夹层、急性闭塞夏洪远

10:45-11:00 前降支CTO 病变PCI 术中并发症的处理李保

11:00-11:15 急性心肌梗死患者冠脉介入诊疗并发急性脑卒中成功救治1例潘德锋

11:15-11:30 左主干Cullote术一例翁少翔

11:30-11:45 FrontierTM分支冠状动脉支架在分叉病变中的应用温尚煜

11:45-12:00 冠状动脉内支架脱载的处理张宇晨

12号厅

8:00-10:00 第六场 (5分钟演讲+10分钟讨论) / 例

主持人霍勇, 郭丽君

点评惠永明马礼坤万征袁洪

8:00-8:15 经导管血栓吸出术在处理急性心肌梗死冠脉内血栓中的应用谭宁

8:15-8:30 急性ST段抬高性心肌梗死Guardwire 支持下直接PCI 高海

8:30-8:45 右冠脉血栓的成功处理荆全民

8:45-9:00 左主干分叉病变李伟杰

9:00-9:15 慢性闭塞病变李悦

9:15-9:30 Retrograde Penetration Wiring and Balloon Dilation in Combination with Antegrade Seesaw Wiring Strategy in Treating Chronic Total Occlusion of Right Coronary Artery

王琼

9:30-9:45 Kissing Stent后血栓形成白小军9:45-10:00 AMI合并心源性休克(亚急性心脏破裂) 的急诊PCI 张玉宵

75


10:00-12:00 第八场 (5分钟演讲+10分钟讨论) / 例

主持人李为民, 周旭晨

点评袁晋青张树林张智伟周立君

10:00-10:15 Y型DES支架技术处理斑块移位所致边支开口严重狭窄李成祥

10:15-10:30 前降支和左旋支同时支架内亚急性血栓形成再次PCI反复闭塞一例吴建东

10:30-10:45 回旋支畸形的病变处理刘寅

10:45-11:00 PCI干预LAD导致LM撕裂1例葛永贵

11:00-11:15 药物洗脱支架术后造影和血管内超声复查：下一步怎样处理？高展

11:15-11:30 反复支架内亚急性血栓李建平

11:30-11:45 简单化策略介入治疗左主干末端分叉病变一例王勇

11:45-12:00 PCI术中出现急性心包填塞抢救成功一例王斌

午间研讨会12:15-13:15

2号厅

急性心肌梗塞的药物治疗：COMMIT/CCS2临床研究结果解读

AstraZeneca主办

主持人高润霖

12:15-12:20 简介

12:20-13:05 急性肌梗塞的药物治疗： COMMIT/CCS2临床研究结果解读蒋立新

13:05-13:20 问答

13:20-13:25 总结

6号厅

远端保护装置：一个拯救生命的技术

Medtronic主办

主持人陈纪林

12:15-12:30 远端保护装置的临床适用情况和 SAFER临床试验 Paul Hsien-Li Kao

12:30-12:45 远端保护装置用在AMI介入治疗的临床试验 CK Chan12:45-13:00 EMERALD 临床实验能够代表临床实际情况吗？颜红兵

13:00-13:15 EZ Adaptor - 新的远端保护装置和使用经验介绍李成祥

13:15-13:20 问答

13:20-13:25 总结

7号厅

有教育意义的病例回顾- 桡动脉介入治疗并发症聚焦

阜外心血管病医院主办

主持人乔树宾

点评专家李为民王伟民王乐丰张抒扬荆全民王雷傅向华

12:15-12:20 目的

12:20-12:35 病例1及点评戴军

12:35-12:50 病例2及点评杨伟宪

12:50-13:05 病例3及点评吕滨

13:05-13:20 病例4及点评刘海波

13:20-13:25 总结

12号厅

76


8号厅

有教育意义的病例回顾- 介入治疗并发症聚焦

阜外心血管病医院主办

主持人陈韵岱

点评专家杜志民陈绍良朱建华郭文怡金元哲周旭晨

12:15-12:20 目的

12:20-12:30 病例1及点评宋现涛

12:30-12:40 病例2及点评聂绍平

12:40-12:50 病例3及点评高阅春

12:50-13:00 病例4及点评赵迎新

13:00-13:10 病例5及点评刘同

13:10-13:20 病例6及点评朱小玲

13:20-13:25 总结

77

示教演示中心

安贞医院, 中国北京

术者：吕树铮、陈韵岱、陈方、马长生、周玉杰、颜红兵、李志忠、张维东、赵全明

特邀术者： Martial Hamon, Shing-Chiu Wong, Ashok Seth

阜外心血管病医院, 中国北京

术者：高润霖、陈纪林、杨跃进、乔树宾、李建军、秦学文、姚民、刘海波、吴永健、袁晋青、陈珏、戴军、尤士杰、张沛、钱杰、高展、慕朝伟、窦克非、邱洪、蒋世良、徐仲英、华伟、姚焰

特邀术者： Antonio Colombo, Jeffrey W. Moses, Hubert Seggewiss, Gary S. Mintz, Patrick W. Serruys, Franz-Josef Neumann, Peter Fitzgerald, Mitchell W. Krucoff, Eric Eeckhout, Yaron Almagor, Harry Suryapranata, Toshiya Muramatsu, Osamu Katoh, Shigeru Saito, Kazuaki Mitsudo, Junko Honye, 王守力, 葛雷

巴斯德医院，法国图卢兹

术者： Jean Fajadet, Bruno Farah, Jean Marco

广东省心血管病研究所，中国广州

术者：陈纪言、靳立军、罗建方、谭宁

特邀术者： Giancarlo Biamino, Samuel K. Mathew, Huay Cheem Tan

友谊医院, 中国北京

术者：王雷、李虹伟、张宇晨、陈晖

特邀术者： Shigeru Saito, Ferdinand Kiemeneij, 杨跃进, Tak Sun Tse, 李伟杰

纽约长老会医院/哥伦比亚大学医疗中心, 美国纽约

术者： Martin B. Leon, Gregg W. Stone, Michael B. Collins, George D. Dangas, William A. Gray, Edward M. Kreps, Issam Moussa, Robert J. Sommer

北京大学第一医院, 中国北京

术者：霍勇、洪涛、陈明、李建平

特邀术者： Marie-Claude Morice, Teguh Santoso

伊丽莎白女王医院, 中国香港

术者： Hung Kwong Duncan Ho, Kam-Tim Chan, Michael Kang-Yin Lee

瑞金医院, 中国上海

术者：沈卫峰、张瑞岩、张奇、张建盛、杨震坤、胡健

特邀术者： Costantino Costantini, Paul Hsien-Li Kao

Scripps纪念医院, 美国圣地亚哥

术者： Richard Fortuna, Maurice Buchbinder

沈阳军区总医院, 中国沈阳

术者：韩雅玲、荆全民、马颖艳、栾波、王耿、梁延春

特邀术者： Eberhard Grube,

Philip Wong

78

CIT2006 EXHIBITORS 参展单位

B.Braun Medical (Shanghai) Int'l Trading Co., Ltd.贝朗医疗(上海)国际贸易有限公司 CB04-05

Bayer Healthcare Co. Ltd.拜耳医药保健有限公司 CB16-19

Beijing AT&M Biomaterials Co., Ltd.北京安泰生物医用材料有限公司 CB27

Beijing Kelida北京科利达/北京迈特 CB23

Beijing Synex Medical Co., Ltd.北京鑫正谊医疗器械有限公司 CB22

Biotronik德国百多力有限与两合公司 CA17

Boston Scientific Corporation波科国际医疗贸易(上海)有限公司 CA12

Cordis/Johnson&Johnson Medical (China) Ltd.强生(中国)医疗器材有限公司 CA05

GE Healthcare通用电气(中国)医疗集团 CA07

Great Dragon Co.北京伟龙科仪贸易有限公司 CB14

Guidant International Corporation佳腾国际公司 CA13

Huaren Medical北京市华仁医疗设备公司 CB26

Invatec S.R.L.意大利英泰克公司北京代表处 CA16

Biosensors International山东吉威医疗制品有限公司 CA08

Beijing Lepu Medical Device, Inc.乐普医疗器械有限公司 CA14

Medtronic China Ltd.美敦力医疗用品技术服务(上海)有限公司 � CA01

MicroPort Medical (Shanghai) Co., Ltd. 微创医疗器械(上海)有限公司 CA06

MSD杭州默沙东制药有限公司 CA03

MVP Medical (China) Co., Ltd.丞龙医疗器材有限公司 CB06-07

OrbusNeich深圳业聚实业有限公司 CA09

Pacific Medical Corporation上海帕斯医疗器材贸易有限公司 CB15

Pfizer辉瑞制药有限公司 CB01-02

Philips飞利浦医疗系统 B11-13

Sahajanand Medical Technologies Pvt. Ltd. CB09-10

Sankyo上海三共制药有限公司 CB25

Sherring先灵(广州)药业有限公司 CB08

Shimadzu岛津国际贸易(上海)有限公司 CB03

Siemens西门子(中国)有限公司 CA04

Singapore LIVE CB21

St. Jude Medical圣犹达医疗用品(上海)有限公司 CA11

Star Progress上海星峰工贸有限公司 CB24

Terumo泰尔茂株式会社 CA02

Victech Scientific纬达科仪(上海)有限公司 CB20

Company Name公司名称

Booth Number展位号

Company Name公司名称

Booth Number展位号

79

Exhibit Floor Plan

9000

3000

7500

7500

3000

2766

2258

2000

544 6000 3000 6000 3000 6000

1478

3146

3000

2579

3830

2916

2869

9000

20005000

CA

0154

sqm

54 s

qm

54 s

qm54

sqm

54 s

qm

45 s

qm27

sqm

36 s

qm

36 s

qm

36 s

qm

18 s

qm

30 s

qm

27 s

qm

45 s

qm

CA

02C

A03

CA

09

CA

04

CA

05C

A06

CA

07C

A08

CA

11

CA

12C

A13

CA

14C

A16

CB

09

CB

26 CB27

CB

10

CB

01C

B02

CB

03

CB

11C

B12

CB

13

CB

04

CB

20C

B21

CB

22C

B23

CB

05C

B06

CB14 CB15 CB16 CB17 CB18 CB19 CB24 CB25

CB

07C

B08 Le

vel 1

Bei

jing

Inte

rnat

iona

l Con

vent

ion

Cen

ter

EN

TR

AN

CE

1

TO LOBBY

80

CIT2006 Exhibitor's Directory (in Alphabetic Order)

All this began more than 160 years ago. The family business started as a pharmacy and developed into a global hospital and medical supply company with subsidiaries in over 50 countries and sales of over 2.4 billion Euro per year.

本公司之母公司--德国贝朗集团成立于1839年，总部位于德国梅尔松根，贝朗集团为世界上最大的医疗产品制造供应商之一。属下机构约一百三十多家，分布全球五十多个国家，雇有员工二万七千多人。其主要子公司包括德国蛇牌公司与美国McGaw公司。

贝朗集团在中国区各主要城市，如上海、北京、广州、武汉、成都、西安、沈阳及香港均设有办事处，其中一九九九年十二月成立的贝朗医疗(上海)国际贸易有限公司为当今中国的总部，该公司为德国贝朗医疗有限公司全资拥有的总公司，通过公司在上海外高桥保税区的仓库进口集团的产品，然后分发至中国境内各地销售。

贝朗集团在中国拥有二家合资企业，在沈阳之企业生产血定安和腹膜透析液；在山东的合资厂生产手术器械类产品。

Bayer Healthcare Co., Ltd.拜耳医药保健有限公司

Booth No.: CB16-19Address: 16/F Fortune Plaza, No.7 Dong San Huan Zhong Road, Beijing 10020 ChinaTel: 010-65998282 Fax: 010-65998181

Bayer HealthCare's links with China go back to early years in 20th century. Bayer set up its first production company in 1936, and manufactured a range of products, including the famous Aspirin? pain relieverSince 1990s Bayer HealthCare started fast business development in China. In 1995 Bayer HealthCare started to build manufacture factory, and in 1997 the drug production started operation.

Currently Bayer HealthCare in China has two joint venture companies, namely Bayer HealthCare Co., Ltd. and Bayer (Sichuan) Animal Health Co., Ltd. Bayer

HealthCare in China is presented by four businesses: pharmaceuticals, consumer care, diagnostics and animal health.

拜耳医药保健和中国的渊源可以追朔到20世纪初期，拜耳于1936年在中国成立了第一个生产公司--拜耳医药公司，生产的产品包括世界著名的止痛药阿司匹林。

拜耳医药保健在中国市场的飞速发展起始于20世纪90年代。1995年在北京开始建立现代化药品生产工厂，1997年，药品生产线开始运转。

目前拜耳医药保健在中国拥有两家合资公司－拜耳医药保健有限公司和拜耳(四川)动物保健公司，致力于四个业务领域：处方药、消费保健品、医学诊断及动物保健。

B.Braun Medical (Shanghai) International Trading Co. Ltd.贝朗医疗(上海)国际贸易有限公司

Booth No.: CB04-05Address：Tower A, 14th Floor, Shanghai International Plaza, 360 Putong South Road, ShanghaiTel： 010-65995580 (Beijing)Fax： 010-65995587 (Beijing)Website：www.bbraun.com

The B.Braun Group: modernity, innovation, and a customer-based orientation are the guiding principles of this worldwide supplier to the health care industry-values put daily into practice by more than 27K employees around the globe.

With this philosophy, the company offers a wide range of medical products - for anesthesia, intensive care, cardiology, or surgery, for example. The product range includes syringes, cannulas and catheters, infusion solutions and systems, as well as infusion pumps, suture materials, surgical instruments, and dialysis technology. Moreover, the company markets products and concepts for doctors' offices and for the home care sector. The caried product portfolio is supplemented finally by a wide range of customer-tailored services.

81


北京安泰生物医用材料有限公司，作为安泰科技股份有限公司的子公司，专门从事生物医用材料和医疗器械的研发、生产与经营。公司本着"科技关爱健康"的宗旨，通过建立一个快速、集中、灵活的组织，依靠富于激情的工作，创新医疗产品和服务，将其价值展示给患者、医生和投资者，以高科技促进人类健康。

自1986年起，齿科充填材料银合金粉、银汞胶囊投放市场以来，由于技术先进、质量稳定，目前占有国内70%的市场份额。口腔系列产品包括GK银合金粉、银汞胶囊、银汞调合器、银汞输送器、光固化机、根管测量仪等。产品通过了美国齿科协会(ADA)和欧洲CE(TüV)认证，畅销30多个国家和地区。

自1991年起，公司开始进行介入性治疗材料及相关器械的研究开发。目前产品包括自弹式不锈钢支架(外周血管用)、Z型激光焊接不锈钢支架(下腔静脉、气管)、NiTi形状记忆合金支架(食道、胆道、尿道、前列腺等)、冠脉支架及输送系统(冠状动脉)。

产品生产的组织和现场，建立了符合GMP标准的现场条件和管理体系。公司的齿科材料和介入性治疗器械均通过了医疗器械行业ISO9001国际质量体系认证。

公司研发力量雄厚，拥有一批由教授、高工、博士后、博士等组成的专业研发队伍，研发设备齐全精良。1994年，公司与北京市科学技术委员会联合组建了北京市生物材料与工程中心，成为生物医用材料研究及高技术产业开发的重要基地。公司研究开发活动坚持医、工、学结合的原则，支持基础性和前瞻性的研究。在介入性治疗技术前沿热点的研究上，如抑制治疗冠心病的支架植入术后再狭窄研究，与国外保持同步。在再生医学方面，采用生化提取的牛骨形态发生蛋白(BMP)和基因重组法制备的BMP-7，实现了骨组织再生与重建，并逐步探讨其医治肾衰竭及老年人骨质疏松的可能性。目前公司承担了2001年北京市科委重大项目"心血管病用器械及介入性治疗支架和导管的产业化技术攻关"、2001年十五"863"新型介入性治疗支架材料的研制、2002年国家计委"介入性治疗材料与器械高技术产业化示范工程"、2002年十五"863"纳米专项"口腔纳米树脂充填材料的研制"等多项重大科研和产业化项目。

Beijing AT&M Biomaterials Co., Ltd.安泰生物医用材料有限公司 Booth No.: CB27Address: No. 12 Yongcheng Bei Road, Yongfeng Industrilization Base,Haidian District, Beijing 100094Tel: 010-58742850 Fax: 010-58742853 Website: www.atmbio.com

As a subsidiary company of AT&M, AT&M Biomaterials Co., Ltd. (AT&M Biomaterials) engages in developing, producing, and marketing medical devices, biomedical materials and health products. Through building a rapid, concentrating and flexible organization and energic activities, we reveal novel therapeutic products and services and show their value to doctors, patients and investors. We take advantage of high-tech to improve the health condition of patients.

Since 1986, AT&M Biomaterials began to supply the dental materials which now occupy seventy percent of marketshare in China. The serial dental products include GK amalgam alloy, amalgam capsule, and automatic amalgamator, amalgam carrier and root canal depth gage etc. The filling materials of amalgam alloy and amalgam capsule have CE certificates. The products have been sold well in more than 40 countries and areas worldwide.

Since 1991, AT&M Biomaterials began to development the interventional therapeutic materials and devices. More than one hundred specifications of self-expandable stainless steel stent, Z-type laser welded stent, Nitinol stent and coronary stent and delivery systems are supplied. The occluders were developed to treat congenital heart disease.

82


3 Quality Assurance and Quality Control in X-ray Diagnostics: Sensitometer, Densitometer, digital KV meter, dosemeter, test charts, test phantom system and service & quality control kits.

北京科利达医疗设备发展有限公司位于北京中关村科技园，是专业从事医疗设备研制、开发、生产和经营的高科技中外合资企业。自1988年成立以来，公司一直致力于医用射线防护服和防护系统、医学影像设备及附件的开发、生产和销售。公司长期与德国、美国专业医疗设备生产企业密切合作，引进国外的先进技术和设备，加工生产高技术、高品质的医疗用品提供给中国的广大医院。科利达公司以高质量的产品和优质的服务赢得了广大用户的信赖，使其产品在同行业中市场占有率遥遥领先。

科利达射线防护系列产品达到国际标准，经德国TUV认证机构批准，2004年科利达公司获得欧盟CE认证。目前科利达产品已进入到国际市场，出口到德国、西班牙、美国、沙特等国家。

目前科利达公司主要产品：1 射线防护系列产品：射线防护衣、防护脖套、防护面罩、性腺防护、铅手套、铅眼镜、移动式射线防护屏、悬吊式射线防护屏等；2 X线诊断设备及附件：自动洗片机、X线暗盒、增感屏、滤线栅、观片灯、暗室设备等；3 QA质量控制检测设备：感光仪、密度仪、数字KV仪、射线剂量仪、分辨率测试卡；

Asian markets. The company is headquartered in Beijing with branch offices in HongKong and Shenzhen and liaison offices in Europe and USA.

北京鑫正谊医疗器械有限公司是一家以提供信息服务及医疗产品销售为专长的股份公司，例如医疗产品的代理和销售，为制造厂商提供商业咨询，及其他信息服务；并针对在中国及亚洲市场上对心脏介入产品、医疗器械产品、药品和卫生保健等方面感兴趣的公司开展联营合作。公司总部设立在北京，分支机构分别位于香港和深圳，并在美国和欧洲均设有联络办事处。

Beijing Kelida北京科利达医疗设备发展有限公司北京迈特医学影像技术开发公司

Booth No.: CB23Address: 北京市海淀区紫竹院路88号紫竹花园F606Tel: 010-88552106Fax: 010-88552107

Beijing Kelida Medical Equipment Developing Co., Ltd. is located in Beijing Zhongguancun Science and Technology Zone. It is a High-Tech enterprise that is engaged in production and trading of medical equipment, specially in X-ray protection and accessories.

Kelida is the biggest manufacturer of X-ray Protective Aprons and X-ray Barriers as well as X-ray protective accessories including Lead Glasses in China. Thanks to the high quality, the X-ray Protective products manufactured in Kelida obtained the CE mark in 2004, and then were exported to Germany, Spain, USA, Saudi Arabia, Palestine, Kazakhstan and other many countries. At present Kelida Co., is selling the main products as following:1 X-ray Protection: X-ray protective aprons, neck & thyroid protection, head protection, X-ray protective glasses and face shields, and X-ray mobile barriers and overhead barriers.

2 X-ray Diagnostic Equipment and Accessories: X-ray film processors, X-ray cassettes and intensifying screens, X-ray grids, darkroom safelights, film viewers, film hangers and lead marks.

Beijing Synex Medical Co., Ltd.北京鑫正谊医疗器械有限公司

Booth No.: CB22Address: Room 304,Tower 2, Suncity No.18 Xinzhong Street Dongcheng District, Beijing 100027, ChinaTel: 010-84472806/07 Fax: 010-84473100Website: www.synexmed.com

Beijing Synex Medical Co. Ltd. is a unique trade & service company providing Product Distribution, Contract Manufacturing, Business Consulting, and Information, to interventional cardiology device, medical device, pharmaceutical, and related healthcare companies interested in the Chinese and

83


development company focused on developing alternatives to traditional surgery. Medi-tech's first products, a family of steerable catheters, were introduced in 1969 and were used in some of the first less-invasive procedures. Versions of these steerable catheters are still used today. In 1979, Abele and Pete Nicholas partnered to buy Medi-tech and together formed Boston Scientific Corporation.

波士顿科学国际有限公司是一家全球性的医疗技术产品研发、生产、营销公司，现有17,500名雇员，2005年的销售收入为63亿美金。在过去的二十五年中，公司为广泛的医疗技术领域提供了具有深度和广度的众多革新产品线，从而推动了微创介入产品的实践和发展。公司的产品通过提供传统外科手术的替代产品，帮助医生和其它医疗行业工作者改善病人的生命质量。

关于更详细的信息，请参阅www.bostonscientific.com。

我们的使命通过倡导和发展微创介入技术，提高病人的护理质量及医疗事业的生产力。我们的使命是通过持续改善现有产品，不断研发能够减少风险、损伤、费用、手术时间和术后护理的新技术来达到的。

公司历史波士科学国际有限公司的历史从二十世纪60年代晚期开始，当时联合创始人John Abele先生收购了Medi-tech公司，此公司是一家专注于发展传统外科手术替代产品的研发型公司。Medi-tech公司的第一个产品--导引导管系列，于1969年推向市场，并在一些早期的微创手术中被使用。当时这些导引导管的部分产品迄今仍然被使用。1979年，Abele先生和Pete Nicholas先生合伙收购了Medi-tech公司并一起组成了波士顿科学国际公司。

Biotronik德国百多力有限与两合公司

Booth No.: CA17

BSC Int'l Medical Trading (Shanghai) Co., Ltd. 波科国际医疗贸易(上海)有限公司

Booth No.: CA12Address: Rm.5301, Hong Kong New World Tower, No.300 Huai Hai Road (Middle), Shanghai 200021Tel: 8621 6391 5600 Fax: 8621 6391 5100Website: www.bostonscientific.com Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices with approximately 17,500 employees and revenue of $6.3 billion in 2005. For more than 25 years, Bostion Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties.The Company's products help physicians and other medical professionals improve their patients' quality of life by providing alternatives to surgery. For more information, please visit www.bostonscientific.com.

MISSIONBoston Scientific's mission is to improve the quality of patient care and the productivity of health care delivery through the development and advocacy of less-invasive medical devices and procedures. This is accomplished through the continuing refinement of existing products and procedures and the investigation and development of new technologies which can reduce risk, trauma, cost, procedure time and the need for aftercare.

HISTORYBoston Scientific's history began in the late 1960s, when co-founder John Abele acquired an equity interest in Medi-tech, Inc., a research and

84


强生医疗器材有限公司, Cordis 介入治疗产品部是美国强生公司下属的一家致力于研究, 开发介入诊疗产品系列(包括心血管, 电生理, 周围血管及神经介入产品)的专业医疗器材公司, 为广大医师和患者提供整体化的诊疗方案.

Cordis 进入中国市场数十年来, 关爱患者, 不断为介入治疗专家提供最新产品和优质服务, 2002年秋天, Cypher心扉雷帕霉素药物支架进入中国, 为治愈冠状动脉狭窄带来了新希望! 同时也减少了患者的长期治疗费用, 大大降低了医疗成本, 为国家节省了有限的医疗卫生资源

Cordis Corporation, Johnson & Johnson Medical (China) Ltd.强生医疗器材有限公司

Booth No.：CA05Address: 3rd Floor, Man Po International Center, 660 Xin Hua Road, Shanghai 200052, ChinaTel: (86 21) 6282 6988　Fax: (86 21) 6282 6495Email: [email protected] Website: www.jnjmedical.com.cn

Since its establishment in 1959, Cordis Corporation, along with its subsidiaries, has been a pioneer in circulatory disease management. Cordis is the world's largest, most comprehensive developer and manufacturer of innovative products for interventional medicine, minimally invasive computer-based imaging, and electrophysiology.

In 1996, Cordis Corporation merged with Johnson & Johnson to form Cordis, a Johnson & Johnson company, with approximately 3,500 employees worldwide.

In 2002, Cypher , Sirolimus-eluting Coronary Stent has been launched in China, making it the first drug/device combination for the treatment of restenosis, more and more Chinese patients are benefit from it.

GE医疗集团隶属于通用电气公司，年销售总额达140亿美元。GE医疗集团提供革新的医疗技术，为病患护理领域开拓新的时代。GE医疗集团在医学影像、信息技术、医疗诊断、患者监护、疾病研究、药物研发以及生物制药等领域均拥有专业技术，长期致力于病症的早期探测，并为病人"量身定制"治疗方案。GE医疗集团提供广泛的服务，以提高医疗工作者的效率，并帮助他们为疑难疾病患者--如癌症、老年痴呆症及心血管疾病患者--提供更佳的诊断、治疗与护理。

GE Healthcare通用电气(中国)医疗集团

Booth No.: CA07Address: 上海市延安西路2201号国际贸易中心2701室Tel: 021-52574530-67040 Fax: 021-62191584

GE Healthcare is a $14 billion unit of GE that provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare's expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals is dedicated to detecting disease earlier and tailoring treatment for individual patients. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, Alzheimer's and cardiovascular diseases.

85


Guidant公司在心血管医疗器械的设计、开发领域居世界领先地位。其产品为医生提供更多先进的医疗手段，使患者恢复健康、正常的生活。公司倡导员工、投资者和业界共享成功的企业文化。公司成立于1994年，至今规模已达年收入38亿美元。在中国，2004年在上海成立独资公司，北京、上海、广州设有办事机构。主要产品包括冠脉支架系统(MULTI-LINK MINI VISIONTM 、MULTI-LINK VISIONTM 等)、冠脉扩张导管(VoyagerTM、PowerSailTM等)、导引导丝(HI-TORQUE BMWTM等)、导引导管、压力泵和PTCA套装配件。公司研发的新一代药物支架已于2006年1月获得欧洲CE认证，敬请期待中国上市。

伟龙公司始终坚持以人为本，以诚信为宗旨，主要代理：GE公司心电产品系列、美国VOLCANO血管内超声成像系统、PB呼吸机系列、德国Mobil动态血压。自主创新的新型医用全无铅X射线系列防护产品。其中IVUS 已经成为心脏介入金标准，VH 技术更是目前国际上最流行的科研诊断技术。

Great Dragon Co., Ltd. 北京伟龙科仪贸易有限公司

Booth No.: CB14Address: Room 0158, Block B, Xiqing Apartment, 101 Lian Hui Road, Beijing, ChinaTel: 010-82211330 Fax: 010-62228747 Great Dragon Medical System Ltd is the distributor of many advanced medical equipment manufactures. They are GEMS-IT, Volcano (IVUS), Tyco (Ventilator), I.E.M (Mobil Blood Pressure Recorders), etc. Great Dragon Medical System Ltd has done researches in X-ray shielding and successfully gained new type of nonlead shielding apron. IVUS technique is becoming the gold standard for PTCA, specially VH technology, give more help to doctors.

Guidant International Trading (Shanghai) Co. LTD概腾国际贸易(上海)有限公司

Booth No.: CA13Add：Room 2201, Hua Xia Bank Tower， No. 256, Pudong Road (S), Shanghai 200120, P. R. ChinaTel：(86 21) 6886 4928 Fax：(86 21) 6886 4572Web site：www.guidant.com Guidant is a world leader in the design and development of cardiovascular medical products. Our devices help patients with heart disease return to active and productive lives. We provide physicians with leading-edge technologies for improved patient management and clinical outcomes. And we've created a culture in which employees; investors and our communities share in our success.Guidant was incorporated in 1994, and since has grown to $3.8 billion in revenue. In China, we established a wholly Guidant owned affiliate in Shanghai in 2004, and have representative/liaison offices in Beijing, Shanghai and Guangzhou. Our major products include guide wire (HI-TORQUE BALANCE MIDDLEWEIGHTTM,etc.), coronary dilatation catheter (VOYAGERTM, PowerSailTM, etc.) and coronary stent system (MULTI-LINK MINI VISIONTM & MULTI-LINK VISIONTM etc.). The new generation Drug Eluting Stent (DES) got CE mark in Jan. 06, please expect its launch in China.

86


transparent lead acrylic protective material, and it has the strongpoint of well protection, wide viewing screen, and excellent light transmission and shock resistance, and convenient movement. Besides, our products accords with the MDD 93/42EEC of EU and the standard IEC 61331-3:1998, and obtain the FDA certificate (registration No.: 3005517128)

北京华仁公司是1993年初成立,位于北京中关村科技园区一家专业研发、生产和经营医用X射线防护用品、装置及其它医用X线设备附件产品的高新技术企业。公司总部设在中关村海淀园区,生产厂和研发中心设在中关村昌平园区。本公司一贯秉承自主创新，技术领先为企业发展的宗旨，在国内率先采用多层薄型防护材料组合式X射线防护服生产工艺，率先开发出悬挂防护屏；在国际上首创出X射线防护面罩。本公司一贯坚持以人为本，科学设计,精细制作，严格检验，规范管理。产品自投入市场十多年来，产品质量越来越受到客户信赖。华仁品牌在国内外医用放射线领域享有盛誉。

我们的主要产品有：华仁牌HR系列医用X射线防护服华仁牌HR系列医用X射线移动式防护屏华仁牌HR医用X射线防护装置系统华仁牌HR系列医用X射线防护面罩华仁牌FG系列医用X射线防护眼镜

华仁系列X射线防护服采用德国最新防护材料和PU防水牛津纺表面材料，产品具有防护性能高、重量轻、厚度薄、质地柔软、美观、耐用等特点；华仁系列X射线防护装置采用日本新型铅有机树脂玻璃和国际先进制造技术，产品具有防护性能可靠、可视面积大、透射率高、抗冲击、移动方便等特点。另外，华仁防护产品符合欧共体医疗器械93/42/EEC指令和IEC 61331-3:1998标准; 获得美国FDA认证(注册号:3005517128)。

Beijing Huaren Medical Equipment Company北京市华仁医疗设备公司

Booth No.: CB26Address: Room 2-304, Eveer Flash Tower, No.45 Xizhimen North Street, Haidian District, Beijing, 10044, P.R. ChinaTel: 010-62222212 Fax: 010-62222022Website: www.beijinghuaren.com.cn

Beijing Huaren Medical Equipment Company was set up at the beginning of 1993, and it is a hi-tech enterprise that specializes in developing, manufacturing and selling X-ray protective products, devices and other X-ray accessories. Its headquarters is located in the zhongguancun of Haidian district and its factory and developing center are located in the Changping district. This company adheres to the tenet of independent innovation and advanced technology, and it is the first one to adopt the technique of combining multiple layers of thin material to become a protective apron and is also the first one to devise the overhead suspended shields inland, and it is the pioneer to develop the X-ray protective mask in the world. We are maintaining the principle of "people first, technical design, fine work, strict test, and normative management". Our products have been on the market about ten years, and the customers have trusted them in their high quality. Huaren brand takes the reputation in the region of medical X-ray indoor and outdoor.

Our main products:HUAREN Brand HR Series of Medical X-ray Protective ApronHUAREN Brand HR Series of Medical X-ray Protective Mobile ShieldHUAREN Brand HR Series of Medical X-ray Table Mounted Shield and Overhead Suspended ShieldHUAREN Brand HR Series of Medical X-ray Protective MaskHUAREN Brand FG Series of Medical X-ray Protective GlassesHUAREN Brand HR Series of Medical X-ray Radiographic Stand.Huaren X-ray series aprons adopt the newest protective material from German and the waterproof PU surface material, and they are excellent at high capability of protection and they are light, thin, soft, nice and durable. Huaren X-ray series protective devices adopt the newest international technology and Japanese new-style

87


INVATEC 公司于1996年成立，前身是创立于1978年的FOGAZZI公司，当时所生产的产品涉及工业和医疗领域，并且与意大利大学和公共研究基金会建立了紧密的合作。

1989年，公司作出决定，将全部精力专注于医疗仪器的开发与生产。在靠近意大利北部城市BRESCIA的高科技技术园区， I N VAT E C成立了研发基地，主要机构包括：FOGAZZI创意研究科技、表面改良实验室、以及位于瑞士的支架科技集团。现在，INVATEC的产品遍及全球40多个国家和地区。公司在意大利和瑞士拥有5个生产基地，每年约有150万条产品投放市场，确保了产品的稳定供应。

随着专为CTO病变设计的1.25MM小球囊、血栓抽吸导管、下肢球囊扩张导管、以及拥有专利技术的MOMA颈动脉脑保护装置等产品的投放，INVATEC将以更多的产品和更优质的服务来回报广大用户。

Invatec S.R.L.意大利英泰克公司

Booth No.: CA16 In 1996 Invatec was created, growing out of FOGAZZI, at that time a small but ever active and growing family run research company established in 1978 by Luigi Venturelli. From the start, FOGAZZI's special know-how has been in plastic processing, extrusion and thermo forming (fuel lines, high pressure tubing, etc.) for the industrial field.

Located in the high tech industrial area close to Brescia, in northern Italy, it was in 1981 that FOGAZZI started moving towards the medical area by prototyping and producing small series of catheters dedicated to specific research projects in cooperation with Italian Universities and Public Research Foundation.

In 1989, with the development of PTLA laser plaque debulking catheters, FOGAZZI initiated the production activity of medical devices. This was soon extended to further manufacturing as an OEM supplier for well established companies in the Interventional Vascular field. As OEM volumes constantly grew throughout the following years, and thanks to the proven design, high performance and acceptance of these products, the decision was taken to establish a proprietary Brand name in addition to the OEM line. To capitalize on more than 15 years of experience in research, development and production in the medical field, Invatec was thus founded in 1996.

ntellect and passion for excellence are the driving factors enabling Invatec to listen and interpret customer's needs and ideas and transfer them into concrete products with unmatched time to market.Invatec prides itself that they are completely vendor independent. Currently Invatec is one of the fastest growing companies in the field of vascular interventions worldwide.

Beside plastic extrusion, thermoforming etc., the Company's core competency and know-how also includes metal processing such as vascular stents and minimally invasive Radiofrequency Ablation Technology.

88


我公司是专业生产医疗器械产品的厂家。PARTNER雷帕霉素药物洗脱支架已经上市。国家机构检验和临床研究表明，PARTNER药物支架各项性能指标都已达到国际同类产品先进水平。临床6个月回访表明，该药物支架MACE率为零。二元性再狭窄率为零，管腔丢失0.03±0.14mm。

Biosensors International山东吉威医疗制品有限公司

Beijing Lepu Medical Device, Inc.乐普医疗器械有限公司

Booth No.: CA14Address: Beikong Building No.10, Baifuquan Rd., Zhongguancun Higi-tech.zone, ChangPing DistrictTel: 010-51262689Fax: 010-82291265Email: [email protected] tLePu medical device, Inc. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical specialties. The company provides products and technologies for use in interventional cardiology, peripheral interventions, and vascular surgery. The major product line is coronary stent systems, used for the treatment of coronary artery disease. The latest advanced product is ParnterTM rapamycin stent (DES), which was approved by China SDA in Nov. 2005. The six-month following-up date shows that both of the MACE (%) and Binary Restonosis rate are zero.

EXCEL是首次采用可生物降解聚合物专利技术的商用SIROLIMUS涂层药物洗脱支架。

SIROLIMUS和可生物降解聚合物形成一种药物复合体，这种复合体具有生物可降解性在支架植入后4-6周内完成药物洗脱，其间包含细胞增殖的关键阶段，因尔有效减少再狭窄。

2004年至今，已经完成近2000例支架植入，安全性和效力在人体研究中得到充分确立。

Booth No.: CA02Address：A908B JiaHua Building,9#,3rd Ave.Shangdi,HaidianBeijing,ChinaTel: 010-62973298Fax: 010-62973738Email: [email protected]: www.jwms.com

EXCEL,the first commercially available Sirolimus Coated Drug Eluting Sent with Patented Biodegradable Polymer.Sirolimus and the Biodegradable Polymer form a Drug Composite which is biodegraded and eluted over a period of 4-6 weeks after stent implantation , covering the most critical period of cell proliferation, thus reducing restenosis effectively.More than 1,000 Excel implantations were made since 2004 with well established safety and efficacy shown in human studies.

89


Medtronic Medical Appliance Technology & Service (Shanghai) Ltd.美敦力 Booth No.: CA01Address: 8/F Zhangjiang Mansion, No. 560 Song Tao Rd., Shanghai 201203Tel: +86 21 50800998Fax: +86 21 50800978Email: [email protected] 美国美敦力公司是全球首屈一指的医疗科技公司，致力于为慢性疾病患者提供终身的治疗方案。其主要产品覆盖心律失常、房颤、心衰、血管疾病、心脏瓣膜置换、体外心脏支持、微创心脏手术、恶性及非恶性疼痛、运动失调、糖尿病、肠胃疾病、泌尿系统疾病、脊椎疾病、神经系统疾病及五官科手术治疗等领域。每6秒钟，世界上就有一名病人因为美敦力的产品而减轻病痛、恢复健康、延长寿命。

美敦力公司主要冠脉介入产品：冠脉支架 PTCA导丝Modular: Drvier, Micro Driver; S7, S660; Cougar冠脉球囊造影导管Sprinter SiteSeer, ProFloExtensor 远端保护装置指引导管 GuardWire PlusLauncher 动脉鞘Z2 Input 系列压力泵

MicroPort Medical (Shanghai) CO., Ltd.微创医疗器械(上海)有限公司

Booth No.：CA06Address: 501 Newton Road Z. J Hi-Tech Park, Shanghai 201203, ChinaTel: 8621-38954600 Fax: 8621-50801305Website: www.microportmedical.com MicroPort Medical (Shanghai) Co. Ltd, was founded in 1998 and since then has been transferred into a sizable corporation with financial backing from MicroPort Medical (Cayman) Corp., Shanghai Industrial Corp. and Otsuka Group. The business focus of Microport is in the area of interventional and minimally invasive medical devices, providing leading-edge technology and products for physicians and life-saving solutions and comforts for patients. The company has been certified as one of the Shanghai Hi-Tech Enterprises.

The aim of Microport Medical is to establish a China people owned, world-class medical group in interventional medical area. The investigation and developing center of Microport is cognized as the Pudong new area investigation and development center on interventional treatment. The company keeps an innovative and entrepreneurial environment, retaining many talents from local and overseas

美敦力公司成立于1949年，现在全球120多个国家开展业务，拥有雇员超过3万名。根据美国《商业周刊》的调查，美敦力公司股票市值位列全球1000家最大公司的第54位。

countries. There are more than 10 technology patents, the drug eluting technology included, and several independent intellectual assets have been acquired. At present, there are various projects on interventional products are under developing such as drug eluting stents, encephalic stents, carotid stents, embolic protection devices, etc., and a number of technology fund support have been invested into several projects by the nation, Shanghai or Pudong New Area.

微创医疗器械(上海)有限公司，由留美科学家创办于一九九八年五月，现已吸收上实医药(集团)有限公司、微创医疗器械(开曼)公司和日本大冢投资有限公司等风险资金和战略投资资金，主要从事各种高科技微创医疗产品的研究、制造、销售和服务，公司被认定为上海市高新技术企业。

公司的宗旨是"以人为本，在微创伤介入医学领域建设属于中华民族的世界级医疗集团"。公司研发中心被认定为"浦东新区微创伤介入治疗研发中心"，吸纳了美国多位著名的生物医学工程界专家和介入医疗界科学家，拥有数十名包括博士、硕士在内的微创伤介入医疗器材产品开发与生产方面的专业人才，拥有药物支架包裹技术等十多项技术专利和多项独立知识产权，目前，正开发药物支架、颅内支架、颈动脉支架、远端保护器等多种高科技微创伤介入治疗产品。多个项目获国家、上海市、浦东新区多项科技基金的资助。

90


HZ MSD has experienced rapid development within the last several years. The number of employees is near to 1000 employees.

"科研为本，健康予人"是我们的价值观与行为准则。我们恪守崇高的职业道德操守，致力于优质的专业服务，并通过优良的管理，来为病人带来最具价值的医药。

多元化产品默沙东在中国市场主要销售17个产品，其中大部分产品已在杭州工厂分装或生产。我们的产品覆盖领域广泛，在降血压、调节血脂、治疗前列腺增生、哮喘、骨关节炎、骨质疏松、男性脱发和艾滋病等多个治疗领域方面均居领先地位。我们还有一系列疫苗预防甲肝、麻疹风疹腮腺炎及肺炎球菌、流感嗜血杆菌引起的疾病。

Hangzhou MSD Pharmaceutical Co., Ltd. Shanghai Office杭州默沙东制药有限公司

Booth No.: CA03Address: 26/F, Shanghai Central Plaza, 381 Huai Hai Middle Road, Shanghai 200020, ChinaTel: +86 21 6391 5522 Fax: +86 21 6391 6350Email: [email protected] MSD is a leading research-driven pharmaceutical company. During the last century, MSD has made significant achievements in the research and production of innovative and high quality products. MSD brings breakthrough medicines and vaccines to the market to improve the lives of human beings.

HZ MSD products cover a broad range of human ailments, including cardiovascular disease, benign hyperplasia of the prostate, osteoporosis, arthritis, asthma and infections. There is also a series of vaccines for the prevention of hepatitis A, rubeola and rubella and parotitis.

上海丞龙医疗器材有限公司(MVP医疗器械（中国）有限公司)－所谓MVP，是取自"Most Valuable Product"这三个单词的英文字母缩写而构成的，意思是"最有价值的产品"，其恰巧反映了我们公司的宗旨。

作为一个正在成长的企业，我们坚信，将为客户提供熟练的销售人员并为实习医生提供向世界一流心脏病专家学者学习的机会。

我们的产品首屈一指。自从公司成立5年以来，我们一直在寻找和提供独特的技术过硬的产品。以下是我们目前在中国代理销售的产品：1.索林生物医疗器械公司的Syncro晶碳烤瓷支架2.德国Devon公司的Maneo支架最后，我要再着重强调一下MVP上海丞龙公司的宗旨－"向我们尊敬的客户提供最独特的产品，满足他们的一切需求。"

MVP Medical (China) Co., Ltd.上海丞龙医疗器材有限公司

Booth No.：CB06-07Address: 605　West Beijing Road C, 9/F, JiaFa Buidling A Jingan District, ShanghaiTel: 8621-62677827 Fax: 8621-62677837 Shanghai chenglong Medical Ltd.(MVP Medical China)-acronym MVP being "Most Valuable Product", parallels precisely the vision of our company.

As a growing enterprise, we believe in education providing our clients highly-skilled sales assistants and international internship opportunities to learn from among the world's top cardiologists.

Our products are second-to -none. Since establishing 5 years ago, we have been searching for and offering products that are unique and technologically sound. Such products which we represent in China at present are:1. Sorin Biomedica's Carbostent-Syncro2. Devon Medical's Maneo stentFinally, we emphasize MVP's mission statement－"To provide our valuable clients with the unique of all unique products, and to tend to their very needs."

91


Orbus-Neich 业聚实业有限公司

Booth No.: CA09Address: 北京市东城区朝阳门北大街8号富华大厦F座501室Tel: 010－65544906 Fax: 010－65544808Email: [email protected] Website: www.orbusneich.com OrbusNeich develops, manufactures and markets an array of cardiovascular products. Our mission is to Urgent delivery of medical technology to patients of the world. OrbusNeich is situated throughout the world with Headquarters in Hong Kong and Global Marketing and Sales Headquarters in The Netherlands. There are nine regional sales offices situated in Europe and Asia Pacific that support direct sales and a network of distributors.

OrbusNeich has Advanced Research and Development operations in Fort Lauderdale, USA, and state-of-the-art manufacturing facilities in Netherlands and Shenzhen, China. Our product includes Coronary stent, Balloon catheter, guiding catheter, diagnostic catheter and Coronary sheath introducer. Genous, an antibody coated stent of OrbusNeich, is the first of a new generation of bio-engineered stents that promote rapid natural healing for the ongoing battle against restenosis and thrombosis. The new HEALING Era Begins Now.

OrbusNeich是一家致力于研发、生产、销售系列心血管介入治疗产品的专业医疗器材公司。公司总部设在香港，市场和销售总部位于荷兰，在亚洲和欧洲拥有9个销售分公司，并对全球的直销和经销网络提供支持。

OrbusNeich产品的概念研发源于美国,生产在荷兰和中国深圳。产品包括冠脉支架系统，冠脉球囊扩张导管，导引导管，造影导管和导管鞘。OrbusNeich公司最新研发的，世界首创生物抗体支架Genous通过加速血管内皮化过程，将血栓发生的危险及再狭窄降至最低，并为全世界的冠心病患者开创了自然修复的新篇章。

Pacific Medical Corporation上海帕斯医疗器材贸易有限公司

Booth No.: CB15Address: 北京市海淀区知春路锦秋国际大厦A座-404室Tel: 8610-8280 0951 Fax: 8610- 8280 0955

上海帕斯医疗器材贸易有限公司成立于1999年在中国设立北京、上海、广州三个办事处。多家欧美产品在中国地区的总代理

代理产品介绍：1、美国雅培药厂心血管部产品2、意大利索林起搏器3、加拿大CryoCath公司的冷冻消融仪、冷冻消融导管及配件

92


在中国，辉瑞公司致力于通过不断引进、生产和推广创新药品，为提高中国人民的医疗保健水平不断努力。与众不同的是，辉瑞公司所有在中国上市的创新药品均与全球同步上市。凭借这些更加丰富的药品组合，辉瑞在心血管科、内分泌科、呼吸系统和感染性疾病、精神科、关节炎和其它炎症、泌尿科、癌症、眼科疾病和其他许多医学领域均保持领先水平。

Pfizer 辉瑞制药有限公司

Booth No.：CB01-02Address: Tower B, 10/F, Full Link Plaza, No.18 Chaoyangmenwai Ave., Beijing 100020, P. R. ChinaTel: (010) 65880288 Fax: (010) 65880266Website: www.pfizer.com.cn In China, we manufacture, introduce and market many of our leading innovative medications, and we are distinctive in our pursuit to make these available to Chinese patients at the same time of their introductions globally. With an unequalled product portfolio, the new Pfizer China maintains category leadership in the therapeutic areas of cardiovascular disease, endocrinology, neuroscience, arthritis and other inflammatory diseases, infectious disease, urology, ophthalmology and oncology.

飞利浦医疗系统是全球最大的医疗设备制造商及相关服务供应商之一。近百年来一直致力于医疗前沿科学的研究及开发，并依靠其全球范围的资源向全球用户提供高品质的医疗设备和全面的医疗解决方案。

飞利浦医疗系统全面创新的设备和服务，可以满足全球医疗服务机构的需求。其主要产品包括: 计算机断层扫描系统、磁共振系统、肿瘤放疗系统、X光产品及血管造影系统、病人监护系统、超声影像系统、核医学及PET系统、临床信息系统及维修服务及技术支持。飞利浦医疗系统正在越来越多的医疗设备领域中发挥独一无二的作用。

Philips (China) InvestmentCompany Ltd.飞利浦(中国)投资有限公司

Booth No.: CB11-13Address: 16/F, China Resources Building, No. 8 Jianguomenbei Avenue, Beijing 100005, ChinaTel: +86 10 6517 2288 Fax: +86 10 6518 1170Email: [email protected] Philips Medical Systems is a leading supplier of medical equipment and related service all over the world. Over a hundred years, PMS has been devoting on R&D. We provide state-of-art technology and equipment with total medical solutions.

Philips Medical Systems delivers one of the world's most robust portfolios of medical devices. The full and innovative range of equipments and services fulfills the needs of health care providers worldwide. Main products include: CT, Magnetic Resonance Imaging, Oncology, X-Ray, Cardiovascular, Patient Monitoring, Ultrasound, Nuclear Medicine, Medial IT and Medical Service. Philips Medical Systems is the technology leader in a growing number of areas in medical equipment.

93


Sahajanand Medical Technologies Pvt. Ltd.

Booth No.: CB09-10Address: 304, Sahajanand house, Parsi Street, Saiyedpura, Surat - 395003, IndiaTel: +91 261 2451451-58 Fax: +91 261 2452458Email: [email protected] Website: www.smtpl.com

"East matches the west" SMTPL is the first stent manufacturing company outside US which has brought out Paclitaxel Eluting "Infinnium? Stent" & Sirolimus Eluting "Supralimus? Stent". Both of which can match their counterparts in Europe & US markets.

SIMPLE 1 data presented initially in Euro PCR 2003 with the extended follow-up presented at TCT 2004 has impressed the interventionalists all over the world. Infinnium Stent is now being used in about 23 countries of the world besides India.

SIMPLE 2 which is a prospective multicentric trial has just been completed in 8 centers all over the world & 6-month follow-up data shall be presented in TCT 2005 this year.

Once again "East has been able to match the West" in innovation of technologies for treatment of coronary artery disease.

Shanghai Sankyo Pharmaceuticals Co.,LTD上海三共制药有限公司

Booth No.: CB25Shanghai Sankyo Pharmaceuticals CO.,LTD地址:上海浦东张江高科技园区居里路500号电话(上海):021-50803338 传真:021-50803102电话(北京):010-85113338 传真:010-85111933邮箱:[email protected]网址:www.sankyo.com.cn

Sankyo pharmaceutical company established in 1899, is the first pharmaceutical factory producing chemical medicine. Shanghai Sankyo pharmaceutical company , a joint venture of sankyo in China, was founded in 1999, with Mevalotin (pravastatin),a cardiovascular product, which was subsumed in table of Beijing medical insurance, and Omeisartan, a new antihypertensive product of angiotensin receptor blocker.

三共株式会社成立于1899年,是日本最早生产西药的制药企业。上海三共制药有限公司是其在中国的合资企业,成立于1999年。生产和销售的心血管产品有：在医保目录中的调脂药物美百乐镇(普伐他汀),另外还有今年在中国上市的ARB类降压药傲坦(奥美沙坦).

94










德国先灵公司，一个以科研为基石的跨国制药企业集团，专注发展：医诊断和放射医学、生育控制及激素治疗、皮肤科、残疾病症的治疗。德国先灵在全球拥有130多个子公司，全球总销售额50多亿欧元，科研开发总投入高达总销售额的18%。

Schering Pharmaceutical Ltd. 先灵(广州)药业有限公司

Booth No.: CB08Address: 103,Youyi Road, Guangzhou Economic and Technological Development District, GuangzhouTel: 020-82214680 Fax: 020-82214681Website: www.schering.com.cn Schering's activities are focused primarily on: 1. Diagnostics and Radio-pharmaceuticals, 2. Fertility Control and Hormone Therapy,3. Dermatology,4. Therapeutics for disabling diseases. Globally, Schering is composed of more than 130 subsidiaries. A total sale of more than 5 billion Euro dollars was accumulated. Of this total, 18% was channeled back into Research and Development.

岛津制作所自1875年创业以来，始终坚持向时代的尖端技术挑战,在医疗器械、生命科学、环境保护等领域不断钻研新技术，开发新产品。尤其在X线诊断设备的开发中一直走在世界的前列，并在2004年制成世界首台直接转换型FPD数字化血管机。

"为了人类和地球的健康"，岛津公司愿与大家共同前进，去实现人类的美好理想。

Shimadzu International Trading (Shanghai)Co., Limited岛津国际贸易(上海)有限公司

Booth No.: CB03Address: 14/F, life Tower, No.16 Chaoyang Men Wai Street, Chao Yang District, Beijing ChinaTel: 8610-8525-2405 Fax: 8610-8525-2379Website: www. shimadzu.com.cn Shimadzu cooperation was founded in 1875. Form then on, we had been persisting in challenging the high-tech up to the minute. We are keeping ahead to research new technique and to develop new product in the area of medical instrument, life sciences, environment protecting, especially in developing x-ray diagnostic equipment.

And we already produced the first direct-transforming FPD digital blood vessel equipment in the world.For the sake of the health of all the human beings and our earth, we, Shimadzu Corporation, hope to make progress with all of you here and make our ideal come ture.

95










SIEMENS西门子(中国)有限公司

Booth No.: CA04Address: 7, Wangjing Zhonghuan Nanlu, Chaoyang District, Beijing 100102, ChinaTel: +86 10 6476 8888 Fax: +86 10 6476 4951

Website: www.siemens.com.cn

Siemens Medical Solutions Group in ChinaSiemens Medical Solutions is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. From imaging systems for diagnosis, to therapy equipment for treatment, to patient monitors to hearing instruments and beyond, Siemens innovations contribute to the health and well-being of people across the globe, while improving operational efficiencies and optimizing workflow in hospitals, clinics, home health agencies, and doctors' offices. Employing approximately 33,000 people worldwide and operating in more than 120 countries.

China has become one of the most rapidly developing markets in Asia, and one that Siemens Medical is paying close attention to. Headquartered in Beijing, Siemens Medical has established 2 joint ventures and 3 wholly owned businesses across China to manufacture high-end products, as well as to engage in research and development that satisfies local demand for technology and products. The establishment of these ventures and a nationwide sales network help Siemens Medical better understand clients, speed up the pace to respond to market requirements and enhance customer satisfaction. Nowadays, Siemens Medical is manufacturing an even more extensive range of healthcare products, including CT Scanners, MR machines and X-ray machines, Ultrasound systems to satisfy the varied demands of the Chinese market.

Siemens Medical 's operating companies in China include: Siemens Technology Development Co., Ltd. Beijing (STDC) is specialized in service support for Med's equipment within China's borders. Siemens Shanghai Medical Equipment Ltd. (SSME) manufactures computed tomography systems. It is the only Siemens' CT installation base with export and R&D capabilities outside Germany. Siemens Hearing Instrument (Suzhou) Co. Ltd. is Siemens' first hearing aid manufacturing base in China. Siemens Mindit Magnetic Resonance Ltd. (SMMR) is the only Siemens' R&D and manufacturing base for Magnetic Resonance Imaging outside of Germany. MR Center of Excellence, located at the Siemens Mindit Magnetic Resonance Ltd., provides products such as Magnetic Resonance Imaging (MRI) systems and components to meet demands from the markets both in China and overseas. In addition, as one of the three Headquarters Support Centers (HSC) (the other two are in Germany and the U.S. respectively), the MR Center of Excellence for Asia will provide the technical support to global Siemens customers as a consulting center and the daily technical support to its customers in Asia-pacific. Siemens X-Ray Vacuum Technology Ltd., Wuxi (SXVT) is a wholly-owned company that produces vacuum x-ray tubes. Siemens R&D and manufacturing base for X-ray tube housing assembly which located at SXVT is the only Siemens facility of its kind outside of Germany to focus on X-ray tube housing assembly.

Promoting "Total Solutions" and "Customer Care" idea, Siemens Medical aims to fulfill its commitment to China's market by high quality products and customer services.

西门子医疗在中国西门子医疗系统集团是全球医疗领域最大的设备供应商之一。集团始终倡导为客户提供创新的医疗科技、医疗信息系统，管理咨询和支持服务，帮助客户最终实现具体的、持续的、临床方面和经济上的回报。集团业务几乎囊括医疗行业的各个领域，从用于诊断的影像系统，到治疗设备、患者监护设备和听力设备，西门子医疗的创新科技优化医院、诊所、家庭医疗机构和医生办公室的工作流程，提高其工作效率，为全球医疗行业的发展和全世界人民的健康做出贡献。西门子医疗系统集团的全球员工大约为33,000名，业务遍及全球120多个国家。

中国是亚太地区经济迅猛发展的国家之一，也是西门子医疗系统集团最为关注的新兴市场。

西门子医疗系统集团与中国有着悠久的合作历史，其医疗设备和技术历来享有盛誉。西门子(中国)有限公司医疗系统集团的总部设在北京，拥有1,300名员工，目前已经在中国各地建立起2家合资企业和3家独资企业。这些企业不仅制造技术先进、质量可靠的高端产品，还作为研发中心不断地提供满足本地市场需求的技术和产品。如今，集团在中国生产包括CT机、MR机、X光机、超声设备等越来越广泛的医疗产品，以满足中国市场全方面的需要。

西门子医疗的在华企业包括：北京西门子技术开发有限公司 (STDC)，专门为西门子在中国的医疗设备提供服务支持；上海西门子医疗器械有限公司(SSME)生产计算机断层扫描系统(CT)，是西门子公司在德国之外唯一一家具备出口和开发能力的CT生产研发中心，现在已发展到可生产X光设备超声等医疗产品；西门子听力仪器(苏州)有限公司是西门子在中国的助听器生产基地；西门子迈迪特(深圳)磁共振有限公司(SMMR)是西门子在德国总部之外唯一的一家磁共振研发和生产基地，位于公司内的西门子磁共振园提供磁共振成像系统及组件等产品，并作为三大"总部支持中心" (Headquarters Support Center)之一(另外两个分别设在德国和美国)，为全球客户提供技术支持，并为亚太地区的客户提供日常技术支持服务。西门子爱克斯射线真空技术(无锡)有限公司(SXVT)是西门子全资生产X光真空球管的工厂，设在公司内的西门子X射线管研发和生产基地是西门子医疗系统集团在德国本土之外唯一的一个X射线管研发和生产基地。

西门子医疗系统集团提倡"全面解决方案"和"客户关爱"理念，旨在通过高质量的产品和客户服务实现对中国市场的承诺。

96


Singapore LIVE

Booth No.: CB21Address: C/o National Heart Center, 226 Outram Road, Blk A, Level 6, SingaporeTel: +65 6236 7420 Fax: +65 6221 0944Email: [email protected] Website: www.singlivecourse.com

圣犹达公司是世界领先的心血管产品研发和生产企业，为医生及病人提供卓越的临床解决方案，其产品包括起博器、植入型心律转复除颤器、血管闭合装置、穿刺鞘、电生理诊断及消融导管、心脏瓣膜及吻合连接器。

圣犹达公司的产品已在全球一百二十多个国家及地区得到广泛的临床使用, 血管闭合器, 能快速有效地闭合诊断性和介入治疗术后患者股动脉的穿刺部位，Angio-Seal 为患者和医务人员提供了既减轻痛苦，节约时间又安全的解决方案。

圣犹达公司的产品已在全球一百二十多个国家及地区得到广泛的临床使用。

St. Jude Medical上海圣尤达

Booth No.: CA11Address: 上海市淮海中路283号香港广场南座3201室 200021Tel: 8621-63906188 ext. 114 Fax: 8610-63906098 Email: [email protected] St. Jude Medical, Inc. (www.sjm.com) is a world leading manufacturer of cardiovascular medical devices offering physicians and patients unmatched clinical performance. The company's product portfolio includes pacemakers, implantable cardioverter defibrillators (ICDs), vascular closure devices, introducers, Electrophysiology diagnostic and ablation catheters, heart valves, and anastomotic connectors.

St. Jude Medical products are sold in more than 120 countries. Their vascular closure devices, Angioseal TM provides a safe and efficient method for closing the femoral arterial puncture site following a catheterization procedure, offering patients an alternative to painful and time-consuming manual compression.

97










Terumo Corporation泰尔茂

Booth No.: CA02Address: Level17, Tower E2, the towers, oriental plaza No.1, East Chang'an Ave., Dong Cheng District Beijing Tel: 010-85185790 Fax: 010-85189267 Email: [email protected]

Medical treatment follows the disease all the time. Meantime, products of Terumo have already been used extensively in more than 150 countries and regions. Terumo begins to launch the business luxuriantly abroad earlier, have already set up the factory in Belgium and U.S.A. 25 years ago. At present, in the luxuriant group of Terumo , not merely have a luxuriant European Company of Terumo which governs the whole Europe business including eastern Europe, general headquarters lie in the continent of New Jersey of U.S.A. to responsible for Canada and American company of Terumo of whole Western Hemisphere business inclusive of South America. Besides, it has also opened up the market including Asia, Middle East and area of Africa in addition.Terumo's work objective is to improve people's life quality all the time. Since we have entered the high-performance catheter market through the launch of angiographic catheter systems in Sep of 1985, Terumo has not only achieved the success on peripheral vascular intervention, but also has been developing Cardiac series products including Angiography Catheter, Guiding Catheter, Guide Wire, Sheath, Balloon Catheter, Stent, etc. Meanwhile, cardiac intervention product of Terumo is a kind of high quality product that futures unique in the related industry, for example, Angiographic catheter(Outlook) with using in left&right coronary artery, pushable balloon catheter(Ryujin) with 1.25mm profile, guiding catheter(Heartrail) with seating deeply of 5 in 6 system, TRI sheath(IK II) with 16 cm length, bare stent system(Tsunami) with high flexibility and excellent conformability and radial artery hemostasis band(TR Band). Nowadays, Terumo also focus on the coronary artery stent with drug coating, and we have confidence in providing better service for Chinese people by PCI products of Terumo in future.

疾病与医疗是无分界的，泰尔茂的产品现已在150多个国家和地区被广泛使用。泰尔茂在日本同行业中较早开始在海外开展业务，25年前即已在比利时和美国建立了工厂。目前，在泰尔茂集团里，不仅有统辖包括东欧在内的整个欧洲地区业务的泰尔茂欧洲公司，还有总部位于美国新泽西洲负责加拿大和南美地区在内的整个西半球业务的泰尔茂美洲公司。另外还开拓了包括亚洲、中东和非洲地区的市场。

从1921年开始，我们一直以"提高人类的生活质量"为奋斗目标。自从1985年9月血管造影用导管系统上市, 泰尔茂不仅在外周介入取得了可喜的成绩，而且相继在心脏介入领域也开发了包括了造影导管、导引导管、导丝、鞘组、球囊导管、支架等一系列产品。心脏介入产品是具备了市场上独一无二的特性的优质产品，比如：左右冠状动脉共用的多功能造影导管，5F进6F深入衔接动脉血管的导引导管，针对完全闭塞病变的1.25毫米超小外径的推送型球囊扩张导管，16厘米长的桡动脉鞘管，高弹性且具有良好血管顺应性的动脉裸支架系统和桡动脉穿刺止血带。目前泰尔茂也正致力于药物涂层冠脉支架的研制，相信在不久的将来，泰尔茂的介入产品将能更好的为中国民众服务。

98










Star Progress Scientific Co., Ltd.星进公司

Booth No.: CB24Address: Suite.7M, Gross Region Plaza, 899 LingLing Rd.,Shanghai 200030 ChinaTel: 021-54891580　 010-68003236 (Beijing Office) Fax: 021-64282818　 010-68003237 (Beijing Office)

Email: [email protected]

Started in 1996, Starprogress has dedicated to promote the stat-of-the-art technologies as well as medical devices and services in China with our international cooperators. We have more than six direct facilities in the domestic and abroad and established distribution networks throughout China. Starporgress is the exclusive distributor of ASAHI, SEDAT, PROTECH and MEDCON etc. in China.

星峰工贸公司成立于1996年。公司自成立，始终致力于将国际最先进的介入疗法、产品和服务推广介绍给中国医疗行业的专家。总公司于北京、上海、广州、美国波士顿、法国巴黎设有分公司、办事处，并与伙伴公司合作建有全国销售网络。目前为日本Asahi、法国Sedat、美国Protech、以色列Medcon等产品的中国总代理。

Victech Scientific纬达科仪(上海)有限公司

Booth No.: CB20Address: Suite 905, 12th Building, Jiawai SOHO, Chaoyang District, 100022Tel: 010-5869 1208 Fax: 010-5869 1207Email: [email protected] Website: www.victech.com.cn

Victech Scientific (Shanghai) Co. Ltd emerges as an independent company from our origins as a subsidiary company of Schmidt Group in Germany. Victech offers International Medical Device Manufacturers a partnership and support to facilitate focused distribution throughout the P.R.C. and Greater China (Taiwan and Hong Kong). Victech is committed to distributing the highest quality medical devices in the interest of patient safety and to maintain our reputation for excellence.

纬达科仪 (上海 )有限公司原为实密集团 ( S C H M I D T GROUP)在中国投资之全资子公司.公司的核心业务是不断引进国外最先进的医疗产品和技术,通过专业的培训和技术服务等方式为广大医师提供优良的售前和售后服务保证.我们的宗旨是创新开拓,透明开放和知识分享,愿我们成为医师临床工作的长期合作伙伴.

99


入住酒店闭路电视

20:00-21:30 重播 "冠脉介入基本教程1" - (15:00-16:30, 2006-4-6, 2号厅)传统和新型引导导管的选择和应用杨跃进

PCI导引钢丝的改进 - 陈纪言

药物洗脱支架的选择 - 陈纪林

药物洗脱支架时代金属裸支架的角色霍勇

导管室的噩梦 - 贾国良

21:30-23:00 重播"同步分会1 - 为什么和怎样应用血管内超声 " - (16:30-18:00, 2006-4-6, 17号厅 )

术前临界狭窄和复杂病变的血管内超声评估 - Junko Honye

应用血管内超声指导支架置入和评价最终结果 - Tino Cost ant ini

血管内超声评价再狭窄的机制 Gary S. Mint z

怎样测量和报告血管内超声的发现钱菊英

应用血管内超声研究急性冠脉综合征和粥样硬化的进展和消退

新型冠脉内影象设备的概论 Gary S. Mintz


北京国际会议中心会场外电视

07:30-09:00 重播"手术转播-沈阳军区总医院" - (13:30-15:00, 2006-4-6, 2号厅)

09:00-10:30 重播"来自中国不断发展中的药物洗脱支架数据：中国Cypher Select注册登记研究的最终结果" -(18:00-19:30, 2006-4-6, 2号厅)

全国性Cypher Select雷帕霉素药物洗脱支架注册登记研究最终临床和造影结果 - 高润霖

中国Cypher Select注册登记研究分叉病变亚组分析 - 吕树铮

中国Cypher Select注册登记研究糖尿病亚组分析 - 陈纪林

中国Cypher Select注册登记研究小血管病变亚组分析 - 陈君柱

中国Cypher Select注册登记研究完全闭塞病变亚组分析 - 韩雅玲

10:30-12:00 重播"手术转播-香港伊丽莎白女王医院" - (15:00-16:30, 2006-4-6, 17号厅)

13:30-15:00 重播"Endeavor药物洗脱支架前景展望" - (18:00-19:30, 2006-4-6, 17号厅)

Endeavor植入后血管内超声结果－安全性方面 - Peter Fitzgerald

Endeavor临床最新进展－有效性方面 - Spencer B. King III

药物洗脱支架前景展望 - 葛均波

15:00-16:30 重播"手术转播-上海瑞金医院"- (16:30-18:00, 2006-4-6, 2号厅)

16:30-18:00 重播"手术转播-纽约长老会医院 / 哥伦比亚大学医疗中心"- (8:00-9:30, 2006-4-7, 1号厅)


20:00-21:30 重播"TCT at CIT" - (9:30-11:00,2006-4-7, 1号厅)

TCT"交叉火力"：血管介入治疗的未来 - Martin B. Leon, Gregg W.Stone

经皮主动脉瓣治疗 - Eberhard Grube再谈药物洗脱支架：当前的局限性和未来的平台 - Jeffrey W. Moses

创伤性易损斑块检测：VH、OCT及更远 - Gary S. Mintz

21:30-22:30 重播"大会2-特邀报告"- (11:00-12:00, 2006-4-7, 1号厅)

心脏介入医师能力的培训和保持：美国模式 - Spencer B. King III

第二代药物洗脱支架：继而是什么？ - Mitchell W. Krucoff

肥厚心肌病：导管还是手术？- Ulrich Sigwart

22:30-24:00 重播"EuroPCR at CIT" - (15:00-16:30, 2006-4-7, 1号厅)

在经皮冠脉介入治疗前怎样准备高危病人（药物环境）？- Franz-J osef Neumann

卵圆孔未闭和房间隔缺损封堵：当代最新观点 - Eric Eeckhout

多支血管病变经皮冠脉介入和搭桥手术对比：当代最新观点 - Pat rick W. Serruys

颈动脉支架术：当代最新观点 - Giancarlo Biamino

CIT电视台节目单

unko Honye

100

电视台节目单



07:30-09:00 重播"手术转播-阜外心血管病医院" - (13:30-15:00, 2006-4-7,1号厅)

09:00-10:30 重播"掌握在手,自由在心 - 第一个第二代药物洗脱支架TAXUS Liberte" - (18:00-19:30, 2006-4-7, 2号厅)

迎接挑战: 复杂PCI治疗新技术,新策略 - Ant onio Colombo

无以伦比的通过性: TAXUS Liberte支架平台技术 - 韩雅玲

循证医学在PCI的实践 : TAXUS临床试验进展 - 杨跃进

10:30-12:00 重播"手术转播-图卢兹巴斯德医院" - (16:30-18:00, 2006-4-7, 1号厅)

13:30-15:00 重播 "国际生物降解药物洗脱支架研讨会 "

- (18:00-19:30, 2006-4-7, 17号厅 )

第一个用于分叉病变治疗的药物洗脱支架Axxess Plus - Eberhard Grube

Excel药物洗脱支架的真实体验

- Teg uh Sant oso

我使用BioMat rix药物洗脱支架的真实体验 - Tian Hai Koh

对药物洗脱支架时代总的观点

- Pet er Fit zg erald

15:00-16:30 重播"手术转播-圣地亚哥Scripps纪念医院"

- (8:00-9:30, 2006-4-8, 1号厅)

16:30-18:00 重播"手术转播-阜外心血管病医院" - (10:30-12:00, 2006-4-8, 1号厅)


20:00-21:00 重播 "大会6 - 特邀报告 "

- (09:30-10:30, 2006-4-8, 1号厅)

心肌的抢救 - David Holmes, J r

药物洗脱支架：病理学 - Renu Virmani

无保护左主干支架术-复杂分叉病变的介入治疗 - Antonio Colombo

在当今支架年代治疗复杂病变的综合策略 - Henry K. Lui

21:00-23:00 重播 "冠脉介入基本教程2"

- (10:00-12:00, 2006-4-8, 2号厅)

冠脉介入治疗适应症：从临床实践到ESC指南2005 - 沈卫峰

如何决定完全或不完全血管重建术? - 朱国英

无保护左主干介入治疗：证据足够吗? - 韩雅玲

分叉病变介入治疗的理想策略 - 葛均波

PCI的抗栓治疗-指南与实践 - 李为民

PCI中的降脂治疗 - 高炜

急性心机梗死的再灌注治疗：从指南到实践 - 何奔

心肾功能不全患者的PCI - 周玉杰

23:00-00:10 重播"经桡动脉介入治疗俱乐部第一节" - (8:10-9:20, 2006-4-8, 2号厅)

手术转播-北京友谊医院

经皮冠脉介入治疗中的微创策略 - Mart ial Hamon

经桡动脉颈动脉和颅内动脉介入治疗 - Chiung -J en Wu



07:30-09:00 重播 "XIENCE精神：破茧化蝶 - 从Vis ion到X I E NC E "

- (18:00-19:30, 2006-4-8, 2号厅)

最好的裸支架：源于临床的使用经验 - Mit chell W. Krucof f

Xience V与其他药物支架的病理学比较 - Renu Virmani

新一代药物支架：Xience V和SPIRIT系列试验 - Pat rick W. Serruys

09:00-10:00 重播"手术转播-广东省心血管病研究所" - (13:30-14:30, 2006-4-8, 1号厅)

10:00-11:30 重播"循证医学：真实世界的火鸟 " - (18:00-19:30, 2006-4-8, 17号厅)

Firebird与Cypher、Taxus临床应用对比研究 - 乔树宾

全国性注册登记FIC研究30天结果 - 高润霖

拉丁美洲Firebird注册登记研究最初6个月随访结果 - Salvador Villablanca

国产雷帕霉素药物洗脱支架治疗冠心病一年临床随访 - 多中心注册研究 - 张奇

11:30-12:15 重播"手术转播-北京大学第一医院" - (15:00-15:45, 2006-4-8, 1号厅)

101

Acknowledgment 1

Chen Xiantang

Chen Yun

Cheng Daoxiao

Cui Li

Dong Jinping

Guo Yue

He Xiaohong

Hou Chunhua

Li Bo

Li Li

Lu Hui

Luo Huankun

Song Li

Wang Lei

Wang Lihui

Wang Wenjuan

Yang Tiecheng

Zhang Xiuyu

Zhao Gongyu

Zheng Qin

Zhu Yin

CIT organization is a year round effort. Many people play a part in its success by contributing their experience and expertise. The Chinese Society of Cardiology wishes to give special thanks to all those

people who work tirelessly and with great dedication to our mission.

Acknowledgement ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

102

Acknowledgment 2

AstraZenecaAT&M

Bayer Healthcare Co. Ltd.B.Braun

Beijing KelidaBeijing Lepu Medical Device, Inc.Beijing Synex Medical Co., Ltd.

Biosensors InternationalBiotronik

Boston Scientific CorporationCordis/Johnson&Johnson Medical (China) Ltd.

GE HealthcareGreat Dragon Co.

Guidant International CorporationHuaren Medical

Invatec S.R.L.Medtronic China Ltd.

Merck ChinaMicroPort Medical (Shanghai) Co., Ltd.

MSDMVP Medical (China) Co., Ltd.

OrbusNeichPacific Medical

PfizerPhilips

Sahajanand Medical Technologies Pvt. Ltd.Sankyo

Sanofi-AventisSherring

ShimadzuSiemens

Singapore LIVEStar Progress

St. Jude MedicalTerumo

TycoVictech Scientific

Chinese Society of Cardiology wishes to give thanks to the following companies for their participation and support to this Congress:

103

The Organizing Committee wishes to thank the following companies forsponsoring the following Congress services

Sponsored Services

Congress Website & Daily Newsletter Cooperator

Name Badge

Pens & Notebooks

Faculty Dinner

Registration Area

104

Acknowledgement 鸣谢

Diamond Sponsors

Gold Sponsors

Platinum Sponsors

Silver Sponsors

Bronze Sponsors

105

6 0 2 T I C s c i t Final Program u e p a r e h T l a n o i t n e v r e t n …1).pdf · 2017. 5. 2. · Xiaocheng Liu, MD Yili Liu, MD Yuqing Liu, MD Zaiying Lu, MD Fanchao Meng,

Documents